89-57-6 | 5-Aminosalicylic acid

Packsize	Purity	Availability	Price	Discounted Price
50mg	98%	in stock	$6.00	$4.00
5g	98%	in stock	$7.00	$5.00
10g	98%	in stock	$10.00	$7.00
25g	98%	in stock	$14.00	$10.00
100g	98%	in stock	$37.00	$26.00
500g	98%	in stock	$84.00	$59.00

Description

• Catalog Number: AB68809
• Chemical Name: 5-Aminosalicylic acid
• CAS Number: 89-57-6
• Molecular Formula: C7H7NO3
• Molecular Weight: 153.1354
• MDL Number: MFCD00007877
• SMILES: Nc1ccc(c(c1)C(=O)O)O

Computed Properties

• Complexity: 160
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 1
• XLogP3: 1.3

Literature

• Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats.

  Chemico-biological interactions 20180601

• Ziziphus spina-christi fruit extract suppresses oxidative stress and p38 MAPK expression in ulcerative colitis in rats via induction of Nrf2 and HO-1 expression.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20180501

• Anti-inflammatory protection afforded by cyanidin-3-glucoside and resveratrol in human intestinal cells via Nrf2 and PPAR-γ: Comparison with 5-aminosalicylic acid.

  Chemico-biological interactions 20161225

• Allicin alleviates inflammation of trinitrobenzenesulfonic acid-induced rats and suppresses P38 and JNK pathways in Caco-2 cells.

  Mediators of inflammation 20150101

• Intervention effects of QRZSLXF, a Chinese medicinal herb recipe, on the DOR-β-arrestin1-Bcl2 signal transduction pathway in a rat model of ulcerative colitis.

  Journal of ethnopharmacology 20140528

• Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice.

  Naunyn-Schmiedeberg's archives of pharmacology 20140101

• Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.

  PloS one 20130101

• Azo dye removal in a membrane-free up-flow biocatalyzed electrolysis reactor coupled with an aerobic bio-contact oxidation reactor.

  Journal of hazardous materials 20121115

• High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: results of a meta-analysis of clinical trials.

  Inflammatory bowel diseases 20121101

• Comparison of the effect of mesalazine and sulfasalazine on laboratory parameters: a retrospective observational study.

  European journal of clinical pharmacology 20121101

• Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.

  Gastroenterology 20121101

• 4-Oxo-1,4-dihydropyridines as selective CB₂ cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis.

  Journal of medicinal chemistry 20121025

• Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20121017

• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20121017

• Curcumin for maintenance of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20121017

• Enhanced anti-influenza agents conjugated with anti-inflammatory activity.

  Journal of medicinal chemistry 20121011

• Mesalazine as a new therapeutic option for chronic idiopathic urticaria.

  The Journal of dermatological treatment 20121001

• Analysis of current treatments used in clinical practice in a pediatric summer camp population for children with inflammatory bowel disease.

  Inflammatory bowel diseases 20121001

• One-year investigator-blind randomized multicenter trial comparing Asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis.

  Inflammatory bowel diseases 20121001

• Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.

  Journal of Crohn's & colitis 20121001

• Cost utility of inflammation-targeted therapy for patients with ulcerative colitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20121001

• An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice.

  Gastroenterology 20121001

• Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.

  The American journal of gastroenterology 20121001

• Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.

  Scandinavian journal of gastroenterology 20121001

• Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare system.

  Alimentary pharmacology & therapeutics 20121001

• Electromembrane extraction of zwitterionic compounds as acid or base: comparison of extraction behavior at acidic and basic pHs.

  Analytica chimica acta 20121001

• The gut barrier: new acquisitions and therapeutic approaches.

  Journal of clinical gastroenterology 20121001

• Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review.

  Diseases of the colon and rectum 20121001

• Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitis.

  Expert opinion on pharmacotherapy 20121001

• The possible effects of mesalazine on the intestinal microbiota.

  Alimentary pharmacology & therapeutics 20121001

• Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20120912

• Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.

  Inflammatory bowel diseases 20120901

• Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics.

  Inflammatory bowel diseases 20120901

• Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity.

  Digestive diseases and sciences 20120901

• Effect of probiotics on serum bile acids in patients with ulcerative colitis.

  Hepato-gastroenterology 20120901

• 2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms.

  Clinical science (London, England : 1979) 20120901

• Systematic review of medical therapy to prevent recurrent diverticulitis.

  International journal of colorectal disease 20120901

• Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis.

  Inflammatory bowel diseases 20120901

• 5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations.

  The American journal of gastroenterology 20120901

• Budesonide use in pediatric Crohn disease.

  Journal of pediatric gastroenterology and nutrition 20120801

• Inflammatory bowel disease and lupus: a systematic review of the literature.

  Journal of Crohn's & colitis 20120801

• Fluorescence characteristics of 5-amino salicylic acid: An iodide recognition study.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120801

• Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120801

• An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series.

  Current clinical pharmacology 20120801

• The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.

  European journal of gastroenterology & hepatology 20120801

• Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.

  Alimentary pharmacology & therapeutics 20120801

• Commentary: impact of MMX mesalazine on health-related quality of life in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20120801

• The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands.

  The Netherlands journal of medicine 20120801

• Exploring novel colon-targeting antihistaminic prodrug for colitis.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120801

• [Rational treatment of ulcerative colitis--local or systemic therapy? Surgery?].

  MMW Fortschritte der Medizin 20120726

• Foam preparations for the treatment of ulcerative colitis.

  Current drug delivery 20120701

• Minilaparoscopy-assisted natural orifice total colectomy: technical report of a minilaparoscopy-assisted transrectal resection.

  Surgical endoscopy 20120701

• 'Ulcerative crepitus' -- a case with subcutaneous emphysema and pneumomediastinum without colonic perforation or toxic megacolon in ulcerative colitis successfully treated conservatively.

  Journal of Crohn's & colitis 20120701

• Prevention of postoperative recurrence of Crohn's disease.

  Journal of Crohn's & colitis 20120701

• Acute motor-sensory axonal neuropathy after cervical spine surgery.

  Journal of neurosurgery. Spine 20120701

• Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.

  The American journal of gastroenterology 20120701

• Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.

  Alimentary pharmacology & therapeutics 20120701

• [Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].

  Psychiatrische Praxis 20120701

• Combination of three metals for the treatment of cancer: gallium, rhenium and platinum. 1. Determination of the optimal schedule of treatment.

  Anticancer research 20120701

• E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.

  Danish medical journal 20120701

• Role of β2-adrenoceptor-β-arrestin2-nuclear factor-κB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis.

  Chinese journal of integrative medicine 20120701

• Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.

  Inflammatory bowel diseases 20120601

• Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study.

  Inflammatory bowel diseases 20120601

• Strategies in maintenance for patients receiving long-term therapy (SIMPLE): a study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis.

  Inflammatory bowel diseases 20120601

• Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.

  Journal of ethnopharmacology 20120601

• Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120601

• Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery.

  Colloids and surfaces. B, Biointerfaces 20120601

• Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120601

• Infliximab for early endoscopic recurrence in patients with Crohn's disease.

  Digestive diseases and sciences 20120601

• The impact of MMX mesalazine on disease-specific health-related quality of life in ulcerative colitis patients.

  Alimentary pharmacology & therapeutics 20120601

• Cytomegalovirus infection in patients with new onset ulcerative colitis: a prospective study.

  Hepato-gastroenterology 20120601

• Evidence-based management of ulcerative colitis.

  Minerva gastroenterologica e dietologica 20120601

• The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD.

  The American journal of gastroenterology 20120601

• Myocarditis due to mesalamine treatment in a patient with Crohn's disease in China.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20120601

• Higher apoptosis index and proliferation index in colonocytes of patients with ulcerative colitis in remission.

  Polski przeglad chirurgiczny 20120601

• Ulcerative colitis.

  BMJ (Clinical research ed.) 20120510

• Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120501

• Erythema induratum (nodular vasculitis) associated with Crohn's disease: a rare type of metastatic Crohn's disease.

  The American Journal of dermatopathology 20120501

• Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

  Digestive diseases and sciences 20120501

• Evaluation of fecal myeloperoxidase as a biomarker of disease activity and severity in ulcerative colitis.

  Digestive diseases and sciences 20120501

• Improvement of replication fidelity by certain mesalazine derivatives.

  International journal of oncology 20120501

• Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing.

  Journal of Crohn's & colitis 20120501

• Can oral 5-aminosalicylic acid be administered once daily in the treatment of mild-to-moderate ulcerative colitis? A meta-analysis of randomized-controlled trials.

  European journal of gastroenterology & hepatology 20120501

• Synthesis and characterization of novel dual-responsive nanogels and their application as drug delivery systems.

  Nanoscale 20120421

• [The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].

  Orvosi hetilap 20120408

• Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.

  Internal and emergency medicine 20120401

• Medical treatment of colonic diverticular disease: are we sure the aim is right?

  Internal and emergency medicine 20120401

• Setting a high threshold for noninferiority: mesalamine and budesonide in Crohn's disease.

  Inflammatory bowel diseases 20120401

• Baicalin down-regulates the expression of macrophage migration inhibitory factor (MIF) effectively for rats with ulcerative colitis.

  Phytotherapy research : PTR 20120401

• Nephrotic syndrome and Moya-moya syndrome in a patient with ulcerative colitis.

  Inflammatory bowel diseases 20120401

• Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).

  Gut 20120401

• Recent advances in understanding ulcerative colitis.

  Internal and emergency medicine 20120401

• Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.

  The American journal of gastroenterology 20120401

• Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.

  Journal of Crohn's & colitis 20120401

• Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.

  Journal of Crohn's & colitis 20120401

• Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis.

  Journal of digestive diseases 20120401

• 5-aminosalicylic acid mediates expression of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase to suppress colorectal tumorigenesis.

  Anticancer research 20120401

• Long-term follow-up of ulcerative colitis in Taiwan.

  Journal of the Chinese Medical Association : JCMA 20120401

• Marine bioactives: pharmacological properties and potential applications against inflammatory diseases.

  Marine drugs 20120401

• [Depression and risk factors in patients with Crohn's disease].

  Journal of Korean Academy of Nursing 20120401

• An infant with severe refractory Crohn's disease and homozygous MEFV mutation who dramatically responded to colchicine.

  Rheumatology international 20120301

• Inflammatory bowel disease characteristics in Hispanic children in Texas.

  Inflammatory bowel diseases 20120301

• Eukaryotic extracellular catalase-peroxidase from Magnaporthe grisea - Biophysical/chemical characterization of the first representative from a novel phytopathogenic KatG group.

  Biochimie 20120301

• Correlation of MMP-3 and MMP-9 with Crohn's disease activity in children.

  Digestive diseases and sciences 20120301

• Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120301

• Influence of some formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres.

  AAPS PharmSciTech 20120301

• MPA: a treatment option for lymphocytic colitis and mesalamine-induced interstitial nephritis.

  Inflammatory bowel diseases 20120301

• Identification of phthalates in medications and dietary supplement formulations in the United States and Canada.

  Environmental health perspectives 20120301

• The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway.

  Carcinogenesis 20120301

• Novel prodrugs for the treatment of colonic diseases based on 5-aminosalicylic acid, 4'-geranyloxyferulic acid, and auraptene: biological activities and analytical assays.

  Current drug delivery 20120301

• Chitosan films: crosslinking with EDTA modifies physicochemical and mechanical properties.

  Journal of materials science. Materials in medicine 20120301

• Drugs for inflammatory bowel disease.

  Treatment guidelines from the Medical Letter 20120301

• 5-aminosalicylates to prevent relapse of Crohn's disease after surgery.

  The American journal of gastroenterology 20120301

• Mesalamine in the treatment and maintenance of remission of ulcerative colitis.

  Expert review of clinical pharmacology 20120301

• Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy.

  Inflammatory bowel diseases 20120201

• Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.

  Gut 20120201

• The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis.

  British journal of pharmacology 20120201

• Review of current classifications for diverticular disease and a translation into clinical practice.

  International journal of colorectal disease 20120201

• Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.

  Digestive diseases and sciences 20120201

• Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.

  Gut 20120201

• Preparation of a composite fibrous membrane loaded with mesalazine and metronidazole by interlaced electrospinning.

  Molecular medicine reports 20120201

• Solitary rectal ulcer syndrome in children and adolescents.

  Journal of pediatric gastroenterology and nutrition 20120201

• Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.

  The American journal of gastroenterology 20120201

• Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.

  Alimentary pharmacology & therapeutics 20120201

• Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis.

  European journal of medicinal chemistry 20120201

• Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome.

  Journal of autoimmunity 20120201

• Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.

  The American journal of gastroenterology 20120201

• The pharmacological profile and clinical use of mesalazine (5-aminosalicylic acid).

  Arzneimittel-Forschung 20120201

• An unusual presentation of inflammatory bowel disease.

  Military medicine 20120201

• [Guidelines for the management of ulcerative colitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20120201

• [Guidelines for the management of Crohn's disease].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20120201

• [Aplastic anemia complicated with ulcerative colitis].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20120201

• Pseudomembranous collagenous colitis.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20120201

• [Clinical study of comprehensive treatment of Chinese medicine in treating ulcerative colitis based on two steps according to the stage of disease].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20120201

• Intensity of proliferative processes and degree of oxidative stress in the mucosa of the ileum in Crohn's disease.

  Bulletin of experimental biology and medicine 20120201

• Adsorption of phenolic compounds from aqueous solution using salicylic acid type adsorbent.

  Journal of hazardous materials 20120130

• Optimisation and scale-up of a highly-loaded 5-ASA multi-particulate dosage form using a factorial approach.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120123

• Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.

  Pharmaceutical development and technology 20120101

• Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.

  Pharmaceutical development and technology 20120101

• Interactions of salicylic acid derivatives with calcite crystals.

  Journal of colloid and interface science 20120101

• Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease.

  European journal of gastroenterology & hepatology 20120101

• Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.

  The patient 20120101

• Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.

  Reumatologia clinica 20120101

• Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.

  Digestive diseases and sciences 20120101

• Are mesalazine granules superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis?

  Alimentary pharmacology & therapeutics 20120101

• The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes.

  Journal of oncology 20120101

• Long term follow-up of appendiceal and distal right-sided colonic inflammation.

  Endoscopy 20120101

• Vitamins A & D inhibit the growth of mycobacteria in radiometric culture.

  PloS one 20120101

• Herbal medicine in the treatment of ulcerative colitis.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20120101

• Novel treatments for metastatic cutaneous melanoma and the management of emergent toxicities.

  Clinical Medicine Insights. Oncology 20120101

• Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease.

  Journal of clinical gastroenterology 20120101

• Evaluation of phenolic contents and antioxidant activity of various solvent extracts of Sonchus asper (L.) Hill.

  Chemistry Central journal 20120101

• Difficulties in taking aminosalicylates for patients with ulcerative colitis.

  Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20120101

• Lactulose: an effective preventive and therapeutic option for ischemic stroke by production of hydrogen.

  Medical gas research 20120101

• Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.

  International journal of nanomedicine 20120101

• Skin manifestations of inflammatory bowel disease.

  Frontiers in physiology 20120101

• Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine.

  Nanoscale research letters 20120101

• Hemagglutinin from the H5N1 virus activates Janus kinase 3 to dysregulate innate immunity.

  PloS one 20120101

• Chemical composition and antioxidant activities of Broussonetia papyrifera fruits.

  PloS one 20120101

• Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice.

  PloS one 20120101

• DNA Damage Protecting Activity and Free Radical Scavenging Activity of Anthocyanins from Red Sorghum (Sorghum bicolor) Bran.

  Biotechnology research international 20120101

• Modulation of ion transport across rat distal colon by cysteine.

  Frontiers in physiology 20120101

• 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging.

  PloS one 20120101

• Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery.

  PloS one 20120101

• The epigenetic effects of butyrate: potential therapeutic implications for clinical practice.

  Clinical epigenetics 20120101

• Fibrillary glomerulonephritis associated with Behçet's syndrome.

  Renal failure 20120101

• Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.

  Medical gas research 20120101

• Variation of chemical composition of essential oils in wild populations of Thymus algeriensis Boiss. et Reut., a North African endemic species.

  Lipids in health and disease 20120101

• The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course.

  PPAR research 20120101

• Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.

  Internal medicine (Tokyo, Japan) 20120101

• The valuable role of endoscopy in inflammatory bowel disease.

  Diagnostic and therapeutic endoscopy 20120101

• Liver disorders in inflammatory bowel disease.

  Gastroenterology research and practice 20120101

• Simultaneous determination of some antiprotozoal drugs in different combined dosage forms by mean centering of ratio spectra and multivariate calibration with model updating methods.

  Chemistry Central journal 20120101

• Systems analysis of inflammatory bowel disease based on comprehensive gene information.

  BMC medical genetics 20120101

• Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for 'Gibsons' Conundrum'.

  International journal of inflammation 20120101

• Network-based gene expression biomarkers for cold and heat patterns of rheumatoid arthritis in traditional chinese medicine.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Occupational asthma: new low-molecular-weight causal agents, 2000-2010.

  Journal of allergy 20120101

• Metabolomic applications to decipher gut microbial metabolic influence in health and disease.

  Frontiers in physiology 20120101

• Biomarkers in diverticular diseases of the colon.

  Digestive diseases (Basel, Switzerland) 20120101

• Aminosalicylates.

  Digestive diseases (Basel, Switzerland) 20120101

• [Treatment strategy for refractory inflammatory bowel disease to improve endoscopic lesions and long-term prognosis].

  Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 20120101

• Development and evaluation of a novel pellet-based tablet system for potential colon delivery of budesonide.

  Journal of drug delivery 20120101

• Intestinal inflammation responds to microbial tissue load independent of pathogen/non-pathogen discrimination.

  PloS one 20120101

• Unilateral hemiparesis with thoracic epidural in an adolescent.

  Case reports in anesthesiology 20120101

• Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA.

  PloS one 20120101

• Ultrasonographic evaluation of bowel wall thickness and intramural blood flow in ulcerative colitis.

  ISRN gastroenterology 20120101

• Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.

  PloS one 20120101

• Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.

  Mediators of inflammation 20120101

• Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Protein-losing enteropathy in ulcerative colitis.

  Case reports in gastroenterology 20120101

• Acute pancreatitis induced by methimazole therapy.

  Case reports in gastroenterology 20120101

• Successful treatment of primary sclerosing cholangitis with a steroid and a probiotic.

  Case reports in gastroenterology 20120101

• Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells.

  PloS one 20120101

• Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.

  Hepato-gastroenterology 20120101

• NFκB and AP-1 drive human myometrial IL8 expression.

  Mediators of inflammation 20120101

• Think small: zebrafish as a model system of human pathology.

  Journal of biomedicine & biotechnology 20120101

• Colorectal cancer chemoprevention by mesalazine and its derivatives.

  Journal of biomedicine & biotechnology 20120101

• A novel preparation method for 5-aminosalicylic acid loaded Eudragit S100 nanoparticles.

  International journal of molecular sciences 20120101

• Infliximab- and immunosuppressant-resistant Crohn's disease successfully treated with adsorptive granulocyte apheresis combined with prednisolone.

  Case reports in gastroenterology 20120101

• [Long-term therapy of idiopathic inflammatory bowel disease].

  Casopis lekaru ceskych 20120101

• Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.

  International journal of biomaterials 20120101

• [Inflammatory bowel diseases in the XXI century].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20120101

• A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn's disease.

  BMC nephrology 20120101

• Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine.

  Clinical pharmacology : advances and applications 20120101

• A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years.

  Internal medicine (Tokyo, Japan) 20120101

• The effect of bifid triple viable on immune function of patients with ulcerative colitis.

  Gastroenterology research and practice 20120101

• Trends in early outpatient drug therapy in pediatric inflammatory bowel disease in Finland: a nationwide register-based study in 1999-2009.

  ISRN gastroenterology 20120101

• [Optimization of cell therapy in patients with inflammatory bowel diseases].

  Terapevticheskii arkhiv 20120101

• Topical therapies in inflammatory bowel disease.

  Digestion 20120101

• Characteristics of inflammatory bowel disease in three tertiary health centers in southern Nigeria.

  West African journal of medicine 20120101

• Microscopic colitis - a missed diagnosis in diarrhea-predominant irritable bowel syndrome.

  Maedica 20120101

• Two cases of diffuse duodenitis associated with ulcerative colitis.

  Case reports in gastrointestinal medicine 20120101

• A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease.

  Archives of medical science : AMS 20111231

• Layered lipid microcapsules for mesalazine delayed-release in children.

  International journal of pharmaceutics 20111215

• Diagnosis and management of Crohn's disease.

  American family physician 20111215

• [FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].

  MMW Fortschritte der Medizin 20111208

• Probiotics for maintenance of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20111207

• Synthesis of mutual azo prodrugs of anti-inflammatory agents and peptides facilitated by α-aminoisobutyric acid.

  The Journal of organic chemistry 20111202

• Changes in immunohistochemical levels and subcellular localization after therapy and correlation and colocalization with CD68 suggest a pathogenetic role of Hsp60 in ulcerative colitis.

  Applied immunohistochemistry & molecular morphology : AIMM 20111201

• Drug development in inflammatory bowel disease: the role of the FDA.

  Inflammatory bowel diseases 20111201

• [Crohn's disease presenting with erythema nodosum as an early sign: a case report].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201

• Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database.

  Digestive diseases and sciences 20111201

• Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.

  The American journal of gastroenterology 20111201

• Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.

  AAPS PharmSciTech 20111201

• Effect of enteral nutrition on dextran sulfate sodium-induced colitis in rats.

  Journal of digestive diseases 20111201

• Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.

  Danish medical bulletin 20111201

• Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice.

  Journal of gastrointestinal and liver diseases : JGLD 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Annular leukocytoclastic vasculitis in a patient with ulcerative colitis.

  Annals of dermatology 20111201

• Abstracts of the 6th cachexia conference, milan, Italy, december 8-10, 2011.

  Journal of cachexia, sarcopenia and muscle 20111201

• A novel oral colon-targeting drug delivery system based on resistant starch acetate.

  Journal of controlled release : official journal of the Controlled Release Society 20111130

• Synthesis of pro-prodrugs L-lysine based for 5-aminosalicylic acid and 6-mercaptopurine colon specific release.

  International journal of pharmaceutics 20111128

• [Topical therapy of ulcerative colitis].

  Praxis 20111116

• Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.

  Inflammatory bowel diseases 20111101

• Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.

  Digestive diseases and sciences 20111101

• Interaction between Eudragit® E100 and anionic drugs: addition of anionic polyelectrolytes and their influence on drug release performance.

  Journal of pharmaceutical sciences 20111101

• Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis.

  Journal of pediatric gastroenterology and nutrition 20111101

• On the cost-effectiveness of the use of probiotics in inflammatory bowel disease.

  Journal of pediatric gastroenterology and nutrition 20111101

• Inflammatory bowel disease of the elderly: frequently asked questions (FAQs).

  The American journal of gastroenterology 20111101

• Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use.

  Rheumatology (Oxford, England) 20111101

• Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis.

  Alimentary pharmacology & therapeutics 20111101

• Novel natural product-based cinnamates and their thio and thiono analogs as potent inhibitors of cell adhesion molecules on human endothelial cells.

  European journal of medicinal chemistry 20111101

• Medical management of Crohn's disease.

  Expert opinion on pharmacotherapy 20111101

• Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies.

  Therapeutic advances in gastroenterology 20111101

• [A case of lung injury induced by long-term administration of mesalazine].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20111101

• [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].

  Kekkaku : [Tuberculosis] 20111101

• [Effect of Pulsatilla Decoction on the expression of proinflammatory cytokines in inflammatory bowel disease].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20111101

• Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy.

  European journal of histochemistry : EJH 20111019

• Inhibition of xc⁻ transporter-mediated cystine uptake by sulfasalazine analogs.

  Bioorganic & medicinal chemistry letters 20111015

• Beneficial effects of THSG on acetic acid-induced experimental colitis: involvement of upregulation of PPAR-γ and inhibition of the Nf-Κb inflammatory pathway.

  Molecules (Basel, Switzerland) 20111012

• Effects of recombinant human intestinal trefoil factor on trinitrobenzene sulphonic acid induced colitis in rats.

  Molecular biology reports 20111001

• Non-coated multiparticulate matrix systems for colon targeting.

  Drug development and industrial pharmacy 20111001

• Individually tailored treatment of medication nonadherence.

  Journal of pediatric gastroenterology and nutrition 20111001

• [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].

  Gastroenterologia y hepatologia 20111001

• Mesalazine-induced bronchiolitis obliterans organizing pneumonia (BOOP) in a patient with ulcerative colitis and primary sclerosing cholangitis.

  Inflammatory bowel diseases 20111001

• Update on the management of ulcerative colitis.

  Current gastroenterology reports 20111001

• Update on the management of Crohn's disease.

  Current gastroenterology reports 20111001

• Silent ulcerative colitis adjacent to a regular sigmoid adenocarcinoma.

  European journal of gastroenterology & hepatology 20111001

• 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.

  Molecular cancer therapeutics 20111001

• Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.

  Alimentary pharmacology & therapeutics 20111001

• Inaccuracies concerning Salofalk granules.

  Alimentary pharmacology & therapeutics 20111001

• Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.

  Diseases of the colon and rectum 20111001

• Questions about mesalazine and the irritable bowel syndrome.

  Alimentary pharmacology & therapeutics 20111001

• Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.

  Journal of Crohn's & colitis 20111001

• Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.

  Journal of Crohn's & colitis 20111001

• In-vitro dissolution testing of 5-aminosalicylic acid release from pH dependent mesalazine formulations.

  Journal of Crohn's & colitis 20111001

• Successful treatment of pediatric immune thrombocytopenic purpura associated with ulcerative colitis.

  Pediatrics international : official journal of the Japan Pediatric Society 20111001

• Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.

  The American journal of gastroenterology 20111001

• Adrenomedulline improves ischemic left colonic anastomotic healing in an experimental rodent model.

  Clinics (Sao Paulo, Brazil) 20111001

• Avascular necrosis of the knees and ulcerative colitis.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20111001

• The immune system in irritable bowel syndrome.

  Journal of neurogastroenterology and motility 20111001

• Regulation of inflammation by short chain fatty acids.

  Nutrients 20111001

• N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.

  International journal of pharmaceutics 20110915

• Efficient removal of heavy metal ions from aqueous solution using salicylic acid type chelate adsorbent.

  Journal of hazardous materials 20110915

• The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis.

  Digestive diseases and sciences 20110901

• Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease.

  Drug development and industrial pharmacy 20110901

• Is 5-ASA still the treatment of choice for ulcerative colitis?

  Current drug targets 20110901

• Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.

  Minerva gastroenterologica e dietologica 20110901

• Pharmacotherapy for acute pouchitis.

  The Annals of pharmacotherapy 20110901

• Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial.

  Inflammatory bowel diseases 20110901

• Genes of intestinal Escherichia coli and their relation to the inflammatory activity in patients with ulcerative colitis and Crohn's disease.

  Folia microbiologica 20110901

• Role of 5-aminosalicylate in preventing colorectal cancer.

  The American journal of gastroenterology 20110901

• Mesalazine. Now authorised for children, but no suitable form.

  Prescrire international 20110901

• 5-[(E)-(2-Fluoro-benzyl-idene)amino]-2-hy-droxy-benzoic acid.

  Acta crystallographica. Section E, Structure reports online 20110901

• [5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review].

  Ugeskrift for laeger 20110829

• Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.

  World journal of gastroenterology 20110814

• Concentration dependence of 5-aminosalicylic acid pharmacological actions in intestinal mucosa after oral administration of a pH-dependent formulation.

  Molecular pharmaceutics 20110801

• Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients.

  Inflammatory bowel diseases 20110801

• Pulmonary nodules as respiratory manifestation of inflammatory bowel disease: case report and review.

  Inflammatory bowel diseases 20110801

• Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome.

  Alimentary pharmacology & therapeutics 20110801

• Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.

  Journal of Crohn's & colitis 20110801

• Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.

  Inflammatory bowel diseases 20110801

• [A case of ulcerative colitis accompanied with myelodysplastic syndrome successfully treated by cyclosporine].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110801

• Treatment of Crohn's disease with cannabis: an observational study.

  The Israel Medical Association journal : IMAJ 20110801

• Is conservative treatment with antibiotics the correct strategy for management of right colonic diverticulitis?: a prospective study.

  Journal of the Korean Society of Coloproctology 20110801

• Current treatment of ulcerative colitis.

  World journal of gastroenterology 20110721

• Risk of postoperative recurrence and postoperative management of Crohn's disease.

  World journal of gastroenterology 20110721

• An unusual case of mesalazine intoxication: oral and rectal overloading of the rectal suppository form.

  Human & experimental toxicology 20110701

• Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis.

  Human pathology 20110701

• Inflammatory bowel disease therapy: current state-of-the-art.

  Current opinion in gastroenterology 20110701

• Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome.

  Alimentary pharmacology & therapeutics 20110701

• The causes of finger clubbing: a list worth learning.

  The American journal of medicine 20110701

• Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease.

  Therapeutic advances in gastroenterology 20110701

• [Pharmacotherapy in patients with ulcerative colitis].

  Zeitschrift fur Gastroenterologie 20110701

• [Two cases of drug-induced intrathoracic lesions caused by mesalazine in patients with ulcerative colitis].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20110701

• Cases of cryptosporidiosis co-infections in AIDS patients: a correlation between clinical presentation and GP60 subgenotype lineages from aged formalin-fixed stool samples.

  Annals of tropical medicine and parasitology 20110701

• Cα-C bond cleavage of the peptide backbone in MALDI in-source decay using salicylic acid derivative matrices.

  Journal of the American Society for Mass Spectrometry 20110701

• New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.

  Bioorganic & medicinal chemistry 20110615

• Mechanism of regulation of Na-H exchanger in inflammatory bowel disease: role of TLR-4 signaling mechanism.

  Digestive diseases and sciences 20110601

• Current concepts in the treatment of epidermolysis bullosa acquisita.

  Expert opinion on pharmacotherapy 20110601

• Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake.

  Drug metabolism and disposition: the biological fate of chemicals 20110601

• A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis.

  Nature chemical biology 20110601

• Endoscopic mucosal healing in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20110601

• Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids.

  Journal of Crohn's & colitis 20110601

• Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.

  Journal of Crohn's & colitis 20110601

• Clinical course of microscopic colitis in a single-center cohort study.

  Journal of Crohn's & colitis 20110601

• Eosinophilic-Crohn overlap colitis and review of the literature.

  Journal of Crohn's & colitis 20110601

• Autologous haematopoietic stem cell transplantation in a patient with refractory Crohn's disease.

  Journal of Crohn's & colitis 20110601

• Curcumin for inflammatory bowel disease: a review of human studies.

  Alternative medicine review : a journal of clinical therapeutic 20110601

• Alterations in the pulmonary function tests of inflammatory bowel diseases.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20110601

• Clinical Characteristics of Microscopic Colitis in Korea: Prospective Multicenter Study by KASID.

  Gut and liver 20110601

• Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20110601

• Gut microbiota and inflammation.

  Nutrients 20110601

• An oral colon-targeting controlled release system based on resistant starch acetate: synthetization, characterization, and preparation of film-coating pellets.

  Journal of agricultural and food chemistry 20110525

• Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

  PLoS currents 20110515

• The neutrophil respiratory burst and bacterial digestion in Crohn's disease.

  Digestive diseases and sciences 20110501

• Six ulcerative colitis patients with refractory symptoms co-infective with Blastocystis hominis in China.

  Parasitology research 20110501

• High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110501

• Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.

  The American journal of gastroenterology 20110501

• Further corroboration of the asthmagenicity of 5-aminosalicylic acid.

  Occupational and environmental medicine 20110501

• Cost effectiveness of treatments for inflammatory bowel disease.

  PharmacoEconomics 20110501

• Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.

  Gut 20110501

• Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20110501

• Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question.

  Alimentary pharmacology & therapeutics 20110501

• Intestinal inflammation and cancer.

  Gastroenterology 20110501

• Conventional medical management of inflammatory bowel disease.

  Gastroenterology 20110501

• Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research.

  Bioanalysis 20110501

• Trabectedin for the treatment of relapsed ovarian cancer.

  Health technology assessment (Winchester, England) 20110501

• Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice.

  Indian journal of experimental biology 20110501

• Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease. Are there predictors of response?

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20110501

• Leucocytoclastic vasculitis in severe ulcerative colitis.

  Military medicine 20110501

• Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's disease.

  Gastroenterology & hepatology 20110501

• Diaphragm disease and small bowel enteropathy due to nonsteroidal anti-inflammatory drugs: a surgical perspective.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20110401

• Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease.

  Inflammatory bowel diseases 20110401

• Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis.

  Digestive diseases and sciences 20110401

• Synthesis and in vitro evaluation of carboxymethyl starch-chitosan nanoparticles as drug delivery system to the colon.

  International journal of biological macromolecules 20110401

• 5-aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream.

  Digestive diseases and sciences 20110401

• Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.

  The American journal of gastroenterology 20110401

• A stomach carpeted red.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20110401

• Review article: remission rates achievable by current therapies for inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20110401

• 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.

  The American journal of gastroenterology 20110401

• Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.

  The American journal of gastroenterology 20110401

• Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.

  The American journal of gastroenterology 20110401

• The clinical implication of drug dependency in children and adults with inflammatory bowel disease: a review.

  Journal of Crohn's & colitis 20110401

• 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial.

  Journal of Crohn's & colitis 20110401

• Development of testicular germ cell cancer following successful infliximab induction therapy for ulcerative colitis.

  Journal of Crohn's & colitis 20110401

• Inflammatory bowel disease unclassified.

  Journal of Zhejiang University. Science. B 20110401

• [A case of fulminant ulcerative colitis initially presenting as fever of unknown origin].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20110401

• The prevention of colitis-related cancer by 5-aminosalicylates: an appealing hypothesis that remains unproven.

  The American journal of gastroenterology 20110401

• Nutritional supplementation and dietary restriction in the resolution of enthesitis-related arthritis.

  JRSM short reports 20110401

• Regulatory filing strategy for generic mesalazine modified release formulations.

  Indian journal of pharmacology 20110401

• Effect of 70-nm silica particles on the toxicity of acetaminophen, tetracycline, trazodone, and 5-aminosalicylic acid in mice.

  Die Pharmazie 20110401

• Irritable bowel syndrome - An inflammatory disease involving mast cells.

  Asia Pacific allergy 20110401

• Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines.

  Journal of pharmaceutical and biomedical analysis 20110325

• 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.

  The American journal of gastroenterology 20110301

• Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity.

  Expert opinion on drug safety 20110301

• Interaction of mesalasine (5-ASA) with translational initiation factors eIF4 partially explains 5-ASA anti-inflammatory and anti-neoplastic activities.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20110301

• Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.

  Alimentary pharmacology & therapeutics 20110301

• VSL#3 and remission in active ulcerative colitis: larger studies required.

  The American journal of gastroenterology 20110301

• Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease.

  Gut and liver 20110301

• Influence of Shenqing Recipe on morphology and quantity of colonic interstitial cells of Cajal in trinitrobenzene sulfonic acid induced rat colitis.

  Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20110301

• Induction of oxidative DNA damage by mesalamine in the presence of copper: a potential mechanism for mesalamine anticancer activity.

  Toxicology 20110227

• Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110215

• Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.

  Journal of drug targeting 20110201

• A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.

  Digestive diseases and sciences 20110201

• New desensitization regimen with mesalamine granules in a patient with ulcerative colitis and mesalamine intolerance.

  Inflammatory bowel diseases 20110201

• Corneal involvement in Crohn's disease: an in vivo confocal microscopy study.

  Cornea 20110201

• Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.

  Current gastroenterology reports 20110201

• Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.

  Gastroenterology 20110201

• Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20110201

• Prevalence of inflammatory bowel disease related dysplasia and cancer in 1500 colonoscopies from a referral center in northwestern Greece.

  Journal of Crohn's & colitis 20110201

• Impact of Clostridium difficile infection in patients with ulcerative colitis.

  Journal of Crohn's & colitis 20110201

• Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation.

  PLoS pathogens 20110201

• [Huangqin decoction lowers the number of mast cells in ulcerative colitis in rats with dampness and heat syndrome].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20110201

• IBD: Potential herbal alternative to mesalazine for ulcerative colitis.

  Nature reviews. Gastroenterology & hepatology 20110201

• [A multi-center randomized double-blinded, placebo-controlled clinical study on efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis of internal dampness-heat accumulation syndrome type].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20110201

• Warfarin-induced eosinophilic pleural effusion.

  Korean circulation journal 20110201

• Effect of fruit extract of Fragaria vesca L. on experimentally induced inflammatory bowel disease in albino rats.

  Indian journal of pharmacology 20110201

• [Molecular mechanisms involved in the treatment of inflammatory bowel disease by Pulsatilla decoction].

  Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20110201

• Probiotics in inflammatory bowel diseases and associated conditions.

  Nutrients 20110201

• MMX® Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis.

  Drugs 20110122

• Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

  The Cochrane database of systematic reviews 20110119

• Cutaneous lymphoproliferative disorder complicating infectious mononucleosis in an immunosuppressed patient.

  Pediatric dermatology 20110101

• Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.

  Journal of clinical gastroenterology 20110101

• Cardiobacterium hominis endocarditis presenting as acute embolic stroke: a case report and review of the literature.

  Heart & lung : the journal of critical care 20110101

• Small intestinal release mesalamine for the treatment of refractory celiac disease type I.

  Journal of clinical gastroenterology 20110101

• Clinical trial: Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study.

  Journal of gastroenterology 20110101

• Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Mesalamine for refractory celiac disease: an old medicine for a new disease.

  Journal of clinical gastroenterology 20110101

• In-vitro characterization of 5-aminosalicylic acid release from MMX mesalamine tablets and determination of tablet coating thickness.

  Advances in therapy 20110101

• Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine.

  Alimentary pharmacology & therapeutics 20110101

• Topical agents for idiopathic distal colitis and proctitis.

  Journal of gastroenterology and hepatology 20110101

• Crohn's disease: a surgeon's perspective.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• Possible role of early transabdominal ultrasound in patients undergoing cytapheresis for active ulcerative colitis.

  Internal medicine (Tokyo, Japan) 20110101

• IBD: Stress causes flares of IBD--how much evidence is enough?

  Nature reviews. Gastroenterology & hepatology 20110101

• Distribution of enteric glia and GDNF during gut inflammation.

  BMC gastroenterology 20110101

• Acute thrombosis of the superior mesenteric artery in a 39-year-old woman with protein-S deficiency: a case report.

  Journal of medical case reports 20110101

• Mesalazine-induced photosensitivity.

  European journal of dermatology : EJD 20110101

• Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands.

  BMC gastroenterology 20110101

• Differential patterns of histone acetylation in inflammatory bowel diseases.

  Journal of inflammation (London, England) 20110101

• Animal models of colitis-associated carcinogenesis.

  Journal of biomedicine & biotechnology 20110101

• Pharmacological and non-pharmacological interventions to influence adipose tissue function.

  Cardiovascular diabetology 20110101

• Bioprotective properties of Dragon's blood resin: in vitro evaluation of antioxidant activity and antimicrobial activity.

  BMC complementary and alternative medicine 20110101

• Efficacy of a symbiotic product during clinical relapse of ulcerative colitis.

  Journal of clinical gastroenterology 20110101

• The actin-bundling protein fascin is overexpressed in inflammatory bowel disease and may be important in tissue repair.

  BMC gastroenterology 20110101

• Brown adipose tissue in morbidly obese subjects.

  PloS one 20110101

• Colonic diverticular disease.

  BMJ clinical evidence 20110101

• Adalimumab - an effective and promising treatment for patients with fistulizing Crohn's disease: a case series.

  Journal of medical case reports 20110101

• Promising effect of infliximab on the extent of involvement in ulcerative colitis.

  Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110101

• Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine.

  Drug design, development and therapy 20110101

• [Inflammatory intestinal diseases. Part 2. Ulcerative colitis].

  Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec 20110101

• Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis.

  BMC gastroenterology 20110101

• The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

  Journal of carcinogenesis 20110101

• Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptor.

  PloS one 20110101

• Pyoderma vegetans associated with ulcerative colitis: a case with good response to steroids.

  Case reports in dermatology 20110101

• Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced inflammatory bowel disease.

  BMC complementary and alternative medicine 20110101

• Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine.

  Arquivos de gastroenterologia 20110101

• A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory bowel disease.

  Dermatology (Basel, Switzerland) 20110101

• A middle-aged woman with a persistent gastrointestinal bleed.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis.

  Current pharmaceutical design 20110101

• A complicated case of tacrolimus-induced rapid remission after cesarean section in the early third trimester for refractory severe ulcerative colitis flaring in the initial period of gestation.

  Case reports in gastroenterology 20110101

• Exacerbation of bloody diarrhea as a side effect of mesalamine treatment of active ulcerative colitis.

  Case reports in gastroenterology 20110101

• Proton Pump Inhibitors in the Management of Tachypnoea following Panproctocolectomy: A Case of High Output Ileostomy.

  Case reports in gastroenterology 20110101

• Current and emerging drugs for the treatment of inflammatory bowel disease.

  Drug design, development and therapy 20110101

• Long-term follow-up of nonspecific small bowel ulcers with a benign course and no requirement for surgery: is this a distinct group?

  BMC gastroenterology 20110101

• Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.

  PloS one 20110101

• Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases.

  BMC infectious diseases 20110101

• Spontaneous remission of Crohn's disease following a febrile infection: case report and literature review.

  BMC gastroenterology 20110101

• Low bone mass in microscopic colitis.

  BMC gastroenterology 20110101

• Glucose-6-phosphatase deficiency.

  Orphanet journal of rare diseases 20110101

• Novel study designs to investigate the placebo response.

  BMC medical research methodology 20110101

• An unusual cutaneous manifestation of Crohn's disease.

  Skinmed 20110101

• Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease.

  BMC genomics 20110101

• Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia.

  Clinical and experimental gastroenterology 20110101

• Mesalazine-induced psoriasis in patients with inflammatory bowel diseases.

  European journal of dermatology : EJD 20110101

• Prolate spheroidal hematite particles equatorially belt with drug-carrying layered double hydroxide disks: Ring Nebula-like nanocomposites.

  Nanoscale research letters 20110101

• Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine.

  BMC health services research 20110101

• Enzyme replacement therapy for pancreatic insufficiency: present and future.

  Clinical and experimental gastroenterology 20110101

• Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome.

  Clinical and experimental gastroenterology 20110101

• Ulcerative colitis after renal transplantation: A case report and review of literature.

  Indian journal of nephrology 20110101

• A case of Crohn's disease with improvement after azathioprine-induced pancytopenia.

  Case reports in gastroenterology 20110101

• Pyoderma gangrenosum: variation in clinical presentation at different ages.

  Indian journal of dermatology 20110101

• Mucosal healing of esophageal involvement of Crohn's disease with granulocyte/monocyte adsorption.

  Journal of clinical apheresis 20110101

• An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease.

  BMC gastroenterology 20110101

• Probiotics, nuclear receptor signaling, and anti-inflammatory pathways.

  Gastroenterology research and practice 20110101

• Anti-inflammatory effects of nicotine in obesity and ulcerative colitis.

  Journal of translational medicine 20110101

• Alopecia areata: a new treatment plan.

  Clinical, cosmetic and investigational dermatology 20110101

• Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine.

  PloS one 20110101

• BTZO-15, an ARE-activator, ameliorates DSS- and TNBS-induced colitis in rats.

  PloS one 20110101

• Treatment of inflammatory bowel disease (IBD).

  Pharmacological reports : PR 20110101

• Prerenal azotemia from excessive sweating in an adult with a cystic fibrosis gene mutation.

  Indian journal of nephrology 20110101

• Lessons Learnt from Post-Infectious IBS.

  Frontiers in physiology 20110101

• Dietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γ.

  PloS one 20110101

• Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year.

  Gastroenterology research and practice 20110101

• A Burkitt's Lymphoma Case Mimicking Crohn's Disease: A Case Report.

  Case reports in medicine 20110101

• Iridoid glycosides fraction of Folium syringae leaves modulates NF-κB signal pathway and intestinal epithelial cells apoptosis in experimental colitis.

  PloS one 20110101

• Eosinophilic enteritis confined to an ileostomy site.

  Case reports in gastroenterology 20110101

• Immunomodulators and immunosuppressants for Japanese patients with ulcerative colitis.

  ISRN gastroenterology 20110101

• Diagnosis and therapy of microscopic colitis with presence of foamy macrophages in children.

  ISRN gastroenterology 20110101

• Atypical mycobacterial infection presenting as persistent skin lesion in a patient with ulcerative colitis.

  Case reports in medicine 20110101

• A pilot study of transrectal endoscopic ultrasound elastography in inflammatory bowel disease.

  BMC gastroenterology 20110101

• New and emerging treatments for the prevention of recurrent diverticulitis.

  Clinical and experimental gastroenterology 20110101

• Protective effect of an aphrodisiac herb Tribulus terrestris Linn on cadmium-induced testicular damage.

  Indian journal of pharmacology 20110101

• Bone marrow cells in murine colitis: multi-signal analysis confirms pericryptal myofibroblast engraftment without epithelial involvement.

  PloS one 20110101

• Collagenous colitis: a retrospective survey of patients with chronic diarrhea.

  Hepato-gastroenterology 20110101

• Successful non-invasive treatment of stricturing fibrosing colonopathy in an adult patient.

  European journal of medical research 20110101

• Mucosal atrophy in collagenous colitis: a case report.

  BMC gastroenterology 20110101

• Identification and characterisation of an iron-responsive candidate probiotic.

  PloS one 20110101

• Capsule-endoscopic findings of ulcerative colitis patients.

  Digestion 20110101

• The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis.

  PloS one 20110101

• Prevalence of microscopic colitis in patients with chronic diarrhea in Egypt: a single-center study.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• Ulcerative colitis in infancy.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20110101

• Antioxidant properties of the edible Basidiomycete Armillaria mellea in submerged cultures.

  International journal of molecular sciences 20110101

• Acetaminophen: beyond pain and Fever-relieving.

  Frontiers in pharmacology 20110101

• Thorax as an extraintestinal target for inflammatory bowel disease.

  Tuberkuloz ve toraks 20110101

• Acute Pancreatitis due to pH-Dependent Mesalazine That Occurred in the Course of Ulcerative Colitis.

  Case reports in gastroenterology 20110101

• An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.

  International journal of clinical and experimental medicine 20110101

• Biologics in paediatric Crohn's disease.

  Gastroenterology research and practice 20110101

• Radiation proctitis: current strategies in management.

  Gastroenterology research and practice 20110101

• [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].

  Nederlands tijdschrift voor geneeskunde 20110101

• Absorption kinetics of 5-aminosalicylic acid in rat: influence of indomethacin-induced gastrointestinal lesions and Escherichia Coli Nissle 1917 medication.

  Neuro endocrinology letters 20110101

• Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

  BMC gastroenterology 20110101

• Identification of Eps15 as antigen recognized by the monoclonal antibodies aa2 and ab52 of the Wuerzburg Hybridoma Library against Drosophila brain.

  PloS one 20110101

• Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.

  Romanian journal of internal medicine = Revue roumaine de medecine interne 20110101

• [Secondary (AA) amyloidosis in Crohn's disease].

  Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20110101

• Catheter-Related Acremonium kiliense Fungemia in a Patient with Ulcerative Colitis under Treatment with Infliximab.

  Case reports in infectious diseases 20110101

• Guillain-Barré Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report.

  Case reports in infectious diseases 20110101

• Mesalamine-induced myocarditis and coronary vasculitis in a pediatric ulcerative colitis patient: a case report.

  Case reports in pediatrics 20110101

• Preparation and gamma scintigraphic evaluation of colon specific pellets of ketoprofen prepared by powder layering technology.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

• Comparison of physicomechanical properties of films prepared from organic solutions and aqueous dispersion of Eudragit RL.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

• Development of novel budesonide pellets based on CODES(TM) technology: In vitro/in vivo evaluation in induced colitis in rats.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

• [Quality of life in inflammatory bowel disease patients].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20110101

• Chitosan microspheres in novel drug delivery systems.

  Indian journal of pharmaceutical sciences 20110101

• Molecular nanofibers of olsalazine form supramolecular hydrogels for reductive release of an anti-inflammatory agent.

  Journal of the American Chemical Society 20101222

• Extrusion-spheronisation of highly loaded 5-ASA multiparticulate dosage forms.

  International journal of pharmaceutics 20101215

• Aminosalicylates for induction of remission or response in Crohn's disease.

  The Cochrane database of systematic reviews 20101208

• Mesalamine induced symptom exacerbation of ulcerative colitis: Case report and brief discussion.

  World journal of gastrointestinal pharmacology and therapeutics 20101206

• [Gastroenterology and hepatology. Using established therapies].

  MMW Fortschritte der Medizin 20101202

• Solitary rectal ulcer syndrome: a case series.

  Indian pediatrics 20101201

• Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.

  Gut 20101201

• Synthesis and characterization of chitosan hydrogels containing 5-aminosalicylic acid nanopendents for colon: specific drug delivery.

  Journal of pharmaceutical sciences 20101201

• Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.

  The Journal of pharmacology and experimental therapeutics 20101201

• Opportunistic streptococcal gastritis in a patient with ulcerative colitis mimicking gastric involvement by inflammatory bowel disease.

  Inflammatory bowel diseases 20101201

• Race and inflammatory bowel disease in an urban healthcare system.

  Digestive diseases and sciences 20101201

• Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.

  The Journal of pharmacy and pharmacology 20101201

• E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach.

  Gut 20101201

• [Study on novel colon position pulsatile capsule and its release in vitro].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20101201

• Diaqua-bis-{2-hy-droxy-5-[(pyridin-2-yl)methyl-idene-amino]-benzoato-κN,N'}zinc(II) dihydrate.

  Acta crystallographica. Section E, Structure reports online 20101201

• 2-Hy-droxy-5-[(E)-(1H-indol-3-yl-methyl-idene)aza-nium-yl]benzoate.

  Acta crystallographica. Section E, Structure reports online 20101201

• Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study.

  Patient education and counseling 20101101

• Ulcerative colitis in Madrid, Spain: current management.

  Inflammatory bowel diseases 20101101

• Thiopurine S-methyltransferase deficiency associated with a novel mutation.

  Inflammatory bowel diseases 20101101

• Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.

  Inflammatory bowel diseases 20101101

• Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

  Inflammatory bowel diseases 20101101

• The inflammatory bowel diseases and ambient air pollution: a novel association.

  The American journal of gastroenterology 20101101

• Clinical presentation and diagnosis of intestinal adenocarcinoma in Crohn's disease: analysis of clinical predictors and of the life-time risk.

  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 20101101

• Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system.

  Gastroenterology 20101101

• Dysplastic lesions in ulcerative colitis: changing paradigms.

  Inflammatory bowel diseases 20101101

• New advances in the understanding of the in-source decay fragmentation of peptides in MALDI-TOF-MS.

  Journal of the American Society for Mass Spectrometry 20101101

• Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents.

  Inflammatory bowel diseases 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Asacol®-induced neutropenia resolution without the use of granulocyte colony-stimulating factor.

  Southern medical journal 20101101

• Occupational asthma due to 5-aminosalicylic acid.

  Occupational and environmental medicine 20101101

• Reporting of relapse rates in a trial of mesalazine for ulcerative colitis.

  Alimentary pharmacology & therapeutics 20101101

• Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis.

  Journal of the American Academy of Nurse Practitioners 20101101

• Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain.

  Journal of Crohn's & colitis 20101101

• 5-aminosalicylic acid dependency in Crohn's disease: a Danish Crohn Colitis Database study.

  Journal of Crohn's & colitis 20101101

• A case of pyoderma gangrenosum with ulcerative colitis treated with mesalazine.

  Annals of dermatology 20101101

• 5-Chloro-2-hy-droxy-benzoic acid.

  Acta crystallographica. Section E, Structure reports online 20101101

• 5-[(E)-(2,6-Dichloro-benzyl-idene)amino]-2-hy-droxy-benzoic acid.

  Acta crystallographica. Section E, Structure reports online 20101101

• Oral budesonide for induction of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20101006

• Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.

  American journal of respiratory cell and molecular biology 20101001

• Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.

  Journal of pediatric psychology 20101001

• Incidence, severity, and etiology of drug-induced acute pancreatitis.

  Digestive diseases and sciences 20101001

• Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

  The American journal of gastroenterology 20101001

• Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis.

  Cardiovascular & hematological agents in medicinal chemistry 20101001

• Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101001

• Vaccinations in patients with immune-mediated inflammatory diseases.

  Rheumatology (Oxford, England) 20101001

• Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats.

  International journal of colorectal disease 20101001

• An unusual cause of rectal bleeding: intestinal myiasis.

  Journal of pediatric gastroenterology and nutrition 20101001

• Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial.

  Alimentary pharmacology & therapeutics 20101001

• [A case of inferior vena cava thrombosis and acute pancreatitis in a patient with ulcerative colitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20101001

• Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20101001

• [Pathogenetic mechanism of beta-arrestin1 in experimental colitis of rats and intervention effects of oxymatrine].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20101001

• Reversal of refractory sulfasalazine-related renal failure after treatment with corticosteroids.

  Clinical therapeutics 20101001

• Pulmonary manifestations of inflammatory bowel disease: case presentations and review.

  Journal of Crohn's & colitis 20101001

• Factors that modify therapy adherence in patients with inflammatory bowel disease.

  Journal of Crohn's & colitis 20101001

• Pseudomembranous colitis complicating ulcerative colitis.

  Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society 20101001

• 2-Hy-droxy-5-{[(E)-4-meth-oxy-benzyl-idene]aza-nium-yl}benzoate.

  Acta crystallographica. Section E, Structure reports online 20101001

• Bone marrow suppression in the setting of normal thiopurine methyltransferase phenotype testing.

  Clinical pediatrics 20100901

• Local immune regulation of mucosal inflammation by tacrolimus.

  Digestive diseases and sciences 20100901

• Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study.

  Inflammatory bowel diseases 20100901

• Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study.

  Inflammatory bowel diseases 20100901

• Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.

  Journal of drug targeting 20100901

• Recurrent pericarditis in a patient with ulcerative proctitis due to mesalazine suppositories.

  International journal of colorectal disease 20100901

• Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.

  Journal of clinical gastroenterology 20100901

• Recurrent ileostomy prolapse: is it a solved problem?

  Techniques in coloproctology 20100901

• New paradigms in the management of diverticular disease.

  Current problems in surgery 20100901

• Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease?

  FEMS microbiology letters 20100901

• Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.

  The American journal of gastroenterology 20100901

• The effect of chitosan as internal or external coating on the 5-ASA release from calcium alginate microparticles.

  AAPS PharmSciTech 20100901

• Amelioration of dextran sulfate sodium-induced chronic colitis by sulfasalazine salicylazosulfapyridine via reducing NF-kappaB transcription factor p65 recruitment to ICAM-1 gene promoters.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20100901

• [Remission of ulcerative colitis after appendectomy: a case report].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100901

• [Clinical study on electroacupuncture combined with acupoint sticking therapy for treatment of chronic ulcerative colitis].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20100901

• Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.

  Gastroenterology clinics of North America 20100901

• Medical treatment of uncomplicated diverticular disease of the colon: any progress?

  Minerva gastroenterologica e dietologica 20100901

• A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis.

  Journal of Crohn's & colitis 20100901

• Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.

  Journal of Crohn's & colitis 20100901

• 5-aminosalicylic acid induced multisystem disorders in the course of Crohn' s disease.

  Journal of Crohn's & colitis 20100901

• Unilateral balsalazide-induced eosinophilic pneumonia in an ulcerative colitis patient.

  The journal of the Royal College of Physicians of Edinburgh 20100901

• Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats.

  Therapeutic advances in gastroenterology 20100901

• 2-[(E)-(3-Carb-oxy-4-hy-droxy-phen-yl)iminiometh-yl]-4-chloro-phenolate.

  Acta crystallographica. Section E, Structure reports online 20100901

• Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.

  Inflammatory bowel diseases 20100801

• Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotide.

  Inflammatory bowel diseases 20100801

• Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100801

• Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis.

  Inflammatory bowel diseases 20100801

• Microwave initiated synthesis of polyacrylamide grafted guar gum (GG-g-PAM)-Characterizations and application as matrix for controlled release of 5-amino salicylic acid.

  International journal of biological macromolecules 20100801

• Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.

  Alimentary pharmacology & therapeutics 20100801

• Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia.

  American journal of hematology 20100801

• Pyodermatitis-pyostomatitis vegetans after subtotal colectomy for ulcerative colitis.

  The Journal of dermatology 20100801

• Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine.

  European journal of gastroenterology & hepatology 20100801

• Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.

  PLoS pathogens 20100801

• Right colonic diverticulitis.

  Journal of the Korean Society of Coloproctology 20100801

• Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases.

  Protein & cell 20100801

• Combination chemotherapy for influenza.

  Viruses 20100801

• Microscopic colitis in children.

  Digestive diseases and sciences 20100701

• Barriers to oral medication adherence for adolescents with inflammatory bowel disease.

  Journal of pediatric psychology 20100701

• Ulcerative colitis in northern Portugal and Galicia in Spain.

  Inflammatory bowel diseases 20100701

• Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates.

  Digestive diseases and sciences 20100701

• Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.

  Journal of clinical gastroenterology 20100701

• Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.

  The American journal of gastroenterology 20100701

• In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study.

  Inflammatory bowel diseases 20100701

• Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis.

  World journal of surgery 20100701

• Proximal extension of backwash ileitis in ulcerative-colitis - associated colon cancer.

  Medical science monitor : international medical journal of experimental and clinical research 20100701

• Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.

  British journal of pharmacology 20100701

• Once-daily mesalamine granules for ulcerative colitis.

  Expert review of clinical immunology 20100701

• Insight into the widespread problem of nonadherence to therapy in ulcerative colitis patients.

  Expert review of clinical immunology 20100701

• Use of budesonide in the treatment of microscopic colitis.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20100701

• Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence.

  Patient related outcome measures 20100701

• Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment.

  European journal of gastroenterology & hepatology 20100601

• Mesalamine protects against colorectal cancer in inflammatory bowel disease.

  Digestive diseases and sciences 20100601

• Inflammatory bowel disease in young people: the case for transitional clinics.

  Inflammatory bowel diseases 20100601

• Health-related quality of life of youth with inflammatory bowel disease: a comparison with published data using the PedsQL 4.0 generic core scales.

  Inflammatory bowel diseases 20100601

• Effect of 5-aminosalicylate on allergic rhinitis model in mice.

  International immunopharmacology 20100601

• In-source decay and fragmentation characteristics of peptides using 5-aminosalicylic acid as a matrix in matrix-assisted laser desorption/ionization mass spectrometry.

  Journal of the American Society for Mass Spectrometry 20100601

• Two cases of inflammatory bowel disease diagnosed in the course of primary biliary cirrhosis.

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100601

• Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

  Gut 20100601

• A retrospective study on a cohort of patients with lymphocytic colitis.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20100601

• Mesalazine induced drug fever.

  Journal of gastrointestinal and liver diseases : JGLD 20100601

• [Differential diagnosis problem of pulmonary changes in ulcerative colitis].

  Vojnosanitetski pregled 20100601

• Omega-3 fatty acids in the maintenance of ulcerative colitis.

  JRSM short reports 20100601

• Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective study.

  Journal of Crohn's & colitis 20100601

• Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.

  Journal of Crohn's & colitis 20100601

• Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease.

  Journal of Crohn's & colitis 20100601

• Colorectal carcinoma and preceding fistula in Crohn's disease.

  Journal of Crohn's & colitis 20100601

• Fournier's gangrene complicating ulcerative pancolitis.

  Journal of Crohn's & colitis 20100601

• Transportation of drug-(polystyrene bead) conjugate by actomyosin motor system.

  Journal of biomedical nanotechnology 20100601

• Preclinical electrogastrography in experimental pigs.

  Interdisciplinary toxicology 20100601

• Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.

  World journal of gastroenterology 20100528

• [Postoperative recurrence of Crohn's disease, and its prevention].

  Orvosi hetilap 20100523

• Mesalamine (pentasa)-induced painful skin lesions.

  Inflammatory bowel diseases 20100501

• Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial.

  Inflammatory bowel diseases 20100501

• Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center.

  Inflammatory bowel diseases 20100501

• Two cases of severe de novo colitis in kidney transplant recipients after conversion to prolonged-release tacrolimus.

  Transplant international : official journal of the European Society for Organ Transplantation 20100501

• Design of a colonic delivery system based on cationic polymethacrylate (Eudragit E100)-mesalamine complexes.

  Drug delivery 20100501

• Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach.

  Pharmacoepidemiology and drug safety 20100501

• Mesalamine lung toxicity.

  Connecticut medicine 20100501

• A rare case of colic thrombotic microangiopathy in renal transplantation.

  Transplantation proceedings 20100501

• [A case of ulcerative colitis found in a patient whose parent has Crohn's disease].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100501

• Efficacy of early treatment with infliximab in pediatric Crohn's disease.

  World journal of gastroenterology 20100414

• Recent advances in the management of distal ulcerative colitis.

  World journal of gastrointestinal pharmacology and therapeutics 20100406

• Development of glomerulonephritis early in the course of Crohn's disease.

  Inflammatory bowel diseases 20100401

• Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis.

  Inflammatory bowel diseases 20100401

• Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.

  Drug development and industrial pharmacy 20100401

• The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity.

  Inflammatory bowel diseases 20100401

• [Mesalazine-induced acute pericarditis].

  Gastroenterologia y hepatologia 20100401

• Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

  Gastroenterology 20100401

• Pancreatitis in inflammatory bowel diseases.

  Journal of clinical gastroenterology 20100401

• Novel pH-sensitive hydrogels for colon-specific drug delivery.

  Drug delivery 20100401

• Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine.

  Journal of pediatric gastroenterology and nutrition 20100401

• [Portal hypertension in patients with inflammatory bowel disease].

  Gastroenterologia y hepatologia 20100401

• Drug induced pancreatitis.

  Best practice & research. Clinical gastroenterology 20100401

• Gastrointestinal and liver adverse effects of drugs used for treating IBD.

  Best practice & research. Clinical gastroenterology 20100401

• Porcine-origin gentamicin-resistant Enterococcus faecalis in humans, Denmark.

  Emerging infectious diseases 20100401

• High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.

  International journal of clinical pharmacology and therapeutics 20100401

• Disseminated coccidioidomycosis in a patient managed with adalimumab for Crohn's disease.

  Nature reviews. Gastroenterology & hepatology 20100401

• Antioxidant activities of Sarcodon imbricatum wildly grown in the Black Sea Region of Turkey.

  Pharmacognosy magazine 20100401

• Controlled release of 5-aminosalicylic acid (5-ASA) from new biodegradable polyurethanes.

  Molecules (Basel, Switzerland) 20100330

• Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100315

• Course of inflammatory bowel disease in patients infected with human immunodeficiency virus.

  Inflammatory bowel diseases 20100301

• 5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes.

  Inflammatory bowel diseases 20100301

• Influence of NFkappaB inhibitors on IL-1beta-induced chemokine CXCL8 and -10 expression levels in intestinal epithelial cell lines: glucocorticoid ineffectiveness and paradoxical effect of PDTC.

  International journal of colorectal disease 20100301

• Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20100301

• [Pulmonary manifestations of inflammatory bowel disease].

  Der Internist 20100301

• Probiotics for maintaining remission of ulcerative colitis in adults.

  The Annals of pharmacotherapy 20100301

• A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective.

  Journal of medical economics 20100301

• Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure.

  Clinical nephrology 20100301

• Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease.

  Nature reviews. Gastroenterology & hepatology 20100301

• Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis.

  Journal of clinical biochemistry and nutrition 20100301

• Peyer's Patches in the Terminal Ileum in Ulcerative Colitis: Magnifying Endoscopic Findings.

  Journal of clinical biochemistry and nutrition 20100301

• Box-Behnken experimental design in the development of pectin-compritol ATO 888 compression coated colon targeted drug delivery of mesalamine.

  Acta pharmaceutica (Zagreb, Croatia) 20100301

• Pharmacogenomics in the treatment of inflammatory bowel disease.

  Pharmacogenomics 20100301

• [Interstitial pneumonia related to mesalamine].

  Gastroenterologie clinique et biologique 20100301

• [A case of segmental colitis associated with diverticular disease].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20100301

• [Domestic chromogenic nutrient medium for differentiation of Klebsiella].

  Klinicheskaia laboratornaia diagnostika 20100301

• A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation.

  Beneficial microbes 20100301

• Crohn's disease of the appendix with enterocutaneous fistula post-appendicectomy: An approach to management.

  North American journal of medical sciences 20100301

• Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling.

  Experimental & molecular medicine 20100227

• Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease.

  Free radical biology & medicine 20100215

• On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease.

  Nitric oxide : biology and chemistry 20100215

• Understanding of chemoprophylaxis and concordance in inflammatory bowel disease.

  World journal of gastroenterology 20100207

• Diverticular disease: A therapeutic overview.

  World journal of gastrointestinal pharmacology and therapeutics 20100206

• Case of lacrimal gland inflammation associated with ulcerative colitis.

  International ophthalmology 20100201

• Efficacy of 5-ASA in the treatment of colonic diverticular disease.

  Journal of clinical gastroenterology 20100201

• Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers.

  Inflammatory bowel diseases 20100201

• Importance of mucosal healing in ulcerative colitis.

  Inflammatory bowel diseases 20100201

• Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery.

  Drug development and industrial pharmacy 20100201

• Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis.

  Gastroenterology 20100201

• Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies.

  The Journal of infectious diseases 20100201

• Diverticular disease: what is the best long-term treatment?

  Nature reviews. Gastroenterology & hepatology 20100201

• Mesalazine in inflammatory bowel disease: a trendy topic once again?

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20100201

• [Usefulness of probiotics in prevention and therapy].

  Deutsche medizinische Wochenschrift (1946) 20100201

• Comparison of methods for proanthocyanidin extraction from pine (Pinus densiflora) needles and biological activities of the extracts.

  Nutrition research and practice 20100201

• Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's.

  Current drug targets 20100201

• Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20100201

• 5-ASA Dose-Response: Maximizing Efficacy and Adherence.

  Gastroenterology & hepatology 20100201

• Mesalazine vanishing time from rectal mucosa following its topical administration.

  Journal of Crohn's & colitis 20100201

• [Myopericarditis in a patient with ulcerative colitis treated with mesalazine].

  Medicina clinica 20100123

• Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20100120

• An unusual presentation of fistulating Crohn's disease: Ascites.

  World journal of gastrointestinal endoscopy 20100116

• Pilot study: the use of sulfasalazine for the treatment of acute pouchitis.

  Alimentary pharmacology & therapeutics 20100115

• Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine.

  Alimentary pharmacology & therapeutics 20100115

• [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].

  MMW Fortschritte der Medizin 20100114

• A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacy.

  World journal of gastroenterology 20100107

• 5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells.

  Cancer letters 20100101

• Chitosan/Kollicoat SR 30D film-coated pellets of aminosalicylates for colonic drug delivery.

  Journal of pharmaceutical sciences 20100101

• Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine.

  Gastroenterology 20100101

• Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells.

  Alimentary pharmacology & therapeutics 20100101

• Role of PPARs in Radiation-Induced Brain Injury.

  PPAR research 20100101

• [Leukocytoclastic vasculitis associated with Crohn's disease].

  Gastroenterologia y hepatologia 20100101

• Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey.

  Journal of gastroenterology and hepatology 20100101

• PPARs in Irradiation-Induced Gastrointestinal Toxicity.

  PPAR research 20100101

• L-lysine pro-prodrug containing trans-ferulic acid for 5-amino salicylic acid colon delivery: synthesis, characterization and in vitro antioxidant activity evaluation.

  Chemical & pharmaceutical bulletin 20100101

• Role of tyrosine 131 in the active site of paAzoR1, an azoreductase with specificity for the inflammatory bowel disease prodrug balsalazide.

  Acta crystallographica. Section F, Structural biology and crystallization communications 20100101

• How do patients with inflammatory bowel disease want their biological therapy administered?

  BMC gastroenterology 20100101

• Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis.

  Journal of clinical gastroenterology 20100101

• Combinational effect of low-dose oral corticosteroid and mizoribine for ulcerative colitis in a patient with systemic sclerosis.

  The Journal of dermatology 20100101

• The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients.

  BMC gastroenterology 20100101

• Lymphocytic colitis presenting as difficult diarrhoea in an African woman: a case report and review of the literature.

  Journal of medical case reports 20100101

• Inhibition of human immunodeficiency virus type-1 by cdk inhibitors.

  AIDS research and therapy 20100101

• New drug delivery systems in inflammatory bowel disease: MMX and tailored delivery to the gut.

  Current medicinal chemistry 20100101

• Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4.

  PloS one 20100101

• [Active and refractory ulcerative proctitis: an update].

  Revista medica de Chile 20100101

• Aortic mural thrombi associated with ulcerative colitis.

  Acta clinica Belgica 20100101

• Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study.

  Radiation oncology (London, England) 20100101

• [Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases].

  Terapevticheskii arkhiv 20100101

• Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).

  BMC complementary and alternative medicine 20100101

• Severe metabolic alkalosis and recurrent acute on chronic kidney injury in a patient with Crohn's disease.

  BMC nephrology 20100101

• Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis.

  Therapeutics and clinical risk management 20100101

• Dietary phenethylisothiocyanate attenuates bowel inflammation in mice.

  BMC chemical biology 20100101

• Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.

  PloS one 20100101

• Mesalazine-induced multi-organ hypersensitivity.

  Clinical drug investigation 20100101

• Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.

  Journal of carcinogenesis 20100101

• Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients.

  Radiation oncology (London, England) 20100101

• Colon-specific drug delivery behavior of pH-responsive PMAA/perlite composite.

  International journal of molecular sciences 20100101

• [Transplantation of allogeneic mesenchymal stem cells from the bone marrow increases duration of remission and reduces the risk of ulcerative colitis relapse].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101

• Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization.

  PloS one 20100101

• Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.

  Journal of experimental & clinical cancer research : CR 20100101

• Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain.

  Molecular pain 20100101

• Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease.

  Journal of clinical apheresis 20100101

• The thioamides methimazole and thiourea inhibit growth of M. avium Subspecies paratuberculosis in culture.

  PloS one 20100101

• The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects.

  The open biochemistry journal 20100101

• Real-time detection of viable microorganisms by intracellular phototautomerism.

  BMC biotechnology 20100101

• New Research in Ulcerative Colitis: Optimizing 5-ASA Administration for Efficacy and Adherence.

  Gastroenterology & hepatology 20100101

• Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.

  BMC gastroenterology 20100101

• Cutaneous Crohn's disease in the pediatric population.

  Pediatric dermatology 20100101

• Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis.

  Arthritis research & therapy 20100101

• Is there a biological basis for treatment of fibrodysplasia ossificans progressiva with rosiglitazone? Potential benefits and undesired effects.

  PPAR research 20100101

• Neuroinflammation in inflammatory bowel disease.

  Journal of neuroinflammation 20100101

• New light on the anti-colitic actions of therapeutic aminosalicylates: the role of heme oxygenase.

  Pharmacological reports : PR 20100101

• Guillain-Barré syndrome, tuberculosis and inflammatory bowel disease: a multiple association.

  International archives of medicine 20100101

• A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial).

  BMC surgery 20100101

• Appendiceal-sigmoid fistula presenting in a man with ulcerative colitis: a case report.

  Journal of medical case reports 20100101

• [Ulcerative colitis initial presentation with multiple extra-intestinal manifestations].

  Acta medica portuguesa 20100101

• Chronic cough associated with Crohn's disease.

  Cough (London, England) 20100101

• [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].

  Nederlands tijdschrift voor geneeskunde 20100101

• Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery.

  The Journal of pharmacy and pharmacology 20100101

• Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study.

  Journal of clinical apheresis 20100101

• Mesalamine-induced myocarditis.

  Cardiology research and practice 20100101

• Gastrointestinal Cytoprotection by PPARγ Ligands.

  PPAR research 20100101

• Does treatment schedule matter? Once daily versus divided doses of 5-ASAs.

  Digestive diseases (Basel, Switzerland) 20100101

• Hepatotoxicity of agents used in the management of inflammatory bowel disease.

  Digestive diseases (Basel, Switzerland) 20100101

• State-of-the-art: Immunosuppression and biologic therapy.

  Digestive diseases (Basel, Switzerland) 20100101

• How rapidly should remission be achieved?

  Digestive diseases (Basel, Switzerland) 20100101

• JC Viral reactivation in a pediatric patient with Crohn's disease.

  International journal of immunopathology and pharmacology 20100101

• Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.

  BMC gastroenterology 20100101

• Esophageal Crohn's disease treated 'topically' with swallowed aerosolized budesonide.

  Case reports in medicine 20100101

• Development and validation of spectrophotometric methods for the estimation of mesalamine in tablet dosage forms.

  Journal of young pharmacists : JYP 20100101

• The use of anti-TNFα medications for rheumatologic disease in pregnancy.

  International journal of women's health 20100101

• Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

  BMC gastroenterology 20100101

• Inflammatory bowel disease as a risk factor for colorectal cancer.

  Digestive diseases (Basel, Switzerland) 20100101

• Comparison of the phenolic content and antioxidant activities of Apocynum venetum L. (Luo-Bu-Ma) and two of its alternative species.

  International journal of molecular sciences 20100101

• Antimicrobial peptides in gastrointestinal inflammation.

  International journal of inflammation 20100101

• Cerebral sinus thrombosis: a fatal neurological complication of ulcerative colitis.

  Pathology research international 20100101

• Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.

  International journal of molecular sciences 20100101

• [Mucocele of the appendix: an unusual finding in a patient with ulcerative colitis].

  Cirugia y cirujanos 20100101

• Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug delivery.

  Scientia pharmaceutica 20100101

• Possible interactions between dietary fibres and 5-aminosalicylic acid [corrected].

  Therapeutic advances in gastroenterology 20100101

• Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults.

  PloS one 20100101

• Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine.

  Redox report : communications in free radical research 20100101

• A gentleman with anemia and cholestasis.

  Case reports in medicine 20100101

• Influence of troglitazone, sodium butyrate, 5-aminosalicylic acid and BAY 11-7082 on the chemokine ENA-78/CXCL5 secretion in the intestinal subepithelial myofibroblasts.

  Acta poloniae pharmaceutica 20100101

• Successful long-term use of infliximab in refractory pouchitis in an adolescent.

  Gastroenterology research and practice 20100101

• [Paeoniflorin increases beta-defensin expression and attenuates lesion in the colonic mucosa from mice with oxazolone-induced colitis].

  Yao xue xue bao = Acta pharmaceutica Sinica 20100101

• [Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101

• Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat.

  International journal of preventive medicine 20100101

• Inflammatory bowel diseases and the general practitioner's role in a region of Central Italy.

  Clinical and experimental gastroenterology 20100101

• Infliximab therapy in pediatric Crohn's disease: a review.

  Clinical and experimental gastroenterology 20100101

• Amino acid-responsive Crohn's disease: a case study.

  Clinical and experimental gastroenterology 20100101

• Polymers for colon targeted drug delivery.

  Indian journal of pharmaceutical sciences 20100101

• Design and evaluation of a metronidazole central core matrix tablet.

  Journal of advanced pharmaceutical technology & research 20100101

• Evaluation of potential of Zn-pectinate gel (ZPG) microparticles containing mesalazine for colonic drug delivery.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

• Non-healing arm wound with a discharging sinus in an elderly patient with diabetes.

  BMJ case reports 20100101

• Acute dacryoadenitis in Crohn's disease.

  BMJ case reports 20100101

• Lymphogranuloma venereum and HIV infection: misdiagnosed as Crohn's disease.

  BMJ case reports 20100101

• Chemical colitis due to glutaraldehyde: case series and review of the literature.

  Digestive diseases and sciences 20091201

• Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20091201

• Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems.

  International journal of pharmaceutics 20091201

• Balsalazide in treating colonic diseases.

  Expert opinion on drug metabolism & toxicology 20091201

• Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis.

  European journal of clinical pharmacology 20091201

• Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.

  The Journal of pharmacology and experimental therapeutics 20091201

• Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.

  Gastroenterology 20091201

• An investigation of medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis, using self-report and urinary drug excretion measurements.

  Alimentary pharmacology & therapeutics 20091201

• Accidentally ASCENDing into comparative effective research for inflammatory bowel disease.

  Gastroenterology 20091201

• Optimizing conventional therapies for inflammatory bowel disease.

  Current gastroenterology reports 20091201

• Managing the risks of IBD therapy.

  Current gastroenterology reports 20091201

• Rifaximin in the management of colonic diverticular disease.

  Expert review of gastroenterology & hepatology 20091201

• Pyoderma gangranosum of the penis.

  Journal of Korean medical science 20091201

• MMX mesalamine is safe and efficacious in achieving clinical and endoscopic remission of active ulcerative colitis.

  Hospital practice (1995) 20091201

• Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.

  Journal of Crohn's & colitis 20091201

• Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.

  Journal of Crohn's & colitis 20091201

• Rheumatic manifestations of inflammatory bowel disease.

  World journal of gastroenterology 20091128

• Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.

  British journal of cancer 20091117

• Pediatric Crohn's disease activity at diagnosis, its influence on pediatrician's prescribing behavior, and clinical outcome 5 years later.

  Inflammatory bowel diseases 20091101

• Mesalamine enema-induced exacerbation of ulcerative colitis.

  International journal of colorectal disease 20091101

• A 38-year-old with recurrent colitis. Is it noncompliance?

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20091101

• Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.

  The American journal of gastroenterology 20091101

• Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.

  Journal of pediatric gastroenterology and nutrition 20091101

• Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.

  Alimentary pharmacology & therapeutics 20091101

• Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study.

  Digestive diseases and sciences 20091101

• Therapy of inflammatory bowel diseases in pregnancy and lactation.

  Expert opinion on drug safety 20091101

• Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20091015

• High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study.

  Alimentary pharmacology & therapeutics 20091015

• Interventions for prevention of post-operative recurrence of Crohn's disease.

  The Cochrane database of systematic reviews 20091007

• Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.

  Inflammatory bowel diseases 20091001

• Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.

  Inflammatory bowel diseases 20091001

• Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.

  European journal of medicinal chemistry 20091001

• Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.

  Inflammatory bowel diseases 20091001

• Treatment options for uncomplicated diverticular disease of the colon.

  Journal of clinical gastroenterology 20091001

• Severe skeletal muscle damage following the administration of mesalazine to a patient with ulcerative colitis.

  Pediatrics international : official journal of the Japan Pediatric Society 20091001

• Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis.

  Expert opinion on drug metabolism & toxicology 20091001

• [A case of renal vein thrombosis in a patient with ulcerative colitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20091001

• [Problems related to postoperative clinical relapse and endoscopic recurrence in Crohn's disease].

  Recenti progressi in medicina 20091001

• 5-ASA in ulcerative colitis: improving treatment compliance.

  World journal of gastroenterology 20090921

• Review article: the current and evolving treatment of colonic diverticular disease.

  Alimentary pharmacology & therapeutics 20090915

• In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20090915

• An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1beta-mediated NFkappaB activation.

  European journal of pharmacology 20090915

• Case of linear IgA bullous dermatosis-involved ulcerative colitis.

  Inflammatory bowel diseases 20090901

• Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?

  Inflammatory bowel diseases 20090901

• On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in culture.

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20090901

• Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates.

  The American journal of gastroenterology 20090901

• DNA-driven nutritional therapy of inflammatory bowel disease.

  Nutrition (Burbank, Los Angeles County, Calif.) 20090901

• Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.

  Journal of renal care 20090901

• Collagenous colitis: description of a single centre series of 83 patients.

  European journal of internal medicine 20090901

• De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20090901

• [Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20090901

• Quality of life in the late follow-up of ulcerative colitis patients submitted to restorative proctocolectomy with sphincter preservation over ten years ago.

  Clinics (Sao Paulo, Brazil) 20090901

• [Synthesis of 2-hydroxyl-5-butyramidobenzoic acid and its effect on acetic acid-induced colitis in rats].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090901

• Artrofoon as alternative preparation in the treatment of uncomplicated forms of nonspecific ulcerative colitis.

  Bulletin of experimental biology and medicine 20090901

• The long journey of salicylates in ulcerative colitis: The past and the future.

  Journal of Crohn's & colitis 20090901

• An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial.

  Journal of Crohn's & colitis 20090901

• Mycosis fungoides and CD30+ cutaneous T-cell lymphoma simulating pyoderma gangrenosum in a patient with ulcerative colitis.

  Journal of dermatological case reports 20090824

• Mesenteric ischemia is a cause of resistance to treatment in IBD.

  Inflammatory bowel diseases 20090801

• Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity.

  Digestive diseases and sciences 20090801

• Starch-based coatings for colon-specific delivery. Part II: physicochemical properties and in vitro drug release from high amylose maize starch films.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090801

• Complicated wireless capsule enteroscopy in a patient with Crohn's disease.

  European journal of gastroenterology & hepatology 20090801

• Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study.

  Alimentary pharmacology & therapeutics 20090801

• Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.

  Gastroenterology 20090801

• [Therapy of refractory proctocolitis and Crohn's disease. Incisionless laparoscopic proctocolectomy with a Brooke ileostomy].

  Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20090801

• Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.

  The American journal of gastroenterology 20090801

• Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone.

  Hepatology (Baltimore, Md.) 20090801

• Mesalamine-induced multiple pulmonary cavitary nodules associated with cytoplasmic antineutrophil cytoplasmic antibody (c-ANCA).

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20090801

• How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.

  Expert review of gastroenterology & hepatology 20090801

• Pharmacokinetics and safety of single and multiple doses of Asacol tablets in Japanese healthy volunteers.

  Advances in therapy 20090801

• Ulcerative colitis associated with leukocytoclastic vasculitis of the skin.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090701

• Adalimumab for the treatment of fistulas in patients with Crohn's disease.

  Gut 20090701

• Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression.

  Inflammatory bowel diseases 20090701

• Induced sputum eosinophilia in ulcerative colitis patients: the lung as a mirror image of intestine?

  Respiratory medicine 20090701

• Advances in the pathogenesis and treatment of IBD.

  Clinical immunology (Orlando, Fla.) 20090701

• Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia.

  Molecular pharmacology 20090701

• Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20090701

• 5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.

  Carcinogenesis 20090701

• Microwave initiated synthesis of polyacrylamide grafted carboxymethylstarch (CMS-g-PAM): application as a novel matrix for sustained drug release.

  International journal of biological macromolecules 20090701

• Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.

  Journal of neurochemistry 20090701

• [The problems of compliance and adherence, using the example of chronic inflammatory bowel disease].

  Deutsche medizinische Wochenschrift (1946) 20090701

• Balsalazine decreases intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice.

  Acta pharmacologica Sinica 20090701

• Clinical inquiries: How can you help prevent a recurrence of diverticulitis?

  The Journal of family practice 20090701

• Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20090701

• Novel polymeric film coatings for colon targeting: Drug release from coated pellets.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090628

• A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis.

  Digestive diseases and sciences 20090601

• Therapeutic strategies for the management of ulcerative colitis.

  Inflammatory bowel diseases 20090601

• A dynamic model of colonic concentrations of delayed-release 5-aminosalicylic acid (Asacol).

  Alimentary pharmacology & therapeutics 20090601

• Development of an automated chemiluminescence flow-through sensor for the determination of 5-aminosalicylic acid in pharmaceuticals: a comparative study between sequential and multicommutated flow techniques.

  Analytical and bioanalytical chemistry 20090601

• Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.

  The American journal of gastroenterology 20090601

• Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis.

  Cancer biotherapy & radiopharmaceuticals 20090601

• Relevance of segmental colitis with diverticulosis (SCAD) to other forms of inflammatory bowel disease.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20090601

• What is the optimal therapy for patients with H5N1 influenza?

  PLoS medicine 20090601

• [A case of mesalazine-induced lung injury improved by only discontinuation of mesalazine].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090601

• Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine.

  Journal of Crohn's & colitis 20090601

• Identification and quantification of ciprofloxacin in urine through excitation-emission fluorescence and three-way PARAFAC calibration.

  Analytica chimica acta 20090529

• Encapsulated mesalamine granules (Apriso) for ulcerative colitis.

  The Medical letter on drugs and therapeutics 20090518

• [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].

  MMW Fortschritte der Medizin 20090507

• Supramolecular structure of 5-aminosalycilic acid/halloysite composites.

  Journal of microencapsulation 20090501

• Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090501

• Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.

  Journal of gastroenterology and hepatology 20090501

• Chemoprevention of colorectal cancer in inflammatory bowel disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090501

• The role of fecal calprotectin in investigating inflammatory bowel diseases.

  Clinics (Sao Paulo, Brazil) 20090501

• Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.

  Diseases of the colon and rectum 20090501

• Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.

  Diseases of the colon and rectum 20090501

• Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?

  World journal of gastroenterology 20090421

• Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats.

  World journal of gastroenterology 20090421

• Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis.

  Alimentary pharmacology & therapeutics 20090415

• Infliximab to treat severe ulcerative colitis.

  World journal of gastroenterology 20090414

• Identification of reaction products between drug substances and excipients by HPLC-SPE-NMR: ester and amide formation between citric acid and 5-aminosalicylic acid.

  Journal of pharmaceutical and biomedical analysis 20090405

• Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis.

  Digestive diseases and sciences 20090401

• Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats.

  Digestive diseases and sciences 20090401

• Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease.

  Inflammatory bowel diseases 20090401

• Myocarditis by mesalazine with cardiac magnetic resonance imaging.

  European heart journal 20090401

• Mesalazine-induced aplastic anemia.

  The American journal of gastroenterology 20090401

• New-onset ulcerative colitis in a patient treated with the anti-CD11a monoclonal antibody efalizumab.

  The American journal of gastroenterology 20090401

• Not all mesalamine enema bottles are created equal.

  The American journal of gastroenterology 20090401

• Hypereosinophilia due to mesalazine treatment.

  Journal of clinical gastroenterology 20090401

• [A case of idiopathic pancreatitis in a patient with Crohn's disease].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20090401

• Reproductive issues in inflammatory bowel disease.

  Medicine and health, Rhode Island 20090401

• Distinguishing tuberculosis and Crohn's disease in developing countries: how certain can you be of the diagnosis?

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20090401

• Longitudinal follow-up of oxidative stress and DNA damage parameters in detergent workers.

  Indian journal of occupational and environmental medicine 20090401

• Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers.

  International journal of pharmaceutics 20090331

• Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease.

  World journal of gastroenterology 20090328

• Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.

  Inflammatory bowel diseases 20090301

• SIMDOT-AbMe: microphysiologically based simulation tool for quantitative prediction of systemic and local bioavailability of targeted oral delivery formulations.

  Drug metabolism and disposition: the biological fate of chemicals 20090301

• Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006).

  Journal of clinical gastroenterology 20090301

• Voting With their Feet (VWF) endpoint: a meta-analysis of an alternative endpoint in clinical trials, using 5-ASA induction studies in ulcerative colitis.

  Inflammatory bowel diseases 20090301

• Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?

  Alimentary pharmacology & therapeutics 20090301

• [Effectiveness of new, once-daily 5-aminosalicylic acid in the treatment of ulcerative colitis].

  Orvosi hetilap 20090301

• New approaches to adherence issues when dosing oral aminosalicylates in ulcerative colitis.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090301

• Meeting the challenge of influenza pandemic preparedness in developing countries.

  Emerging infectious diseases 20090301

• Factors predictive of Crohn disease following colectomy in medically refractory pediatric colitis.

  Journal of pediatric gastroenterology and nutrition 20090301

• [Effect of balsalazide on intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice].

  Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20090301

• Renal effects of long-term treatment with 5-aminosalicylic acid.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20090301

• Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease?

  PLoS pathogens 20090301

• Medical therapy of IBD in 2009.

  Medicine and health, Rhode Island 20090301

• [Alopecia as adverse reaction of mesalazine].

  Revista clinica espanola 20090301

• Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery.

  International journal of pharmaceutics 20090223

• Use of spray-dried chitosan acetate and ethylcellulose as compression coats for colonic drug delivery: effect of swelling on triggering in vitro drug release.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090201

• Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.

  Gut 20090201

• Co-prescribing azathiopurine or 6-mercaptopurine and 5-aminosalicylate compounds in ulcerative colitis.

  Inflammatory bowel diseases 20090201

• Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.

  Alimentary pharmacology & therapeutics 20090201

• Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20090201

• Comment: Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis and the Kounis syndrome.

  The Annals of pharmacotherapy 20090201

• Granulomatous pigmented purpura: an unusual histological variant.

  The American Journal of dermatopathology 20090201

• Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.

  The American journal of gastroenterology 20090201

• Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.

  The American journal of gastroenterology 20090201

• All that bleeds is not infliximab-refractory ulcerative colitis.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20090201

• Colon cancer: preventive agents and the present status of chemoprevention.

  Expert opinion on pharmacotherapy 20090201

• [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20090201

• Medications as a potential source of exposure to phthalates in the U.S. population.

  Environmental health perspectives 20090201

• The prevalence and clinical characteristics of esophageal involvement in patients with Behçet's disease: a single center experience in Korea.

  Journal of Korean medical science 20090201

• Retraction notice to 'Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease' [Bioorg. Med. Chem. Lett. 17 (2007) 1897-1902].

  Bioorganic & medicinal chemistry letters 20090201

• An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.

  Journal of Crohn's & colitis 20090201

• Non-toxic megacolon due to transverse and sigmoid colon volvulus in a patient with ulcerative colitis.

  Journal of Crohn's & colitis 20090201

• [Treatment of Crohn's disease].

  Praxis 20090121

• Budesonide for maintenance of remission in Crohn's disease.

  The Cochrane database of systematic reviews 20090121

• Retraction notice to 'Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats' [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909].

  Bioorganic & medicinal chemistry 20090115

• Combined treatment of Caco-2 cells with butyrate and mesalazine inhibits cell proliferation and reduces Survivin protein level.

  Cancer letters 20090108

• N,N'-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis.

  Journal of pharmaceutical sciences 20090101

• Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats.

  European journal of medicinal chemistry 20090101

• Paraoxonase-1 status in Crohn's disease and ulcerative colitis.

  Inflammatory bowel diseases 20090101

• Mesalamine-induced pleuritis in a patient with ulcerative colitis.

  Inflammatory bowel diseases 20090101

• Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.

  Inflammatory bowel diseases 20090101

• Mesalazine pharmacokinetics and NAT2 phenotype.

  European journal of clinical pharmacology 20090101

• Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.

  Scandinavian journal of gastroenterology 20090101

• Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.

  International journal of colorectal disease 20090101

• Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.

  Pharmaceutical development and technology 20090101

• Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.

  Pharmaceutical development and technology 20090101

• Faecal calprotectin in colonic diverticular disease: a case-control study.

  International journal of colorectal disease 20090101

• Association of idiopathic inflammatory myopathy and Crohn's disease.

  Clinical rheumatology 20090101

• Immune-mediated myositis in Crohn's disease.

  Muscle & nerve 20090101

• Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials.

  The American journal of gastroenterology 20090101

• Inflammatory bowel disease classification through multigene analysis: fact or fiction?

  Expert review of molecular diagnostics 20090101

• Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial.

  Gastroenterologie clinique et biologique 20090101

• [Case of scattered gastritis associated with ulcerative proctitis].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20090101

• Augmented lung inflammation protects against influenza A pneumonia.

  PloS one 20090101

• Current strategies for the treatment of ulcerative colitis.

  Recent patents on inflammation & allergy drug discovery 20090101

• [A case of pulmonary thromboembolism in active ulcerative colitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20090101

• Advances in inflammatory bowel disease: are patients taking their medicines? Interview by Paul C. Adams.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20090101

• [Severe tubulo-interstitial nephritis secondary to 5-ASA].

  Gastroenterologia y hepatologia 20090101

• Inhibitory effects of an aqueous extract of Cornus kousa Burg. leaves on TNF-alpha-induced chemokine expression and monocyte adhesion to human colonic epithelial cells.

  Archives of pharmacal research 20090101

• Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes.

  BMC microbiology 20090101

• Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.

  PloS one 20090101

• Transcript levels of different cytokines and chemokines correlate with clinical and endoscopic activity in ulcerative colitis.

  BMC gastroenterology 20090101

• Mesalazine-induced interstitial nephritis.

  Renal failure 20090101

• Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.

  Digestion 20090101

• IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.

  PloS one 20090101

• Cytotoxicity of dental adhesives in vitro.

  European journal of dentistry 20090101

• Effect of high amylose maize starches on colonic fermentation and apoptotic response to DNA-damage in the colon of rats.

  Nutrition & metabolism 20090101

• Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study.

  BMC gastroenterology 20090101

• Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric culture.

  Gut pathogens 20090101

• Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance rates.

  Methods and findings in experimental and clinical pharmacology 20090101

• [Methotrexate in the treatment of peripheral arthritis in ulcerative colitis].

  Reumatismo 20090101

• Novel pathogenic mutations and skin biopsy analysis in Knobloch syndrome.

  Molecular vision 20090101

• Evaluation of the passage of Lactobacillus gasseri K7 and bifidobacteria from the stomach to intestines using a single reactor model.

  BMC microbiology 20090101

• Beta-catenin pathway in ulcerative colitis-associated colorectal cancer and therapeutic implication.

  Journal of gastrointestinal cancer 20090101

• Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.

  PloS one 20090101

• Comparison of the analgesic effect of ibuprofen with mesalamine after discectomy surgery in patients with lumbar disc herniation: a double-blind randomized controlled trial.

  Neurology India 20090101

• Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario.

  Gut pathogens 20090101

• Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.

  BMC gastroenterology 20090101

• Macroscopic and histopathological examination of the gastric mucosa in dogs with inflammatory bowel disease (IBD) treated with mesalazine.

  Polish journal of veterinary sciences 20090101

• Inflammation and proliferation act together to mediate intestinal cell fusion.

  PloS one 20090101

• High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD.

  Mediators of inflammation 20090101

• The endogenous hydrogen sulfide producing enzyme cystathionine-beta synthase contributes to visceral hypersensitivity in a rat model of irritable bowel syndrome.

  Molecular pain 20090101

• Inhibitory effect of flavonoids on the efflux of N-acetyl 5-aminosalicylic acid intracellularly formed in Caco-2 cells.

  Journal of biomedicine & biotechnology 20090101

• The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.

  European review for medical and pharmacological sciences 20090101

• A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease.

  BMC microbiology 20090101

• Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

  Therapeutics and clinical risk management 20090101

• Biologic targeting in the treatment of inflammatory bowel diseases.

  Biologics : targets & therapy 20090101

• Butyrate-induced transcriptional changes in human colonic mucosa.

  PloS one 20090101

• Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue.

  PloS one 20090101

• Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study.

  BMC gastroenterology 20090101

• Bowel ultrasound and mucosal healing in ulcerative colitis.

  Digestive diseases (Basel, Switzerland) 20090101

• Management of inflammatory bowel diseases during pregnancy.

  Digestive diseases (Basel, Switzerland) 20090101

• Mild to moderate Crohn's disease: still room for step-up therapies?

  Digestive diseases (Basel, Switzerland) 20090101

• Prebiotics, probiotics and helminths: the 'natural' solution?

  Digestive diseases (Basel, Switzerland) 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis.

  Digestion 20090101

• Collagenous gastritis, a new spectrum of disease in pediatric patients: two case reports.

  Cases journal 20090101

• Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report.

  Journal of medical case reports 20090101

• Technetium-99m scan in the laparoscopic management of a misdiagnosed Meckel's diverticulum: a case report.

  Journal of medical case reports 20090101

• Venlafaxine-induced hepatotoxicity in a patient with ulcerative colitis.

  Annals of hepatology 20090101

• Current understanding of the role of PPARγ in gastrointestinal cancers.

  PPAR research 20090101

• Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats.

  Scandinavian journal of gastroenterology 20090101

• Primary sclerosing cholangitis: a clinical case.

  Digestive diseases (Basel, Switzerland) 20090101

• Medical management of ulcerative colitis.

  Digestive diseases (Basel, Switzerland) 20090101

• Diagnostic and treatment algorithms of ulcerative colitis in Ukraine.

  Digestive diseases (Basel, Switzerland) 20090101

• The future of inflammatory bowel disease care.

  Reviews in gastroenterological disorders 20090101

• Diminished macrophage apoptosis and reactive oxygen species generation after phorbol ester stimulation in Crohn's disease.

  PloS one 20090101

• Simultaneous occurrence of hyperthyroidism and fistulizing Crohn's disease complicated with intra-abdominal fistulas and abscess: a case report and review of the literature.

  Cases journal 20090101

• Hypersensitivity to mesalazine in a patient with inflammatory bowel disease: a case report.

  Cases journal 20090101

• Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine.

  Patient preference and adherence 20090101

• Lacrimal obstruction in inflammatory bowel disease.

  Ophthalmic plastic and reconstructive surgery 20090101

• Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis.

  Cost effectiveness and resource allocation : C/E 20090101

• An evidence-based review of natalizumab therapy in the management of Crohn's disease.

  Therapeutics and clinical risk management 20090101

• Effects of hydrogen sulfide on inflammation in caerulein-induced acute pancreatitis.

  Journal of inflammation (London, England) 20090101

• Fish faddism causing low-level mercury poisoning in the Caribbean: two case reports.

  Cases journal 20090101

• IBD and IBS: novel mechanisms and future practice. Preface.

  Digestive diseases (Basel, Switzerland) 20090101

• Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome.

  Digestive diseases (Basel, Switzerland) 20090101

• Collagenous and lymphocytic colitis: systematic review and update of the literature.

  Digestive diseases (Basel, Switzerland) 20090101

• Mesalazine-induced eosinophilic variant of Wegener's granulomatosis in an ulcerative colitis patient.

  Journal of Ayub Medical College, Abbottabad : JAMC 20090101

• Coexistence of medullary sponge kidney and ulcerative colitis in the same patient: long-term follow-up.

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20090101

• In vitro controlled release of colon targeted mesalamine from compritol ATO 888 based matrix tablets using factorial design.

  Research in pharmaceutical sciences 20090101

• Asymptomatic presentation of mesalamine-induced lung injury in an adolescent with Crohn disease.

  BMJ case reports 20090101

• New biologics in the management of Crohn's disease: focus on certolizumab pegol.

  Clinical and experimental gastroenterology 20090101

• The impact of biologics on health-related quality of life in patients with inflammatory bowel disease.

  Clinical and experimental gastroenterology 20090101

• Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease.

  Clinical and experimental gastroenterology 20090101

• Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update.

  Clinical and experimental gastroenterology 20090101

• Mesalamine hypersensitivity and Kounis syndrome in a pediatric ulcerative colitis patient.

  World journal of gastroenterology 20081214

• Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.

  Journal of controlled release : official journal of the Controlled Release Society 20081208

• Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse.

  Digestive diseases and sciences 20081201

• An unusual case of pneumonia.

  Internal and emergency medicine 20081201

• Synchronous fluorescence determination and molecular modeling of 5-Aminosalicylic acid (5-ASA) interacted with human serum albumin.

  Journal of molecular modeling 20081201

• Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis.

  The American journal of gastroenterology 20081201

• The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis.

  Biomaterials 20081201

• The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis.

  Alimentary pharmacology & therapeutics 20081201

• The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis.

  Alimentary pharmacology & therapeutics 20081201

• [Modern therapy of diverticular disease].

  Der Internist 20081201

• Optimizing conventional therapy for inflammatory bowel disease.

  Current gastroenterology reports 20081201

• Investigational treatment options in microscopic colitis.

  Expert opinion on investigational drugs 20081201

• Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?

  Minerva gastroenterologica e dietologica 20081201

• Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways.

  PLoS medicine 20081201

• Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.

  The American journal of gastroenterology 20081201

• Alpha-defensins and clostridium difficile recent growing concerns in inflammatory bowel disease.

  The American journal of gastroenterology 20081201

• Rapidly growing giant solitary cavernous hemangioma in a patient with ulcerative colitis.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20081201

• Retraction notice to 'Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease' [European Journal of Medicinal Chemistry 42 (2006) 885-890].

  European journal of medicinal chemistry 20081201

• Balsalazide-induced myocarditis.

  International journal of cardiology 20081128

• Segmental colitis associated with diverticulosis syndrome.

  World journal of gastroenterology 20081114

• Enzyme-catalyzed formation and structure characteristics of a protein-based hydrogel.

  The journal of physical chemistry. B 20081106

• A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20081101

• Is once-daily dosing of mesalazine effective for maintenance of remission in patients with ulcerative colitis?

  Nature clinical practice. Gastroenterology & hepatology 20081101

• Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.

  Journal of gastroenterology and hepatology 20081101

• Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20081101

• [Myocarditis or subendocardial myocardial infarction: role of MRI illustrated by a case report].

  Annales de cardiologie et d'angeiologie 20081101

• Chemoprevention of colorectal cancer: feasibility in everyday practice?

  European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 20081101

• [Contemporary views on non-specific ulcerative colitis and conservative methods of its treatment ].

  Voenno-meditsinskii zhurnal 20081101

• Rectal administration of d-alpha tocopherol for active ulcerative colitis: a preliminary report.

  World journal of gastroenterology 20081021

• Insights into inflammation and influenza.

  The New England journal of medicine 20081009

• Paediatric inflammatory bowel disease in New Zealand.

  The New Zealand medical journal 20081003

• 5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.

  Inflammatory bowel diseases 20081001

• Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy.

  Inflammatory bowel diseases 20081001

• Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20081001

• Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats.

  Experimental biology and medicine (Maywood, N.J.) 20081001

• Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study.

  The American journal of gastroenterology 20081001

• Development and in-vitro evaluation of a colon-specific controlled release drug delivery system.

  The Journal of pharmacy and pharmacology 20081001

• Adverse events of IBD therapies.

  Inflammatory bowel diseases 20081001

• What is the optimal maintenance treatment for ulcerative colitis?

  Inflammatory bowel diseases 20081001

• How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?

  Inflammatory bowel diseases 20081001

• Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?

  Inflammatory bowel diseases 20081001

• Which are the 5-ASA compound side effects and how is it possible to avoid them?

  Inflammatory bowel diseases 20081001

• What is the optimal therapy for severe ulcerative colitis?

  Inflammatory bowel diseases 20081001

• Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20081001

• Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study.

  Gastroenterologia y hepatologia 20081001

• Treatment of Crohn's disease with colony-stimulating factors: An overview.

  Therapeutics and clinical risk management 20081001

• [Functional and motor gastrointestinal disorders].

  Gastroenterologia y hepatologia 20081001

• [Update on the treatment of ulcerative colitis].

  Gastroenterologia y hepatologia 20081001

• Immune system and inflammation.

  Indian journal of pharmacology 20081001

• Prize sessions.

  Indian journal of pharmacology 20081001

• Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis--methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa.

  Alimentary pharmacology & therapeutics 20080915

• Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease.

  Alimentary pharmacology & therapeutics 20080915

• Annular lichen planus in association with Crohn disease.

  Dermatology online journal 20080915

• Medication adherence and quality of life in pediatric inflammatory bowel disease.

  Journal of pediatric psychology 20080901

• Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome).

  Digestive diseases and sciences 20080901

• Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20080901

• Mesalazine-induced jaundice, eosonophilia, and thrombocytopenia.

  Inflammatory bowel diseases 20080901

• Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.

  Alimentary pharmacology & therapeutics 20080901

• Combined butyric acid/mesalazine treatment in ulcerative colitis with mild-moderate activity. Results of a multicentre pilot study.

  Minerva gastroenterologica e dietologica 20080901

• Collagenous colitis with unique colonoscopic findings.

  Endoscopy 20080901

• Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080901

• Is rosiglitazone a promising treatment for ulcerative colitis?

  Nature clinical practice. Gastroenterology & hepatology 20080901

• Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone.

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080901

• Balsalazide plus high-potency probiotic preparation (VSL[sharp]3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon.

  Journal of clinical gastroenterology 20080901

• Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.

  Zeitschrift fur Gastroenterologie 20080901

• [A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080901

• Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

  Biologics : targets & therapy 20080901

• Infliximab in ulcerative colitis.

  Biologics : targets & therapy 20080901

• Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol.

  International journal of pharmaceutics 20080806

• Parotitis and acute pancreatitis in a patient with ulcerative colitis.

  European journal of pediatrics 20080801

• Mea culpa.

  Nature clinical practice. Gastroenterology & hepatology 20080801

• Microscopic colitis: an approach to treatment.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20080801

• Palmar-plantar erythrodysesthesia caused by mercaptopurine and mesalamine.

  Archives of dermatology 20080801

• [Crohn's disease in association with IgA nephropathy].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080801

• Molecular basis of the potential of mesalazine to prevent colorectal cancer.

  World journal of gastroenterology 20080728

• Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease.

  World journal of gastroenterology 20080721

• Severe chest pain in a pediatric ulcerative colitis patient after 5-aminosalicylic acid therapy.

  World journal of gastroenterology 20080721

• Budesonide for induction of remission in Crohn's disease.

  The Cochrane database of systematic reviews 20080716

• Clinical use of E. coli Nissle 1917 in inflammatory bowel disease.

  Inflammatory bowel diseases 20080701

• Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis.

  Gut 20080701

• How important is mesalamine in the maintenance of steroid-refractory colitis?

  Inflammatory bowel diseases 20080701

• PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells.

  Carcinogenesis 20080701

• Treatment of inflammatory bowel disease: a role for hypnotherapy?

  The International journal of clinical and experimental hypnosis 20080701

• De-novo [corrected] post renal transplantation inflammatory bowel disease.

  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20080701

• Therapy of ulcerative colitis: state of the art.

  Current opinion in gastroenterology 20080701

• Effects and treatment of inflammatory bowel disease during pregnancy.

  Canadian family physician Medecin de famille canadien 20080701

• [Effect of retention enema with combination of compound glutamine entero-soluble capsule and glucocorticoids for treatment of ulcerative colitis].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20080701

• [Studied on the determination of protein by probe of zinc 5-aminosalicylate].

  Guang pu xue yu guang pu fen xi = Guang pu 20080701

• [Relapse rates of ulcerative colitis in remission and factors related to relapse].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080701

• [Relapse of ulcerative colitis in remission].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080701

• Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.

  World journal of gastroenterology 20080614

• Can 5-aminosalicylic acid suppository decrease the pain after rectal band ligation?

  World journal of gastroenterology 20080614

• Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).

  Journal of medicinal chemistry 20080612

• Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis.

  Digestive diseases and sciences 20080601

• Prevention of postoperative recurrence in Crohn's disease.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20080601

• Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells.

  Gut 20080601

• Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis.

  Inflammatory bowel diseases 20080601

• MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.

  Alimentary pharmacology & therapeutics 20080601

• Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies.

  Alimentary pharmacology & therapeutics 20080601

• Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.

  The Annals of pharmacotherapy 20080601

• Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase.

  Carcinogenesis 20080601

• Ulcerative colitis and PPAR gamma ligand. Is cardiac toxicity on the other side of the coin?

  The American journal of gastroenterology 20080601

• Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17.

  British journal of pharmacology 20080601

• Anti-inflammatory activity of some potassium salts of N,N-disubstituted 4-aminoazobenzenesulfonic acids in rat adjuvant arthritis.

  Archives of pharmacal research 20080601

• Mesalamine with MMX technology for the treatment of ulcerative colitis.

  Expert review of gastroenterology & hepatology 20080601

• Natalizumab in the treatment of Crohn's disease.

  Biologics : targets & therapy 20080601

• N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study.

  World journal of gastroenterology 20080514

• The manufacture and characterisation of hot-melt extruded enteric tablets.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080501

• Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.

  The American journal of gastroenterology 20080501

• Cobblestone appearance in the colon of a 24-year-old man.

  Gut 20080501

• Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.

  Journal of digestive diseases 20080501

• Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review.

  Zeitschrift fur Gastroenterologie 20080501

• Understanding the Mechanism of 5-ASA in Treating Colonic Inflammation.

  Gastroenterology & hepatology 20080501

• Synthesis and biological activity of peptide derivatives of iodoquinazolinones/nitroimidazoles.

  Molecules (Basel, Switzerland) 20080424

• Interventions for treating collagenous colitis.

  The Cochrane database of systematic reviews 20080416

• Interventions for treating lymphocytic colitis.

  The Cochrane database of systematic reviews 20080416

• Traditional corticosteroids for induction of remission in Crohn's disease.

  The Cochrane database of systematic reviews 20080416

• [Treating distal ulcerative colitis intrarectally. Foam instead of enema, low volume rather than high volume].

  MMW Fortschritte der Medizin 20080410

• Delayed release tablet dissolution related to coating thickness by terahertz pulsed image mapping.

  Journal of pharmaceutical sciences 20080401

• Medication non-adherence is associated with increased medical health care costs.

  Digestive diseases and sciences 20080401

• Oral 5-ASA therapy in ulcerative colitis: what are the implications of the new formulations?

  Journal of clinical gastroenterology 20080401

• Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1.

  Biochemical pharmacology 20080401

• Ulcerative proctitis: a review of pharmacotherapy and management.

  Expert opinion on pharmacotherapy 20080401

• MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis.

  Expert opinion on pharmacotherapy 20080401

• Balsalazide disodium for the treatment of ulcerative colitis.

  Expert review of gastroenterology & hepatology 20080401

• [Once daily mesalazine for long-term remission. Ulcerative colitis: maintenance therapy becomes easier].

  MMW Fortschritte der Medizin 20080313

• The involvement of heme oxygenase-1 activity in the therapeutic actions of 5-aminosalicylic acid in rat colitis.

  European journal of pharmacology 20080310

• Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.

  The Journal of pharmacology and experimental therapeutics 20080301

• Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.

  European journal of gastroenterology & hepatology 20080301

• Review article: evolving concepts in treatment and disease modification in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20080301

• NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitis.

  Zeitschrift fur Gastroenterologie 20080301

• The effect of propolisis and mesalazine on bacterial translocation in an experimental colitis model.

  Saudi medical journal 20080301

• Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission.

  The American journal of gastroenterology 20080301

• Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.

  The AAPS journal 20080301

• Mesalamine for inflammatory bowel disease: recent reappraisals.

  Inflammation & allergy drug targets 20080301

• Complete remission of a primary rectal lymphoma on ulcerative colitis, after withdrawal of azathioprine and infliximab.

  Journal of Crohn's & colitis 20080301

• Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080201

• Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?

  Inflammatory bowel diseases 20080201

• Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.

  Inflammatory bowel diseases 20080201

• Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine.

  Inflammatory bowel diseases 20080201

• Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

  Biochemical pharmacology 20080201

• Effect of mesalamine on healing in experimental colon anastomosis: a randomised experimental study.

  International journal of surgery (London, England) 20080201

• Multi-matrix system mesalamine: to use or not to use.

  The Annals of pharmacotherapy 20080201

• Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.

  Reproductive toxicology (Elmsford, N.Y.) 20080201

• Management of distal ulcerative colitis: frequently asked questions analysis.

  Internal medicine journal 20080201

• Current practice in management of Crohn's disease in Wales.

  The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 20080201

• In vivo radioprotection by 5-aminosalicylic acid.

  Mutation research 20080131

• Quality of care for patients with inflammatory bowel disease in East China.

  World journal of gastroenterology 20080128

• Treatment of inflammatory bowel disease: a review of medical therapy.

  World journal of gastroenterology 20080121

• Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.

  Bioorganic & medicinal chemistry 20080115

• Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice.

  European journal of pharmacology 20080114

• A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis.

  World journal of gastroenterology 20080107

• 5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats.

  Digestive diseases and sciences 20080101

• Chronic pericarditis and pericardial tamponade associated with ulcerative colitis.

  Digestive diseases and sciences 20080101

• Review article: the evidence base for interventions used to maintain remission in Crohn's disease.

  Alimentary pharmacology & therapeutics 20080101

• Amphotericin B-induced cutaneous leucocytoclastic vasculitis: case report.

  Mycoses 20080101

• Synthesis and properties of N,N'-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine.

  Drug delivery 20080101

• Synthesis and theoretical calculations of 5-aminosalicylic acid derivatives as potential analgesic agents.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20080101

• Acute jejunoileal obstruction due to a pseudopolyp in a child with undiagnosed crohn disease: a case report.

  Journal of medical case reports 20080101

• Pulmonary manifestations in a pediatric patient with ulcerative colitis: a case report.

  Journal of medical case reports 20080101

• Granulomatous cheilitis associated with exacerbations of Crohn's disease: a case report.

  Journal of medical case reports 20080101

• Stroke in inflammatory bowel disease: a report of two cases and review of the literature.

  Thrombosis journal 20080101

• Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events.

  BMC musculoskeletal disorders 20080101

• A combination of rectal beclomethasone diproprionate and mesalazine in ulcerative proctitis.

  Scandinavian journal of gastroenterology 20080101

• Rebleeding rate after interventional therapy directed by capsule endoscopy in patients with obscure gastrointestinal bleeding.

  BMC gastroenterology 20080101

• Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.

  Reviews in gastroenterological disorders 20080101

• Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.

  Drugs 20080101

• PPARgamma Inhibitors as Novel Tubulin-Targeting Agents.

  PPAR research 20080101

• Radioprotection by copper and zinc complexes of 5-aminosalicylic acid: a preliminary study.

  Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 20080101

• Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.

  AIDS research and therapy 20080101

• [Inflammatory bowel disease. Should aminosalicylates be administered in a single daily dose in ulcerative colitis?].

  Gastroenterologia y hepatologia 20080101

• On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis.

  PloS one 20080101

• Collagenous colitis in a Japanese woman: successful treatment with mesalazine.

  Digestion 20080101

• Ulcerative colitis with positivity for proteinase 3-antineutrophil cytoplasmic antibody.

  Digestion 20080101

• Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission.

  Scandinavian journal of gastroenterology 20080101

• Sweet's syndrome in a patient with Crohn's disease: a case report.

  Journal of medical case reports 20080101

• Pulmonary complications resembling Wegener's granulomatosis in ulcerative colitis with elevated proteinase-3 anti-neutrophil cytoplasmic antibody.

  Internal medicine (Tokyo, Japan) 20080101

• Extreme thrombocytosis--an unusual presentation of inflammatory bowel disease.

  Internal medicine (Tokyo, Japan) 20080101

• On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease.

  PloS one 20080101

• Five mucosal transcripts of interest in ulcerative colitis identified by quantitative real-time PCR: a prospective study.

  BMC gastroenterology 20080101

• Mesalazine and/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon.

  Hepato-gastroenterology 20080101

• Novel 5-aminosalicylic acid formulations in ulcerative colitis: old dog, new tricks.

  Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20080101

• Cutaneous polyarteritis nodosa in a patient with Crohn's disease.

  Modern rheumatology 20080101

• Nicotine enemas for active Crohn's colitis: an open pilot study.

  Gastroenterology research and practice 20080101

• Design of a potential colonic drug delivery system of mesalamine.

  Pharmaceutical development and technology 20080101

• Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?

  Pharmacological research 20080101

• Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity.

  Health and quality of life outcomes 20080101

• High-utilizing Crohn's disease patients under psychosomatic therapy.

  BioPsychoSocial medicine 20080101

• Emerging therapies for diverticular disease of the colon.

  Journal of clinical gastroenterology 20080101

• Role of nitric oxide in the gastrointestinal tract.

  Arthritis research & therapy 20080101

• A short-oligonucleotide microarray that allows improved detection of gastrointestinal tract microbial communities.

  BMC microbiology 20080101

• Mild to moderate Crohn's disease: an evidence-based treatment algorithm.

  Drugs 20080101

• Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.

  BMC gastroenterology 20080101

• The changing face of spondyloarthropathies under TNF α blockade.

  The open rheumatology journal 20080101

• Frankincense: systematic review.

  BMJ (Clinical research ed.) 20080101

• Strategies to improve adherence and outcomes in patients with ulcerative colitis.

  Drugs 20080101

• PPARs Mediate Lipid Signaling in Inflammation and Cancer.

  PPAR research 20080101

• Selective drug delivery to the colon using pectin-coated pellets.

  PDA journal of pharmaceutical science and technology 20080101

• Ulcerative colitis.

  The Journal of practical nursing 20080101

• [Crohn's disease surgery: problems of postoperative recurrence].

  Chirurgia italiana 20080101

• Lymphocytic colitis in a child with non-responsive celiac disease.

  Acta gastro-enterologica Belgica 20080101

• Preparation, GIAO NMR calculations and acidic properties of some novel 4,5-dihydro-1H-1,2,4-triazol-5-one derivatives with their antioxidant activities.

  International journal of molecular sciences 20080101

• [Activity indices--objective criteria of the estimation of severity level of ulcerous colitis].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20080101

• Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

  Gene regulation and systems biology 20080101

• Metastatic Crohn's disease of external genitalia.

  Indian journal of dermatology 20080101

• Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial.

  Patient preference and adherence 20080101

• Exploration of cold extrusion for the preparation of enteric minitablets of isoniazid.

  Indian journal of pharmaceutical sciences 20080101

• Herbal excipients in novel drug delivery systems.

  Indian journal of pharmaceutical sciences 20080101

• Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives.

  Indian journal of pharmaceutical sciences 20080101

• An interesting case of mistaken identity.

  Case reports in gastroenterology 20080101

• Oropharyngeal Crohn's disease.

  Clinical and experimental gastroenterology 20080101

• Leukocytoclastic vasculitis as an onset symptom of Crohn's disease.

  Case reports in gastroenterology 20080101

• 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization.

  International journal of pharmaceutics 20071210

• Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism.

  The American journal of gastroenterology 20071201

• Pyoderma gangrenosum and interleukin 8.

  The British journal of dermatology 20071201

• Outcome of childhood ulcerative colitis at 2 years.

  Acta paediatrica (Oslo, Norway : 1992) 20071201

• Enteral nutrition-the new maintenance therapy in Crohn's disease?

  Inflammatory bowel diseases 20071201

• Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20071201

• Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.

  Zeitschrift fur Gastroenterologie 20071201

• Review article: Management of diverticulitis.

  Alimentary pharmacology & therapeutics 20071201

• [A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20071201

• Optimizing drug therapy in inflammatory bowel disease.

  Current gastroenterology reports 20071201

• Are we ready for top-down therapy for inflammatory bowel diseases: pro.

  Expert review of gastroenterology & hepatology 20071201

• Pulmonary abnormalities in inflammatory bowel disease.

  Journal of Crohn's & colitis 20071201

• 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.

  Journal of controlled release : official journal of the Controlled Release Society 20071120

• [Protective effect of epigallocatechin-3-gallate on inflammatory bowel disease: experiment with rat models of induced colitis].

  Zhonghua yi xue za zhi 20071113

• Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease.

  Digestive diseases and sciences 20071101

• Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.

  Digestive diseases and sciences 20071101

• A meta-analysis of antibiotic therapy for active ulcerative colitis.

  Digestive diseases and sciences 20071101

• Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis.

  Current medical research and opinion 20071101

• Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.

  Alimentary pharmacology & therapeutics 20071101

• Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.

  Alimentary pharmacology & therapeutics 20071101

• Estimating the economic burden of inflammatory bowel disease in Canada: physician office visits and mesalamine prescriptions dispensed as surrogate markers.

  The American journal of gastroenterology 20071101

• 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071101

• Ulcerative colitis: diagnosis and treatment.

  American family physician 20071101

• Use of a sulfated chitosan derivative to reduce bladder inflammation in the rat.

  Urology 20071101

• Is mesalamine safe?

  Gastroenterology & hepatology 20071101

• [Colorectal cancer in inflammatory bowel disease].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20071018

• Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.

  Journal of thrombosis and thrombolysis 20071001

• Nonadherence in inflammatory bowel disease: results of factor analysis.

  Inflammatory bowel diseases 20071001

• Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.

  Inflammatory bowel diseases 20071001

• Mud-bath treatment in spondylitis associated with inflammatory bowel disease--a pilot randomised clinical trial.

  Joint, bone, spine : revue du rhumatisme 20071001

• Education and imaging. Gastrointestinal: gastric Crohn's disease.

  Journal of gastroenterology and hepatology 20071001

• Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.

  Alimentary pharmacology & therapeutics 20071001

• Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes.

  Alimentary pharmacology & therapeutics 20071001

• The effect of propolisis and mesalazine on bacterial translocation in an experimental colitis model.

  Saudi medical journal 20071001

• A case of intestinal Behcet's disease similar to Crohn's colitis.

  Journal of Korean medical science 20071001

• Silent perforation: an iatrogenic complication of colonoscopy.

  Surgical laparoscopy, endoscopy & percutaneous techniques 20071001

• Editorial foreword.

  Therapeutics and clinical risk management 20071001

• The role of mesalamine in the treatment of ulcerative colitis.

  Therapeutics and clinical risk management 20071001

• Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis.

  Therapeutics and clinical risk management 20071001

• Overcoming adherence issues in ulcerative colitis.

  Gastroenterology & hepatology 20071001

• [Drug-induced pericarditis].

  Nihon rinsho. Japanese journal of clinical medicine 20070928

• Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.

  International journal of pharmaceutics 20070905

• Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.

  International journal of colorectal disease 20070901

• Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.

  International journal of colorectal disease 20070901

• Evaluation of alginate based mesalazine tablets for intestinal drug delivery.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070901

• Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study.

  Inflammatory bowel diseases 20070901

• Parallel manifestation of Crohn's disease and acute pericarditis: a report of two cases.

  International journal of colorectal disease 20070901

• [Collagenous colitis. Clinicopathological study of 18 cases].

  Revista clinica espanola 20070901

• Acute pancreatitis as a possible consequence of metronidazole during a relapse of ulcerative colitis.

  European journal of gastroenterology & hepatology 20070901

• Mild-to-moderate ulcerative colitis: your role in patient compliance and health care costs.

  Journal of managed care pharmacy : JMCP 20070901

• Ulcerative colitis: responding to the challenges.

  Cleveland Clinic journal of medicine 20070901

• Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.

  Drug development and industrial pharmacy 20070901

• The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems.

  International journal of nanomedicine 20070901

• Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis.

  Journal of Crohn's & colitis 20070901

• Mucocutaneous lesions of Behcet's disease.

  Yonsei medical journal 20070831

• Duration of treatment with 5-aminosalicylic acid compounds.

  World journal of gastroenterology 20070828

• Toxic epidermal necrosis associated with mesalamine in a patient with ulcerative colitis.

  Inflammatory bowel diseases 20070801

• 5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists.

  Inflammatory bowel diseases 20070801

• Extracorporeal leukocyte removal therapy for patients with ulcerative colitis.

  Pediatrics international : official journal of the Japan Pediatric Society 20070801

• A case of sequential development of celiac disease and ulcerative colitis.

  Nature clinical practice. Gastroenterology & hepatology 20070801

• Synthesis of chemically cross-linked hydroxypropyl methyl cellulose hydrogels and their application in controlled release of 5-amino salicylic acid.

  Drug development and industrial pharmacy 20070801

• Experimental validation for the use of a film on the basis of modified hyaluronic acid for prevention of postoperative peritoneal adhesions.

  Bulletin of experimental biology and medicine 20070801

• Enteral nutrition for maintenance of remission in Crohn's disease.

  The Cochrane database of systematic reviews 20070718

• Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.

  Bioorganic & medicinal chemistry 20070715

• MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.

  Alimentary pharmacology & therapeutics 20070715

• Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.

  International journal of colorectal disease 20070701

• Intercenter variation in initial management of children with Crohn's disease.

  Inflammatory bowel diseases 20070701

• Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.

  The American journal of gastroenterology 20070701

• Predictors of medication adherence in inflammatory bowel disease.

  The American journal of gastroenterology 20070701

• The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis.

  Diseases of the colon and rectum 20070701

• Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis.

  Alimentary pharmacology & therapeutics 20070701

• A clinical trial on absorption and N-acetylation of oral and rectal mesalazine.

  European journal of clinical investigation 20070701

• The effect of acetaminophen on oxidative modification of low-density lipoproteins in hypercholesterolemic rabbits.

  Journal of clinical biochemistry and nutrition 20070701

• [Medical therapy of inflammatory bowel diseases: ulcerative colitis].

  Orvosi hetilap 20070624

• [Medical therapy of inflammatory bowel diseases: Crohn's disease].

  Orvosi hetilap 20070617

• Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease.

  Alimentary pharmacology & therapeutics 20070615

• Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?

  Alimentary pharmacology & therapeutics 20070615

• Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.

  European journal of medicinal chemistry 20070601

• Microscopic colitis.

  Current treatment options in gastroenterology 20070601

• Combination therapy with symbiotics and local anti-inflammatories for red anusitis.

  Minerva gastroenterologica e dietologica 20070601

• Microscopic colitis: not just for aristocrats.

  Journal of gastroenterology and hepatology 20070601

• Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial.

  Journal of gastroenterology and hepatology 20070601

• [Treatment of chronic inflammatory bowel diseases].

  Bulletin de l'Academie nationale de medecine 20070601

• 5-aminosalicylic acid in combination with nimesulide inhibits proliferation of colon carcinoma cells in vitro.

  World journal of gastroenterology 20070528

• [Patients prefer foam].

  MMW Fortschritte der Medizin 20070524

• Inflammatory bowel disease: clinical aspects and established and evolving therapies.

  Lancet (London, England) 20070512

• Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.

  Diseases of the colon and rectum 20070501

• 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.

  Inflammatory bowel diseases 20070501

• Pyoderma gangrenosum associated with collagenous colitis.

  Clinical and experimental dermatology 20070501

• Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin.

  Alimentary pharmacology & therapeutics 20070501

• Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study).

  Scandinavian journal of gastroenterology 20070501

• Curcumin for maintenance therapy in ulcerative colitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070501

• [News from the Cochrane Library: Maintenance of remission in ulcerative colitis].

  Zeitschrift fur Gastroenterologie 20070501

• De novo Crohn's disease in a renal transplant recipient.

  Transplantation proceedings 20070501

• [A case of ulcerative colitis relapsed by influenza vaccination].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20070501

• [Crohn disease, exacerbated during pregnancy].

  Deutsche medizinische Wochenschrift (1946) 20070420

• Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis.

  Alimentary pharmacology & therapeutics 20070415

• 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.

  Inflammatory bowel diseases 20070401

• Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease.

  Inflammatory bowel diseases 20070401

• Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

  The American journal of gastroenterology 20070401

• Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.

  Diseases of the colon and rectum 20070401

• Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.

  Bioorganic & medicinal chemistry letters 20070401

• The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.

  European journal of pediatrics 20070401

• Topical treatment of ulcerative colitis. Some reflections.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20070401

• Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis.

  British journal of pharmacology 20070401

• Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20070401

• A case report of the therapeutic effect of cryofiltration in a patient with glucocorticoid-resistant ulcerative colitis.

  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20070401

• Colonic infiltration with chronic myelomonocytic leukemia.

  Nature clinical practice. Gastroenterology & hepatology 20070401

• 5-ASA and colorectal cell-cycle progression.

  Gastroenterology 20070401

• Effect of sulphasalazine and balsalazide on histamine release from mast cells.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20070401

• Once-daily mesalamine (Lialda) for ulcerative colitis.

  The Medical letter on drugs and therapeutics 20070326

• Severe myalgia associated with mesalazine treatment in a child with Crohn's disease.

  European journal of clinical pharmacology 20070301

• Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.

  Pharmaceutical research 20070301

• Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon.

  Digestive diseases and sciences 20070301

• Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers.

  Journal of clinical pharmacology 20070301

• Successful treatment with topical 5-aminosalicylic acid ointment and spray of refractory oral and pharyngeal ulcerations in a child with Crohn disease.

  Journal of pediatric gastroenterology and nutrition 20070301

• Mesalazine-induced bronchiectasis and eosinophilia in a patient with ulcerative colitis: a case report.

  Journal of the Royal Society of Medicine 20070301

• Drug insight: aminosalicylates for the treatment of IBD.

  Nature clinical practice. Gastroenterology & hepatology 20070301

• Biological variability and targeted delivery of therapeutics for inflammatory bowel diseases: an in silico approach.

  Inflammation & allergy drug targets 20070301

• Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis.

  Scandinavian journal of gastroenterology 20070301

• The risks and the benefits of mesalazine as a treatment for ulcerative colitis.

  Expert opinion on drug safety 20070301

• Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab).

  The Korean journal of internal medicine 20070301

• New pH-sensitive glycopolymers for colon-specific drug delivery.

  Drug delivery 20070301

• Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis.

  Pharmacogenetics and genomics 20070301

• Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).

  International journal of nanomedicine 20070301

• [Treatment of inflammatory bowel disease].

  Praxis 20070227

• ['Treatment refractory' ulcerative colitis].

  MMW Fortschritte der Medizin 20070215

• [Course and conservative treatment of diverticular disease].

  Praxis 20070214

• Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20070201

• Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.

  Gut 20070201

• Pyostomatitis vegetans: A clinical marker of silent ulcerative colitis.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070201

• Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease.

  Journal of pediatric gastroenterology and nutrition 20070201

• New physiopathological and therapeutic approaches to diverticular disease of the colon.

  Expert opinion on pharmacotherapy 20070201

• Measurement of small-bowel polyp size in patients with Peutz-Jeghers syndrome by using reference granules during video capsule endoscopy.

  Endoscopy 20070201

• Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.

  Therapeutic drug monitoring 20070201

• Bacillus cereus strain 10-L-2 produces two arylamine N-acetyltransferases that transform 4-phenylenediamine into 4-aminoacetanilide.

  Journal of bioscience and bioengineering 20070201

• [Benign intracranial hypertension and ulcerative colitis].

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20070201

• Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20070124

• A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20070101

• Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease.

  Acta paediatrica (Oslo, Norway : 1992) 20070101

• Does colonoscopy cause increased ulcerative colitis symptoms?

  Inflammatory bowel diseases 20070101

• Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.

  Inflammatory bowel diseases 20070101

• Effect of pioglitazone treatment on behavioral symptoms in autistic children.

  Journal of neuroinflammation 20070101

• Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery.

  Journal of pediatric surgery 20070101

• Drug-induced pericarditis mimicking Brugada syndrome.

  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20070101

• Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070101

• Once-daily, high-concentration MMX mesalamine in active ulcerative colitis.

  Gastroenterology 20070101

• 5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint.

  Gastroenterology 20070101

• Inflammatory bowel disease: past, present, and future.

  Journal of gastroenterology 20070101

• Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa.

  BMC biochemistry 20070101

• Gastroparesis in patients with inactive Crohn's disease: a case series.

  BMC gastroenterology 20070101

• Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli.

  BMC microbiology 20070101

• Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study.

  BMC gastroenterology 20070101

• [Ulcerative colitis and thrombocytopenia: a clinical case of fortuitous association?].

  La Clinica terapeutica 20070101

• Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.

  BMC medical genetics 20070101

• Medication beliefs among patients with inflammatory bowel disease who report low quality of life: a qualitative study.

  BMC gastroenterology 20070101

• On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis.

  PloS one 20070101

• Septic thrombophlebitis of the superior mesenteric vein and multiple liver abscesses in a patient with Crohn's disease at onset.

  BMC gastroenterology 20070101

• 'Take your medicine': nonadherence issues in patients with ulcerative colitis.

  Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 20070101

• Ulcerative colitis treatment for children and teens.

  FDA consumer 20070101

• Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation.

  Trials 20070101

• Crohn's disease and its mucocutaneous involvement.

  Skinmed 20070101

• [Anorectal tuberculosis. Case report].

  Revista de gastroenterologia de Mexico 20070101

• Acute motor sensory polyneuropathy (AMSAN) complicating active ulcerative colitis with a patchy distribution.

  Acta gastro-enterologica Belgica 20070101

• Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.

  BMC gastroenterology 20070101

• Bowel associated dermatosis - arthritis syndrome: a case report.

  Journal of medical case reports 20070101

• Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment?

  Digestive diseases (Basel, Switzerland) 20070101

• Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.

  Best practice & research. Clinical gastroenterology 20070101

• Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system.

  Advances in therapy 20070101

• Misleading pustular plaques of the lower limbs during Crohn's disease: two case reports.

  Journal of medical case reports 20070101

• Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.

  Dermatology (Basel, Switzerland) 20070101

• Effectiveness of mesalamine and propolis in experimental colitis.

  Advances in therapy 20070101

• Delayed-release Multi Matrix System (MMX) mesalazine: in ulcerative colitis.

  Drugs 20070101

• Delayed-release Multi Matrix System (MMX) mesalazine in ulcerative colitis: a viewpoint by Cosimo Prantera.

  Drugs 20070101

• Delayed-release Multi Matrix System (MMX) mesalazine in ulcerative colitis: a viewpoint by Ake Nilsson.

  Drugs 20070101

• Antioxidant effect of 5-amino salicylic acid on copper-mediated LDL oxidation.

  Biological research 20070101

• Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literature.

  Journal of medical case reports 20070101

• Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.

  PloS one 20070101

• Drug-induced pulmonary toxicity in a patient treated with mesalazine and azathioprine for ulcerative colitis.

  Acta gastro-enterologica Belgica 20070101

• Infectious mononucleosis-like syndrome induced by salazosulfapyridine in a patient with rheumatoid arthritis.

  Modern rheumatology 20070101

• Mild-to-moderate active luminal Crohn's disease.

  Digestion 20070101

• Maintenance of surgically induced remission of Crohn's disease.

  Digestion 20070101

• Upper gastrointestinal Crohn's disease.

  Digestion 20070101

• Pregnancy and breastfeeding in patients with Crohn's disease.

  Digestion 20070101

• Drug safety in Crohn's disease therapy.

  Digestion 20070101

• [New approaches to surgical treatment of Crohn's disease].

  Likars'ka sprava 20070101

• Pregnancy and inflammatory bowel disease: a prospective case-control study.

  Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20070101

• Colonic diverticular disease.

  BMJ clinical evidence 20070101

• Enterovesical fistulas secondary to Crohn's disease:medical versus surgical therapies.

  Urologia 20070101

• Infliximab: the evidence for its place in therapy in ulcerative colitis.

  Core evidence 20070101

• Adminstration of PEG-Interferon to a Patient with Ulcerative Colitis and Chronic Hepatitis C Correlated with Reduced Colonic Inflammation and Reversal of Peripheral Th1/Th2 Ratios.

  Case reports in gastroenterology 20070101

• Invasive amoebiasis complicating iflammatory bowel disease.

  The Libyan journal of medicine 20070101

• Refractory ulcerative colitis treatment.

  Gastroenterology & hepatology 20070101

• Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.

  Journal of clinical apheresis 20061201

• Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activity.

  Carcinogenesis 20061201

• Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.

  Diseases of the colon and rectum 20061201

• Medication-taking behavior in a cohort of patients with inflammatory bowel disease.

  Digestive diseases and sciences 20061201

• Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20061201

• Neoplasia in inflammatory bowel disease: surveillance and management strategies.

  Current gastroenterology reports 20061201

• Infliximab in ulcerative colitis.

  Gastroenterology clinics of North America 20061201

• Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis.

  Carbohydrate research 20061127

• Efficacy of granulocyte apheresis in pediatric patients with ulcerative colitis: a pilot study.

  Journal of pediatric gastroenterology and nutrition 20061101

• [Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates].

  Medizinische Klinik (Munich, Germany : 1983) 20061015

• [Inflammatory bowel disease and colorectal cancer].

  Orvosi hetilap 20061015

• Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

  World journal of gastroenterology 20061014

• Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.

  The Journal of pharmacology and experimental therapeutics 20061001

• 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity.

  The Journal of pharmacology and experimental therapeutics 20061001

• 5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death.

  European journal of cancer (Oxford, England : 1990) 20061001

• Transport studies with 5-aminosalicylate.

  European journal of clinical pharmacology 20061001

• Review article: can post-operative recurrence in Crohn's disease be prevented?

  Alimentary pharmacology & therapeutics 20061001

• Review article: recurrence of Crohn's disease after surgery - the need for treatment of new lesions.

  Alimentary pharmacology & therapeutics 20061001

• Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20061001

• Review article: aminosalicylates for distal colitis.

  Alimentary pharmacology & therapeutics 20061001

• Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20061001

• Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease.

  Gut 20061001

• Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.

  Alimentary pharmacology & therapeutics 20061001

• Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.

  Inflammatory bowel diseases 20061001

• Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.

  Inflammatory bowel diseases 20061001

• Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid.

  Inflammatory bowel diseases 20061001

• Leukocytapheresis in patients with moderate-severe steroid-dependant ulcerative colitis: clinical response without endoscopic response.

  Inflammatory bowel diseases 20061001

• Butyrate induces necrotic cell death in murine colonic epithelial cell MCE301.

  Biological & pharmaceutical bulletin 20061001

• A two-stage decision analysis to assess the cost of 5-aminosalicylic acid failure and the economics of balsalazide versus mesalamine in the treatment of ulcerative colitis.

  Managed care interface 20061001

• [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].

  La Tunisie medicale 20061001

• Diffuse gastroduodenitis and pouchitis associated with ulcerative colitis.

  World journal of gastroenterology 20060928

• Colitis and bronchiolitis obliterans organising pneumonia--the treatment or the disease?

  The New Zealand medical journal 20060908

• Granulomatous enterocolitis associated with Hermansky-Pudlak syndrome.

  The American journal of gastroenterology 20060901

• A case of Crohn's disease with hydronephrosis caused by ureteropelvic junction obstruction.

  European journal of gastroenterology & hepatology 20060901

• PPARgamma as a new therapeutic target in inflammatory bowel diseases.

  Gut 20060901

• Herpes simplex virus colitis in ulcerative colitis, simulating malignancy.

  Histopathology 20060901

• Editorial: mesalazine in ulcerative colitis--is it time to revise treatment guidelines in the UK?

  Alimentary pharmacology & therapeutics 20060901

• Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.

  Alimentary pharmacology & therapeutics 20060901

• Review article: induction therapy for patients with active ulcerative colitis.

  Alimentary pharmacology & therapeutics 20060901

• Review article: maintenance therapy in patients with ulcerative colitis.

  Alimentary pharmacology & therapeutics 20060901

• Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.

  Gastroenterology 20060901

• Natural history and management of flat and polypoid dysplasia in inflammatory bowel disease.

  Gastroenterology clinics of North America 20060901

• Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.

  Gastroenterology clinics of North America 20060901

• [A case report: Severe bone marrow suppression caused by 6-mercaptopurin in Crohn's disease patient].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20060901

• [A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin for chronic hepatitis C].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20060901

• Steroid dependent ulcerative colitis: azathioprine use is finally 'evidence-based'.

  Inflammatory bowel diseases 20060901

• Lack of cross-reactivity between 5-aminosalicylic acid-based drugs: a case report and review of the literature.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20060901

• [Probiotics in chronic inflammatory bowel disease].

  MMW Fortschritte der Medizin 20060831

• Conventional therapy for Crohn's disease.

  World journal of gastroenterology 20060814

• Histopathological comparison of topical therapy modalities for acute radiation proctitis in an experimental rat model.

  World journal of gastroenterology 20060814

• Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.

  Scandinavian journal of gastroenterology 20060801

• What do we know about diverticular disease? A brief overview.

  Journal of clinical gastroenterology 20060801

• A hypothesis: is diverticulitis a type of inflammatory bowel disease?

  Journal of clinical gastroenterology 20060801

• The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.

  Journal of clinical gastroenterology 20060801

• Use of mesalazine in diverticular disease.

  Journal of clinical gastroenterology 20060801

• Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20060801

• Variation in severity assessment and initial mesalamine dose selection for ulcerative colitis in community practice.

  Journal of clinical gastroenterology 20060801

• Growth factors as treatment options for intestinal inflammation.

  Annals of the New York Academy of Sciences 20060801

• [Diverticulitis and diverticulosis].

  MMW Fortschritte der Medizin 20060720

• Postoperative maintenance therapy for inflammatory bowel disease.

  Current opinion in gastroenterology 20060701

• Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis.

  Inflammatory bowel diseases 20060701

• Microbial transformation of aniline derivatives: regioselective biotransformation and detoxification of 2-phenylenediamine by Bacillus cereus strain PDa-1.

  Journal of bioscience and bioengineering 20060701

• [A clinical trial of rosiglitazone and 5-aminosalicylate combination for ulcerative colitis].

  Zhonghua nei ke za zhi 20060701

• High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma.

  Journal of chromatography. A 20060630

• Pharmacogenetics in inflammatory bowel disease.

  World journal of gastroenterology 20060621

• Collagenous colitis and spondylarthropathy.

  Arthritis and rheumatism 20060615

• [Chronic inflammatory bowel diseases. Proven and innovative in the treatment].

  MMW Fortschritte der Medizin 20060615

• Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20060601

• Guidelines for the treatment of Crohn's disease in children.

  Pediatrics international : official journal of the Japan Pediatric Society 20060601

• Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.

  Gastroenterology 20060601

• [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].

  Zeitschrift fur Gastroenterologie 20060601

• Risk factors for colorectal cancer in Crohn's colitis: a case-control study.

  Inflammatory bowel diseases 20060601

• Mesalamine may be preferable to sulfasalazine in dermatologic therapeutics.

  International journal of dermatology 20060601

• [The usefulness of mesalazine suppositories for the treatment of lymphoid follicular proctitis].

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060601

• Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration.

  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20060601

• Acute tubulointerstitial nephritis due to 5-aminosalicylic acid in a patient with ulcerative colitis and chronic renal failure.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20060601

• [Lymphocitic colitis and celiac disease].

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20060601

• Management of diverticular disease is changing.

  World journal of gastroenterology 20060528

• [5-aminosalicylic acid and cancer prophylaxis?].

  Ugeskrift for laeger 20060522

• [Does 5-ASA prevent development of colon cancer in ulcerative colitis?].

  Ugeskrift for laeger 20060522

• Review article: uncomplicated diverticular disease of the colon.

  Alimentary pharmacology & therapeutics 20060515

• Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.

  Alimentary pharmacology & therapeutics 20060515

• Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.

  Gut 20060501

• Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060501

• Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20060501

• What's new: innovative concepts in inflammatory bowel disease.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20060501

• New patients: should children be treated differently?

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20060501

• New lessons: classic treatments, expanding options in ulcerative colitis.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20060501

• Combined oral and topical mesalazine treatment for extensive ulcerative colitis.

  Nature clinical practice. Gastroenterology & hepatology 20060501

• Behçet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease.

  Clinical and experimental dermatology 20060501

• [Infliximab-induced hepatitis in a patient with Crohn's disease].

  Gastroenterologia y hepatologia 20060501

• Colon-specific delivery of mesalazine chitosan microspheres.

  Journal of microencapsulation 20060501

• [Sinus bradycardia associated with mesalazine].

  Medicina clinica 20060429

• Intestinal Behcet's disease with esophageal ulcers and colonic longitudinal ulcers.

  World journal of gastroenterology 20060428

• Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20060419

• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20060419

• A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon.

  Molecular pharmacology 20060401

• Prevention of postoperative recurrence of Crohn's disease by infliximab.

  European journal of gastroenterology & hepatology 20060401

• Systematic review: the use of mesalazine in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20060401

• Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis.

  Alimentary pharmacology & therapeutics 20060401

• A patient with anemia of obscure origin: Crohn's disease in disguise.

  Nature clinical practice. Gastroenterology & hepatology 20060401

• Management of inflammatory bowel diseases in Eastern Europe.

  Postgraduate medical journal 20060401

• Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis.

  Digestive diseases and sciences 20060401

• Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060401

• Risk factors for initial surgery in pediatric patients with Crohn's disease.

  Gastroenterology 20060401

• 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.

  Inflammatory bowel diseases 20060401

• Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.

  Inflammatory bowel diseases 20060401

• Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine.

  Inflammatory bowel diseases 20060401

• Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study.

  Journal of clinical gastroenterology 20060401

• [Massive pulmonary embolism in a patient with ulcerative colitis and hyperhomocysteinaemia -- a case report].

  Kardiologia polska 20060401

• Inflammatory bowel disease in children: a pediatrician's perspective.

  Minerva pediatrica 20060401

• [Experimental methods in the treatment of Leśniowski-Crohn disease].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20060401

• The application of LC-NMR and LC-MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid.

  Journal of pharmaceutical and biomedical analysis 20060318

• [Colostomy as a cause of deviation colitis in a blind-ended bowel segment].

  Nederlands tijdschrift voor geneeskunde 20060311

• Mesalazine-induced myopericarditis in a patient with ulcerative colitis.

  International journal of colorectal disease 20060301

• Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060301

• Systematic review: adherence issues in the treatment of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20060301

• European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

  Gut 20060301

• [Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].

  Zeitschrift fur Gastroenterologie 20060301

• Appendix adenocarcinoma associated with ulcerative colitis: a case report and literature review.

  Techniques in coloproctology 20060301

• Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon.

  Digestive diseases and sciences 20060301

• Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats.

  Digestive diseases and sciences 20060301

• [Infliximab in the treatment of patients with Crohn's disease: preliminary report].

  Revista medica de Chile 20060301

• [Modern indications on the medical treatment of symptomatic diverticular disease].

  Il Giornale di chirurgia 20060301

• [A case of Crohn's disease successfully treated with infliximab without steroid].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20060301

• Dense eosinophilic infiltration of the mucosa preceding ulcerative colitis and mimicking eosinophilic colitis: report of two cases.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20060301

• Motor axonal polyneuropathy in the course of ulcerative colitis: a case report.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20060301

• Synthesis and characterization of acrylic type hydrogels containing azo derivatives of 5-amino salicylic acid for colon-specific drug delivery.

  Inflammopharmacology 20060301

• Inflammatory bowel disease in Thai children: presentations and outcomes of treatment.

  Asian Pacific journal of allergy and immunology 20060301

• Higher platelet P-selectin in male patients with inflammatory bowel disease compared to healthy males.

  World journal of gastroenterology 20060227

• Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature.

  World journal of gastroenterology 20060227

• Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?

  World journal of gastroenterology 20060207

• Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells.

  Cell death and differentiation 20060201

• Small bowel infarction in a patient with coeliac disease.

  Journal of clinical pathology 20060201

• [MALT lymphoma in a patient with Crohn's disease. A causal or incidental association?].

  Gastroenterologia y hepatologia 20060201

• Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats.

  Postgraduate medical journal 20060201

• Azathioprine versus mesalamine in steroid-dependent ulcerative colitis: long-awaited results?

  Gastroenterology 20060201

• Acute duodenal Crohn's disease successfully managed with low-speed elemental diet infusion via nasogastric tube: a case report.

  World journal of gastroenterology 20060128

• [Inflammatory diseases of the intestines].

  Revue medicale suisse 20060118

• [Diverticulosis/diverticulitis? What are conservative therapy possibilities?].

  Medizinische Klinik (Munich, Germany : 1983) 20060115

• A multi-scale stochastic drug release model for polymer-coated targeted drug delivery systems.

  Journal of controlled release : official journal of the Controlled Release Society 20060110

• [Treatment of servere ulcerative colitis].

  Nederlands tijdschrift voor geneeskunde 20060107

• Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.

  Gut 20060101

• 5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers.

  Alimentary pharmacology & therapeutics 20060101

• Distal adenomatous polyps are rare in patients with inflammatory bowel disease.

  Postgraduate medical journal 20060101

• Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.

  Digestion 20060101

• Acute cytomegalovirus infection associated with the onset of inflammatory bowel disease.

  The American journal of the medical sciences 20060101

• Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients.

  Digestive diseases and sciences 20060101

• [Palliative therapy in patients with biliary tract cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• Acute onset of ulcerative colitis following an operation for sigmoid colon cancer.

  Journal of gastroenterology 20060101

• Changes in ion transport in inflammatory disease.

  Journal of inflammation (London, England) 20060101

• Clinical aspects of ulcerative colitis in mainland China.

  Chinese journal of digestive diseases 20060101

• Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.

  Reviews in gastroenterological disorders 20060101

• Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.

  BMC complementary and alternative medicine 20060101

• Fecopneumothorax and colopleural fistula - uncommon complications of Crohn's disease.

  BMC gastroenterology 20060101

• Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.

  Hepato-gastroenterology 20060101

• Mesalazine-induced Churg-Strauss syndrome in a patient with Crohn's disease and sclerosing cholangitis.

  Clinical and experimental rheumatology 20060101

• Factors associated with disease evolution in Greek patients with inflammatory bowel disease.

  BMC gastroenterology 20060101

• A subgroup of first-degree relatives of Crohn's disease patients shows a profile of inflammatory markers in the blood which is more typical of Crohn's disease patients than of normal individuals.

  Mediators of inflammation 20060101

• 36 year old man presenting with pancreatitis and a history of recent commencement of Orlistat case report.

  Nutrition journal 20060101

• Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis.

  Digestion 20060101

• MMX mesalamine.

  Reviews in gastroenterological disorders 20060101

• Antidepressants and inflammatory bowel disease: a systematic review.

  Clinical practice and epidemiology in mental health : CP & EMH 20060101

• [Inflammatory bowel disease and lung].

  Tuberkuloz ve toraks 20060101

• Adrenal incidentaloma: review of 197 patients and report of a drug-related false-positive urinary normetanephrine result.

  Surgery today 20060101

• 'In vitro' activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis.

  Annals of clinical microbiology and antimicrobials 20060101

• Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.

  Drugs 20060101

• Autoimmune hearing loss and ulcerative colitis.

  Brazilian journal of otorhinolaryngology 20060101

• Mesalazine interstitial nephritis presenting as colitis ulcerosa exacerbation.

  Acta gastro-enterologica Belgica 20060101

• [The influence of Candida albicans on the course of ulcerative colitis].

  Przeglad lekarski 20060101

• [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20060101

• [Pulmonary complications in patient with ulcerative colitis, treated with 5-aminosalicylic preparations].

  Pneumonologia i alergologia polska 20060101

• Pericarditis in exacerbation of ulcerative colitis.

  Acta gastro-enterologica Belgica 20060101

• Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-alpha, NF-kappaBp65, IL-6) in TNBS-induced colitis in rats.

  Mediators of inflammation 20060101

• Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase.

  Mediators of inflammation 20060101

• Azo chemistry and its potential for colonic delivery.

  Critical reviews in therapeutic drug carrier systems 20060101

• Ileoileal intussusception as initial manifestation of Crohn's disease.

  McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students 20060101

• Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates.

  World journal of gastroenterology 20051221

• Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study.

  World journal of gastroenterology 20051207

• Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.

  International journal of radiation oncology, biology, physics 20051201

• Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.

  Alimentary pharmacology & therapeutics 20051201

• Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment.

  Inflammatory bowel diseases 20051201

• What is the optimal dosage of mesalazine to maintain remission in patients with ulcerative colitis?

  Nature clinical practice. Gastroenterology & hepatology 20051201

• Managing complicated Crohn's disease in children and adolescents.

  Nature clinical practice. Gastroenterology & hepatology 20051201

• Two cases of systemic lupus erythematosus complicated with colonic ulcers.

  Internal medicine (Tokyo, Japan) 20051201

• [Induction of tolerance in hypersensitivity to mesalazine (5-ASA)].

  Anales de medicina interna (Madrid, Spain : 1984) 20051201

• Colonic diverticular disease.

  Clinical evidence 20051201

• A case of bowel schistosomiasis not adhering to endoscopic findings.

  World journal of gastroenterology 20051128

• 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.

  Gut 20051101

• 5-Aminosalicylates and effects on renal function in patients with Crohn's disease.

  Inflammatory bowel diseases 20051101

• A randomized trial of nicotine enemas for active ulcerative colitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051101

• Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.

  The American journal of gastroenterology 20051101

• Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity.

  Free radical research 20051101

• Drug-induced bullous pemphigoid caused by a generic Canadian medication obtained over the internet.

  Archives of dermatology 20051101

• Takayasu's arteritis and ulcerative colitis in a young non-Asian woman: a rare association.

  VASA. Zeitschrift fur Gefasskrankheiten 20051101

• Budesonide for induction of remission in Crohn's disease.

  The Cochrane database of systematic reviews 20051019

• Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?

  Journal of clinical apheresis 20051001

• 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for 'best evidence'?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20051001

• Reaction of 5-aminosalicylic acid with peroxyl radicals: protection and recovery by ascorbic acid and amino acids.

  Pharmaceutical research 20051001

• The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.

  Alimentary pharmacology & therapeutics 20051001

• Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.

  Digestive diseases and sciences 20051001

• Inflammatory bowel disease and drug intake.

  Inflammatory bowel diseases 20051001

• Horseradish peroxidase-catalyzed oxidation of rifampicin: reaction rate enhancement by co-oxidation with anti-inflammatory drugs.

  Biological & pharmaceutical bulletin 20051001

• Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report.

  Journal of pediatric gastroenterology and nutrition 20051001

• Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20051001

• Treatment-resistant lingual Crohn's disease disappears after infliximab.

  Scandinavian journal of gastroenterology 20051001

• Mesalazine-associated acute tubulointerstitial nephritis in a patient with spondylarthropathy.

  The New Zealand medical journal 20050916

• Refractory ulcerative colitis accompanied with cytomegalovirus colitis and multiple liver abscesses: a case report.

  World journal of gastroenterology 20050907

• Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.

  Pharmacological research 20050901

• Drug-induced pancreatitis: an update.

  Journal of clinical gastroenterology 20050901

• Comparative study of enema retention and preference in ulcerative colitis.

  Postgraduate medical journal 20050901

• [A case of mesalazine-induced pleuritis with hemophagocytic findings].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20050901

• Severe exudative ascites as an initial presentation of Crohn's disease.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20050901

• Significance of salicylate intolerance in diseases of the lower gastrointestinal tract.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20050901

• Melatonin reduces inflammatory injury through inhibiting NF-kappaB activation in rats with colitis.

  Mediators of inflammation 20050831

• Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets.

  International journal of pharmaceutics 20050826

• [Paradigmatic shift in drug treatment of Crohn disease].

  Ugeskrift for laeger 20050815

• [Mesalazine for maintenance of medically-induced remission in Crohn disease: a survey of a Cochrane review].

  Ugeskrift for laeger 20050815

• Update in medical therapy of ulcerative colitis: newer concepts and therapies.

  Journal of clinical gastroenterology 20050801

• 5-Aminosalicylic acid reverses endosulfan-induced testicular toxicity in male rats.

  Mutation research 20050801

• Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.

  Pharmaceutical research 20050801

• Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.

  Gastroenterology 20050801

• Safety of high doses of mesalazine during pregnancy.

  The American journal of gastroenterology 20050801

• Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.

  PLoS medicine 20050801

• Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism.

  Scandinavian journal of gastroenterology 20050801

• Drug release from the enzyme-degradable and pH-sensitive hydrogel composed of glycidyl methacrylate dextran and poly(acrylic acid).

  Archives of pharmacal research 20050801

• Factors affecting recurrence after surgery for Crohn's disease.

  World journal of gastroenterology 20050714

• Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.

  Gut 20050701

• Efficacy and safety of mesalamine 1 g HS versus 500 mg BID suppositories in mild to moderate ulcerative proctitis: a multicenter randomized study.

  Inflammatory bowel diseases 20050701

• Is non-adherence to blame?

  Inflammatory bowel diseases 20050701

• [A case of simple ulcer with ulcerative colitis].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20050701

• [Primary sclerosing cholangitis: a twelve-year experience].

  Revista medica de Chile 20050701

• Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin.

  The New England journal of medicine 20050616

• A validated HPLC method with electrochemical detection for simultaneous assay of 5-aminosalicylic acid and its metabolite in human plasma.

  Biomedical chromatography : BMC 20050601

• Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.

  Journal of microbiological methods 20050601

• Colonic targeting of aminosalicylates for the treatment of ulcerative colitis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050601

• The case for using 5-aminosalicyclates in Crohn's disease: pro.

  Inflammatory bowel diseases 20050601

• The case against using 5-aminosalicyclates in Crohn's disease: con.

  Inflammatory bowel diseases 20050601

• Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.

  Inflammatory bowel diseases 20050601

• Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

  The American journal of gastroenterology 20050601

• Will a 5-ASA a day keep the cancer (and dysplasia) away?

  The American journal of gastroenterology 20050601

• Are patients with inflammatory bowel disease receiving optimal care?

  The American journal of gastroenterology 20050601

• Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis.

  Alimentary pharmacology & therapeutics 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model.

  The Journal of pharmacy and pharmacology 20050601

• Acute pancreatitis in patients with ulcerative colitis.

  Digestive diseases and sciences 20050601

• Synthesis and anti-inflammatory testing of some new compounds incorporating 5-aminosalicylic acid (5-ASA) as potential prodrugs.

  Archives of pharmacal research 20050601

• [Primary chemoprevention of colorectal cancer in patients with inflammatory bowel diseases].

  Likars'ka sprava 20050601

• [Pharmacogenetics of inflammatory bowel disease].

  Orvosi hetilap 20050522

• Experience of 5-aminosalicylate nephrotoxicity in the United Kingdom.

  Alimentary pharmacology & therapeutics 20050515

• Mesalazine improves replication fidelity in cultured colorectal cells.

  Cancer research 20050515

• [Treatment strategies for inflammatory bowel disease].

  La Revue du praticien 20050515

• Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon.

  World journal of gastroenterology 20050514

• [Improved treatment of Crohn's disease].

  Revue medicale suisse 20050504

• Multicentre randomized-controlled clinical trial of Ipocol, a new enteric-coated form of mesalazine, in comparison with Asacol in the treatment of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20050501

• Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20050501

• Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.

  Alimentary pharmacology & therapeutics 20050501

• A new oral delivery system for 5-ASA: preliminary clinical findings for MMx.

  Inflammatory bowel diseases 20050501

• Antibiotic use and the risk of flare of inflammatory bowel disease.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20050501

• [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• [Immunosuppressants for therapy of patients with ulcerative colitis].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• [Enema therapy for ulcerative colitis patients].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• [Guidelines for treatment of ulcerative colitis in children].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis.

  Gastroenterology 20050501

• Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity.

  Apoptosis : an international journal on programmed cell death 20050501

• [Ulcerative colitis and Crohn's disease].

  Nihon rinsho. Japanese journal of clinical medicine 20050501

• Effect of simulated gastrointestinal conditions on drug release from pectin/ethylcellulose as film coating for drug delivery to the colon.

  Drug development and industrial pharmacy 20050501

• [Chronic inflammatory bowel diseases. Update on evidence-based therapy].

  MMW Fortschritte der Medizin 20050428

• Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.

  The Journal of experimental medicine 20050418

• [Mesalazine is effective in Crohn disease].

  Ugeskrift for laeger 20050418

• [Mesalamine in the treatment of Crohn disease?].

  Ugeskrift for laeger 20050411

• Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents.

  Biomaterials 20050401

• Effects of Boswellia serrata in mouse models of chemically induced colitis.

  American journal of physiology. Gastrointestinal and liver physiology 20050401

• Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.

  Journal of clinical gastroenterology 20050401

• Development of Crohn's disease in a patient taking etanercept.

  The Journal of rheumatology 20050401

• Desensitization treatment of an aspirin- and mesalamine-sensitive patient with Crohn's disease.

  Inflammatory bowel diseases 20050401

• Inflammatory bowel disease.

  Australian family physician 20050401

• Acute interstitial nephritis due to mesalazine.

  Nephrology (Carlton, Vic.) 20050401

• Adherence to treatment in inflammatory bowel disease.

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20050401

• [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].

  MMW Fortschritte der Medizin 20050331

• [Patients with inflammatory bowel disease in specialist gastroenterology practice: a prospective survey].

  Praxis 20050323

• [Mesalazine is effective in Crohn disease 1].

  Ugeskrift for laeger 20050314

• [Mesalazine is effective in Crohn disease 2].

  Ugeskrift for laeger 20050314

• Protective effect of Radix Acanthopanacis Senticosi capsule on colon of rat depression model.

  World journal of gastroenterology 20050307

• Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.

  Inflammatory bowel diseases 20050301

• Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.

  The Mount Sinai journal of medicine, New York 20050301

• Medical and surgical management of chronic ulcerative colitis.

  Archives of surgery (Chicago, Ill. : 1960) 20050301

• Inhibition of Clostridium difficile toxin A-induced colitis in rats by APAZA.

  Digestive diseases and sciences 20050301

• Efficacy of mesalazine in the treatment of symptomatic diverticular disease.

  Digestive diseases and sciences 20050301

• Occult inflammatory small-bowel disease: not so occult anymore.

  Scandinavian journal of gastroenterology 20050301

• 5-ASA therapy and renal function in inflammatory bowel disease.

  The American journal of gastroenterology 20050201

• Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland.

  European journal of gastroenterology & hepatology 20050201

• Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20050201

• Cytomegalovirus infection in a patient with Crohn's ileocolitis.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20050201

• Dose escalation of 5ASA: does it work?

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050201

• Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050201

• The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20050201

• Validation of the treatment satisfaction questionnaire for Crohn's disease (TSQ-C).

  Digestive diseases and sciences 20050201

• Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.

  The Cochrane database of systematic reviews 20050125

• 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.

  World journal of gastroenterology 20050121

• Mucocele of the appendix: an unusual cause of lower abdominal pain in a patient with ulcerative colitis. A case report and review of literature.

  World journal of gastroenterology 20050121

• [Mesalazine is without clinical effect in patients with Crohn disease].

  Ugeskrift for laeger 20050117

• Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase.

  The Biochemical journal 20050115

• Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.

  Biochemical pharmacology 20050115

• [S3 guideline by the German Society of Digestive and Metabolic Diseases and the Competence Network of Chronic Inflammatory Bowel diseases on diagnosis and therapy of ulcerative colitis. An update].

  Medizinische Klinik (Munich, Germany : 1983) 20050115

• A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis.

  Alimentary pharmacology & therapeutics 20050115

• Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease.

  Advanced drug delivery reviews 20050106

• Mesalamine delivery systems: do they really make much difference?

  Advanced drug delivery reviews 20050106

• Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide.

  Advanced drug delivery reviews 20050106

• The spectrum of segmental colitis associated with diverticulosis.

  International journal of colorectal disease 20050101

• Properties of hot-melt extruded tablet formulations for the colonic delivery of 5-aminosalicylic acid.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20050101

• Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20050101

• Is mesalazine really safe for use in breastfeeding mothers?

  Gut 20050101

• Mesalamine in the treatment of active Crohn's disease.

  Gastroenterology 20050101

• 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

  Gastroenterology 20050101

• Ulcerative colitis activity index: a useful prognostic factor for predicting ulcerative colitis outcome.

  The Journal of international medical research 20050101

• Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.

  BMC gastroenterology 20050101

• Looking in the rear view mirror at Pentasa in active Crohn's disease: results may be smaller than they first appear.

  Inflammatory bowel diseases 20050101

• Mesalazine for diverticular disease of the colon--a new role for an old drug.

  Expert opinion on pharmacotherapy 20050101

• Therapy of mild to moderate luminal Crohn's disease.

  Digestion 20050101

• Treatment of postoperative Crohn's disease.

  Digestion 20050101

• Pregnancy and Crohn's disease.

  Digestion 20050101

• Elaboration and 'in vitro' characterization of 5-ASA beads.

  Drug development and industrial pharmacy 20050101

• Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.

  In vivo (Athens, Greece) 20050101

• Pharmacokinetics and pilot efficacy of a mesalazine rectal gel in distal ulcerative colitis.

  Drugs in R&D 20050101

• Metastatic Crohn's disease mimicking genital pyoderma gangrenosum in an HIV patient.

  Acta dermato-venereologica 20050101

• Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands.

  BMC cancer 20050101

• Littoral cell angioma of the spleen treated by laparoscopic splenectomy.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20050101

• Safety of balsalazide therapy in the treatment of inflammatory bowel disease.

  Reviews in gastroenterological disorders 20050101

• Rhinosinusitis derived Staphylococcal enterotoxin B possibly associates with pathogenesis of ulcerative colitis.

  BMC gastroenterology 20050101

• Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.

  BMC gastroenterology 20050101

• How important is onset of action in ulcerative colitis therapy?

  Drugs 20050101

• [Therapy of Lesniowski-Crohn disease of the upper part of the gastrointestinal tract].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20050101

• Absence of autoantibodies against correctly folded recombinant fibrillin-1 protein in systemic sclerosis patients.

  Arthritis research & therapy 20050101

• The relation between swelling properties and cross-linking of hydrogels designed for colon-specific drug delivery.

  Drug delivery 20050101

• Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India.

  BMC gastroenterology 20050101

• A case of cryptogenic organizing pneumonia occurring in Crohn's disease.

  Canadian respiratory journal 20050101

• Synchronous adenocarcinoma and carcinoid tumor of the terminal ileum in a Crohn's disease patient.

  BMC cancer 20050101

• The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.

  BMC medical genetics 20050101

• Ulcerative colitis therapy: importance of delivery mechanisms.

  Reviews in gastroenterological disorders 20050101

• Effects of an experimentally developed adhesive resin system and CO2 laser irradiation on direct pulp capping.

  Operative dentistry 20050101

• [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].

  Gastroenterologia y hepatologia 20041201

• Preventive therapy for complicated diverticular disease of the colon: looking for a correct therapeutic approach.

  Gastroenterology 20041201

• Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.

  Alimentary pharmacology & therapeutics 20041201

• Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20041201

• Skip lesion of the cecum associated with proctitis: an atypical case of ulcerative colitis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20041201

• Crohn's disease over 20 years after diagnosis in a referral population.

  Gastroenterologie clinique et biologique 20041201

• Primary AL-amyloidosis, ulcerative colitis and collagenous colitis in a 57-year-old woman: a case study.

  Scandinavian journal of gastroenterology 20041201

• Colonic diverticular disease.

  Clinical evidence 20041201

• Evaluation of biotransformation of sulphasalazine in the colon epithelial Caco-2 cells.

  Acta poloniae pharmaceutica 20041201

• Ulcerative colitis case beginning during pregnancy in a patient with antiphospholipid antibody syndrome.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20041201

• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

  Gut 20041101

• Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.

  Gut 20041101

• Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

  Medical science monitor : international medical journal of experimental and clinical research 20041101

• Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis.

  Journal of pharmacological sciences 20041101

• Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema.

  Internal medicine (Tokyo, Japan) 20041101

• Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis.

  Inflammatory bowel diseases 20041101

• [Ulcerative colitis and eosinophilic corpus gastritis].

  Orvosi hetilap 20041031

• Determination of impurities in the drug 5-aminosalicylic acid by micellar electrokinetic capillary chromatography using an electrolyte pH that approaches the isoelectric point of the parent compound.

  Journal of chromatography. A 20041022

• Transdermal nicotine for induction of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20041018

• Current concept of pathophysiological understanding and natural course of ulcerative colitis.

  Langenbeck's archives of surgery 20041001

• Ulcerative colitis: conservative management and long-term effects.

  Langenbeck's archives of surgery 20041001

• Review article: the chemoprevention of colorectal carcinoma.

  Alimentary pharmacology & therapeutics 20041001

• Review article: aminosalicylates in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20041001

• Review article: inflammatory bowel disease--empowering the patient and improving outcome.

  Alimentary pharmacology & therapeutics 20041001

• Review article: the management of mild to severe acute ulcerative colitis.

  Alimentary pharmacology & therapeutics 20041001

• Review article: the long-term management of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20041001

• Review article: chronic active disease and maintaining remission in Crohn's disease.

  Alimentary pharmacology & therapeutics 20041001

• Diagnosis and treatment of ulcerative proctitis.

  Journal of clinical gastroenterology 20041001

• Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis.

  Journal of gastroenterology and hepatology 20041001

• [Ulcerative colitis and erythema multiforme].

  Gastroenterologia y hepatologia 20041001

• Salmonellosis and ulcerative colitis. A causal relationship or just a coincidence.

  Saudi medical journal 20041001

• Effect of 5-substituted benzylideneaminosalicylic acid on carrageenan-induced ulcerative colitis.

  Bollettino chimico farmaceutico 20041001

• Identification of 5-aminosalicylic acid, ciprofloxacin and azithromycin by abrasive stripping voltammetry.

  Journal of pharmaceutical and biomedical analysis 20040921

• Endoscopic identification of Peyer's patches of the terminal ileum in a patient with Crohn's disease.

  World journal of gastroenterology 20040915

• Azathioprine formulation optimizes metabolite profile in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20040915

• Biochemical and molecular characterization of a ring fission dioxygenase with the ability to oxidize (substituted) salicylate(s) from Pseudaminobacter salicylatoxidans.

  The Journal of biological chemistry 20040903

• LC-MS/MS and FT-IR analyses of stones from a patient with Crohn's disease: a case report.

  Journal of pharmaceutical and biomedical analysis 20040903

• Inflammatory bowel disease: management issues during pregnancy.

  Archives of gynecology and obstetrics 20040901

• An investigation on the analytical potential of polymerized liposomes bound to lanthanide ions for protein analysis.

  Journal of the American Chemical Society 20040901

• Inhibitory effect of flavonoids on N-acetylation of 5-aminosalicylic acid in cultured rat hepatocytes.

  Biological & pharmaceutical bulletin 20040901

• Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

  Gastroenterology 20040901

• Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.

  Gastroenterology 20040901

• Ulcerative colitis with low-grade dysplasia.

  Gastroenterology 20040901

• Mesalamine in IBD: multiple hats?

  Gastroenterology 20040901

• [Effects of recombinant Helicobacter pylori catalase on oxidative stress in colonic mucosal epithelial cells].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20040901

• [Ulcerative colitis. Acute episode].

  Zeitschrift fur Gastroenterologie 20040901

• [Ulcerative colitis. Complementary therapies].

  Zeitschrift fur Gastroenterologie 20040901

• Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease.

  Inflammatory bowel diseases 20040901

• [Case of ulcerative colitis induced by mesalazine with acute aggravated colitis-like symptoms].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20040901

• Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats.

  Digestive diseases and sciences 20040901

• Drug therapy for ulcerative colitis.

  World journal of gastroenterology 20040815

• Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis.

  The American journal of gastroenterology 20040801

• You're the flight surgeon. Crohn's disease.

  Aviation, space, and environmental medicine 20040801

• Mesalazine-induced reversible infertility in a young male.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040801

• Interstitial lung disease associated with drug therapy.

  British journal of cancer 20040801

• How effective are the usual treatments for Crohn's disease?

  Alimentary pharmacology & therapeutics 20040715

• Degradation of raw or film-incorporated beta-cyclodextrin by enzymes and colonic bacteria.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20040701

• [A case of Crohn's disease with broncho-bronchiolitis].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20040701

• Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.

  Inflammatory bowel diseases 20040701

• Pregnancy and inflammatory bowel disease.

  Current opinion in gastroenterology 20040701

• Therapy of ulcerative colitis.

  Current opinion in gastroenterology 20040701

• [In spite of lacking abdominal complaints. Intestinal disease was diagnosed because of the lips].

  MMW Fortschritte der Medizin 20040617

• Large-artery stroke in a young patient with Crohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia.

  Journal of the neurological sciences 20040615

• Time- and pH-dependent colon-specific drug delivery for orally administered diclofenac sodium and 5-aminosalicylic acid.

  World journal of gastroenterology 20040615

• Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy.

  British journal of cancer 20040614

• [Mesalazine granules instead of tablets. New ulcerative colitis therapy confirmed also in general practice routine].

  MMW Fortschritte der Medizin 20040610

• [Intestinal mucosa as the focal point. In distal ulcerative colitis relief with topical therapy].

  MMW Fortschritte der Medizin 20040603

• [Newcomer in ulcerative colitis: beclomethasone dipropionate: a corticoid with aim: colonic mucosa and colitis].

  MMW Fortschritte der Medizin 20040603

• Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role.

  Helicobacter 20040601

• Susceptibility of Desulfovibrio desulfuricans intestinal strains to sulfasalazine and its biotransformation products.

  Medical science monitor : international medical journal of experimental and clinical research 20040601

• Left-sided ulcerative colitis.

  Gastroenterology clinics of North America 20040601

• Mesalamine derivatives in the treatment of Crohn's disease.

  Gastroenterology clinics of North America 20040601

• A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.

  The American journal of gastroenterology 20040601

• 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.

  Gastroenterology 20040601

• Successful treatment of cap polyposis with infliximab.

  Gastroenterology 20040601

• 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis.

  Journal of gastroenterology 20040601

• Ulcerative colitis that developed 8 years after human parvovirus B19 encephalopathy.

  European journal of pediatrics 20040601

• Colonic diverticular disease.

  Clinical evidence 20040601

• Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.

  Alimentary pharmacology & therapeutics 20040515

• A novel anti-oxidant and anti-cancer strategy: a peptoid anti-inflammatory drug conjugate with SOD mimic activity.

  Biochemical and biophysical research communications 20040514

• Interstitial nephritis from mesalazine: case report and literature review.

  Pediatric nephrology (Berlin, Germany) 20040501

• Germinated barley foodstuff prolongs remission in patients with ulcerative colitis.

  International journal of molecular medicine 20040501

• Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.

  Medical science monitor : international medical journal of experimental and clinical research 20040501

• 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040501

• Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20040501

• Medications as a source of human exposure to phthalates.

  Environmental health perspectives 20040501

• Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.

  The American journal of gastroenterology 20040501

• Anti-Saccharomyces cerevisiae antibody and 5-aminosalicylic acid treatment.

  The American journal of gastroenterology 20040501

• Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.

  Gastroenterology 20040501

• [A case of eosinophilic pneumonia possibly associated with 5-aminosalicylic acid (5-ASA)].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20040501

• [5-aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease?].

  Gastroenterologie clinique et biologique 20040501

• Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis.

  Inflammatory bowel diseases 20040501

• Diverticular disease of the colon.

  Lancet (London, England) 20040424

• Management of inflammatory bowel disease.

  Postgraduate medical journal 20040401

• The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients.

  The American journal of gastroenterology 20040401

• [New research results give hope. Causal therapy of Crohn disease in sight].

  MMW Fortschritte der Medizin 20040401

• [Colon carcinoma. Outlooks of prevention useful].

  MMW Fortschritte der Medizin 20040401

• [Pathophysiology of inflammatory bowel diseases and the therapeutic strategy].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040310

• Seasonal variation in flares of inflammatory bowel disease.

  Gastroenterology 20040301

• Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.

  Clinical and diagnostic laboratory immunology 20040301

• A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis.

  The American journal of gastroenterology 20040301

• [Aspirin--a suitable drug for cancer prevention?].

  Deutsche medizinische Wochenschrift (1946) 20040227

• Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational study.

  Alimentary pharmacology & therapeutics 20040215

• Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.

  British journal of cancer 20040209

• Utilization of aminoaromatic acids by a methanogenic enrichment culture and by a novel Citrobacter freundii strain.

  Archives of microbiology 20040201

• Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts.

  Molecular pharmacology 20040201

• Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

  Gastroenterology 20040201

• Clinical features and management of Crohn's disease in Chinese patients.

  Chinese medical journal 20040201

• Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.

  Alimentary pharmacology & therapeutics 20040201

• Renal impairment in patients with inflammatory bowel disease: association with aminosalicylate therapy?

  Clinical nephrology 20040201

• Long-term intermittent treatment with low-dose 5-aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis.

  Scandinavian journal of gastroenterology 20040201

• Obstructing Crohn's disease of the duodenum: is surgery always mandatory?

  International journal of clinical practice 20040201

• In-vitro and in-vivo evaluation of mesalazine-guar gum matrix tablets for colonic drug delivery.

  Journal of drug targeting 20040201

• Ulcerative proctitis.

  Clinics in colon and rectal surgery 20040201

• Fluorescence spectroscopy studies on 5-aminosalicylic acid and zinc 5-aminosalylicylate interaction with human serum albumin.

  Journal of pharmaceutical and biomedical analysis 20040127

• Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20040115

• Acute diverticulitis of the colon--current medical therapeutic management.

  Expert opinion on pharmacotherapy 20040101

• Mesalazine is safe for the treatment of IBD.

  Gut 20040101

• [Thrombosis of the superior sagittal sinus in an infant: secondary to prolonged exposure to mesalazine?].

  Revista de neurologia 20040101

• Therapeutic equivalence of mesalamine products.

  Reviews in gastroenterological disorders 20040101

• Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays.

  Inflammatory bowel diseases 20040101

• Diagnosis and management of microscopic colitis syndrome.

  Journal of clinical gastroenterology 20040101

• The diagnosis and treatment of pouchitis in inflammatory bowel disease.

  Journal of clinical gastroenterology 20040101

• Maintenance of remission in Crohn's disease: current and emerging therapeutic options.

  Drugs 20040101

• Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?).

  Hepato-gastroenterology 20040101

• You're the flight surgeon. Ulcerative colitis.

  Aviation, space, and environmental medicine 20040101

• The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.

  Reviews in gastroenterological disorders 20040101

• [Are granulomas necessary for the final diagnosis of Crohn disease?].

  Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 20040101

• Controversies with aminosalicylates in inflammatory bowel disease.

  Reviews in gastroenterological disorders 20040101

• A case of hilar bile duct cancer with intestinal Behçet's disease.

  The Kurume medical journal 20040101

• [Endocrine cells of rectal epithelium in health, in nonspecific ulcerative colitis and irritable colon syndrome in the treatment with prednisolone and salofalk and in the absence of treatment].

  Arkhiv patologii 20040101

• [Association between membranous glomerulonephritis and Crohn's disease].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101

• [The conservative treatment of nonspecific inflammatory bowel diseases].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20040101

• Mesalazine and para-phenylenediamine allergy.

  Contact dermatitis 20040101

• Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis.

  Digestion 20040101

• Metastatic crohn's disease--penile and scrotal involvement.

  Scandinavian journal of urology and nephrology 20040101

• Crohn's disease--when to operate?

  Acta chirurgica Iugoslavica 20040101

• Clostridium difficile toxin assay in psoriatic patients.

  Tropical gastroenterology : official journal of the Digestive Diseases Foundation 20040101

• Ulcerative colitis: Al-Gassim experience.

  Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 20040101

• Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats.

  World journal of gastroenterology 20031215

• Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England.

  European journal of gastroenterology & hepatology 20031201

• Risk of early surgery for Crohn's disease: implications for early treatment strategies.

  The American journal of gastroenterology 20031201

• Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

  The American journal of gastroenterology 20031201

• Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions.

  The Israel Medical Association journal : IMAJ 20031201

• Maintenance therapy for inflammatory bowel disease.

  The American journal of gastroenterology 20031201

• Treatment of inflammatory bowel disease: safety and tolerability issues.

  The American journal of gastroenterology 20031201

• Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature.

  Digestive diseases and sciences 20031201

• Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20031201

• Cyclosporin for severe ulcerative colitis attacks.

  Hepato-gastroenterology 20031201

• [Colitis therapy becomes more acceptable for patients. Rectal foam instead of enema].

  MMW Fortschritte der Medizin 20031120

• Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats.

  World journal of gastroenterology 20031115

• Are drugs a risk factor of post-ERCP pancreatitis?

  Gastrointestinal endoscopy 20031101

• Diagnosis and management of microscopic colitis.

  Canadian family physician Medecin de famille canadien 20031101

• The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production.

  Inflammatory bowel diseases 20031101

• Infliximab-induced lupus in Crohn's disease: a case report.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20031101

• Identification and prediction of promiscuous aggregating inhibitors among known drugs.

  Journal of medicinal chemistry 20031009

• Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.

  Gut 20031001

• Oral budesonide in the management of Crohn's disease.

  The Annals of pharmacotherapy 20031001

• Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.

  The American journal of gastroenterology 20031001

• [A case of ammonium urate urolithiasis with Crohn's disease].

  Hinyokika kiyo. Acta urologica Japonica 20031001

• [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20030925

• Rate and extent of ion-exchange process: the effect of physico-chemical characteristics of salicylate anions.

  Journal of controlled release : official journal of the Controlled Release Society 20030904

• Chemoprevention of colorectal cancer in ulcerative colitis.

  International journal of colorectal disease 20030901

• No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases.

  International journal of colorectal disease 20030901

• Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20030901

• Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20030901

• Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20030901

• Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease.

  Clinical and diagnostic laboratory immunology 20030901

• Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.

  Inflammatory bowel diseases 20030901

• Efficacy of Pentasa tablets for the treatment of inflammatory bowel disease.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20030901

• Eosinophilic pneumonia caused by mesalazine. Report of one case.

  Revista medica de Chile 20030901

• [Successful delivery in case of pregnancy with type 1 diabetes mellitus complicated by ulcerative colitis ].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20030810

• Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation.

  Bone marrow transplantation 20030801

• Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis.

  European journal of gastroenterology & hepatology 20030801

• Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.

  Alimentary pharmacology & therapeutics 20030801

• Composite film-coated tablets intended for colon-specific delivery of 5-aminosalicylic acid: using deesterified pectin.

  Pharmaceutical development and technology 20030801

• Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.

  The American journal of gastroenterology 20030801

• Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine.

  Digestive diseases and sciences 20030801

• Ulcerative colitis and motor neurone disease: causal or coincidental?

  Singapore medical journal 20030801

• Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.

  The New England journal of medicine 20030724

• Epidermal growth factor for ulcerative colitis.

  The New England journal of medicine 20030724

• Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20030715

• Successful use of mesalamine in the treatment of chronic segmental lesion in a case of ischemic colitis.

  Journal of gastroenterology and hepatology 20030701

• Severe gastrointestinal illness associated with olestra ingestion.

  Journal of pediatric gastroenterology and nutrition 20030701

• Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis.

  American journal of ophthalmology 20030701

• Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20030701

• Prevention by intrarectal 5-aminosalicylic acid of N-methylnitrosourea-induced colon cancer in F344 rats.

  Diseases of the colon and rectum 20030701

• Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis.

  Diseases of the colon and rectum 20030701

• Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis.

  The Journal of rheumatology 20030701

• Collagenous colitis associated with Clostridium difficile: a cause effect?

  Digestive diseases and sciences 20030701

• Ulcerative colitis associated with aplastic anemia.

  Digestive diseases and sciences 20030701

• Patient nonadherence to medication in inflammatory bowel disease.

  The American journal of gastroenterology 20030701

• Effect of 5-aminosalicylic acid on radiation-induced micronuclei in mouse bone marrow.

  Mutation research 20030619

• Oral beclometasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicentre randomised study.

  Alimentary pharmacology & therapeutics 20030615

• Review article: diagnosis, monitoring and treatment of distal colitis.

  Alimentary pharmacology & therapeutics 20030601

• Review article: medical treatment of mild to moderately active Crohn's disease.

  Alimentary pharmacology & therapeutics 20030601

• Review article: maintenance treatment of Crohn's disease.

  Alimentary pharmacology & therapeutics 20030601

• Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.

  Alimentary pharmacology & therapeutics 20030601

• Sulphasalazine-induced leucopenia in a patient with renal dysfunction.

  Journal of clinical pharmacy and therapeutics 20030601

• How safe are the safest IBD drugs?

  Gastroenterology 20030601

• [Thrombosis of the superior sagittal sinus in a breast fed infant: secondary to prolonged exposure to mesalazine?].

  Revista de neurologia 20030601

• [A case of acute phase ulcerative colitis like colitis developed by the interferon-beta therapy for chronic hepatitis C].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20030601

• A pilot trial of Saccharomyces boulardii in ulcerative colitis.

  European journal of gastroenterology & hepatology 20030601

• [Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].

  Laryngo- rhino- otologie 20030601

• Colonic diverticular disease.

  Clinical evidence 20030601

• Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa.

  Regulatory peptides 20030515

• Review article: Oral, modified-release mesalazine formulations--proprietary versus generic.

  Alimentary pharmacology & therapeutics 20030515

• [Crohn disease].

  Praxis 20030514

• Which 5-ASA?

  Gut 20030501

• CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease.

  Clinical and experimental immunology 20030501

• Combined scintigraphic and pharmacokinetic investigation of enteric-coated mesalazine micropellets in healthy subjects.

  Alimentary pharmacology & therapeutics 20030501

• Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers.

  Alimentary pharmacology & therapeutics 20030501

• [Absorption and distribution of 5-aminosalicylic acid from its chitosan capsule degraded by colon bacteria-released enzymes in rats].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20030501

• Sensorimotor polyneuropathy with 5-aminosalicylic acid: a case report.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20030501

• Ulcerating proctitis in a patient with congenital neutropenia.

  The American journal of gastroenterology 20030501

• Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20030501

• A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030501

• Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.

  European journal of pharmacology 20030425

• Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis.

  Alimentary pharmacology & therapeutics 20030401

• Bloody diarrhea, fever, and pancytopenia in a patient with active ulcerative colitis.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20030401

• Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.

  Archives of pharmacal research 20030401

• Elevated serum values of procollagen III peptide (PIIIP) in patients with ulcerative colitis who will develop pseudopolyps.

  World journal of gastroenterology 20030315

• 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease.

  European journal of nuclear medicine and molecular imaging 20030301

• Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS).

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20030301

• Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial.

  European journal of clinical investigation 20030301

• Immunomodulators and 'on demand' therapy with infliximab in Crohn's disease: clinical experience with 400 infusions.

  The American journal of gastroenterology 20030301

• Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.

  The American journal of gastroenterology 20030301

• Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells.

  Carcinogenesis 20030301

• [Management of ulcerative colitis].

  Therapeutische Umschau. Revue therapeutique 20030301

• [Treatment of Crohn's disease].

  Therapeutische Umschau. Revue therapeutique 20030301

• The future of IBD treatment.

  Journal of gastroenterology 20030301

• [Pitfalls in the diagnosis of carcinoids in patients treated with aminosalicylates].

  Vnitrni lekarstvi 20030301

• Correlation between circulating soluble ICAM-1 and prednisolone-induced amelioration of ulcerative colitis.

  Scandinavian journal of gastroenterology 20030301

• Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030301

• [Collagenous colitis: macroscopically invisible, but with various treatment options].

  Nederlands tijdschrift voor geneeskunde 20030222

• Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.

  Alimentary pharmacology & therapeutics 20030215

• Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid.

  Journal of controlled release : official journal of the Controlled Release Society 20030214

• Determination of 5-aminosalicylic acid in pharmaceutical formulation by differential pulse voltammetry.

  Journal of pharmaceutical and biomedical analysis 20030205

• Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.

  Gut 20030201

• Noninfectious lung pathology in patients with Crohn's disease.

  The American journal of surgical pathology 20030201

• The mesalamine wars heat up-enter balsalazide.

  Gastroenterology 20030201

• Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation.

  Alimentary pharmacology & therapeutics 20030201

• Clostridium difficile infection--an unusual cause of refractory pouchitis: report of a case.

  Diseases of the colon and rectum 20030201

• Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up.

  The American journal of gastroenterology 20030201

• Strategies in the prevention of post-operative recurrence in Crohn's disease.

  Best practice & research. Clinical gastroenterology 20030201

• Extracorporeal monocyte granulocytapheresis was effective for a patient of erythema nodosum concomitant with ulcerative colitis.

  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20030201

• Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model.

  Journal of controlled release : official journal of the Controlled Release Society 20030117

• Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease.

  Journal of clinical gastroenterology 20030101

• Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20030101

• Rectal tissue, plasma and urine concentrations of mesalazine after single and multiple administrations of 500 mg suppositories to healthy volunteers and ulcerative proctitis patients.

  Alimentary pharmacology & therapeutics 20030101

• Butyrate modulates intestinal epithelial cell-mediated neutrophil migration.

  Clinical and experimental immunology 20030101

• [Treatment of steroid-refractory ulcerative colitis with infliximab].

  Gastroenterologia y hepatologia 20030101

• Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis.

  The American journal of gastroenterology 20030101

• Treatment of ulcerative colitis with balsalazide: response to editorial by Drs. Farrell and Peppercorn and letter to the editor by Dr. Hanauer.

  The American journal of gastroenterology 20030101

• [Acute episode].

  Zeitschrift fur Gastroenterologie 20030101

• [Maintaining a remission].

  Zeitschrift fur Gastroenterologie 20030101

• Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.

  The American journal of medicine 20030101

• Segmental colitis: so what?

  European journal of gastroenterology & hepatology 20030101

• Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy.

  European journal of gastroenterology & hepatology 20030101

• Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.

  Hepato-gastroenterology 20030101

• [Eosinophilic pneumonia caused by mesalazine. Report of one case].

  Revista medica de Chile 20030101

• The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.

  Inflammatory bowel diseases 20030101

• [Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20030101

• Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent.

  Dermatology (Basel, Switzerland) 20030101

• Activation of peroxidase-catalyzed oxidation of aromatic amines with 2-aminothiazole and melamine.

  Biochemistry. Biokhimiia 20030101

• Balsalazide achieved symptomatic remission sooner than mesalamine for ulcerative colitis.

  ACP journal club 20030101

• Pharmaceutical approaches to colon targeted drug delivery systems.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20030101

• A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.

  Hepato-gastroenterology 20030101

• Laparoscopic management of complex Crohn's disease.

  JSLS : Journal of the Society of Laparoendoscopic Surgeons 20030101

• Multiple pulmonary nodules in a patient with Crohn's disease.

  Respiration; international review of thoracic diseases 20030101

• Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20030101

• Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20030101

• The effect of sulphasalazine and its metabolites on the colonic epithelial Caco-2 cells.

  Acta poloniae pharmaceutica 20030101

• Immune thrombocytopenic purpura in patients with ulcerative colitis.

  Journal of gastroenterology 20030101

• Standard treatment of ulcerative colitis.

  Digestive diseases (Basel, Switzerland) 20030101

• [Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency].

  Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20030101

• [Interstitial nephritis associated with mesalazine therapy].

  Duodecim; laaketieteellinen aikakauskirja 20030101

• The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review.

  Reviews in gastroenterological disorders 20030101

• Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis?

  Hepato-gastroenterology 20030101

• [Focal segmental glomerulosclerosis with IgA deposits in a patient with ulcerative colitis].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20030101

• Optimal dosing of 5-aminosalicylic acid: 5 decades of choosing between politicians.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030101

• The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine.

  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030101

• [Ulcerative colitis and Crohn's disease].

  Medicinski arhiv 20030101

• [Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].

  Annali italiani di chirurgia 20030101

• [Surgical options in the treatment of perianal Crohn's disease].

  Annali italiani di chirurgia 20030101

• [Conservative therapy of inflammatory bowel diseases].

  Orvosi hetilap 20021215

• Studies on lactulose formulations for colon-specific drug delivery.

  International journal of pharmaceutics 20021205

• Evolving medical therapies for ulcerative colitis.

  Current gastroenterology reports 20021201

• Is your patient taking the medicine? A simple assay to measure compliance with 5-aminosalicylic acid-containing compounds.

  Alimentary pharmacology & therapeutics 20021201

• Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis.

  The American journal of gastroenterology 20021201

• Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.

  The American journal of gastroenterology 20021201

• [A case of neonatal severe hypereosinophilia associated with mesalazine administered during pregnancy].

  Arerugi = [Allergy] 20021201

• Conventional treatments for ankylosing spondylitis.

  Annals of the rheumatic diseases 20021101

• Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study.

  Alimentary pharmacology & therapeutics 20021101

• Primary chronic interstitial nephritis in Crohn's disease.

  Gastroenterology 20021101

• Bioequivalence testing for locally acting gastrointestinal products: what role for gamma scintigraphy?

  Journal of clinical pharmacology 20021101

• A limited form of Wegener's granulomatosis with bronchiolitis obliterans organizing pneumonitis-like variant in an ulcerative colitis patient.

  Internal medicine (Tokyo, Japan) 20021101

• [Standard therapy of ulcerative colitis. Evidence- and consensus-based recommendations].

  Der Internist 20021101

• RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20021101

• Does length really matter? ... Oral and topical 5-aminosalicylic acid therapy for ulcerative colitis.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20021101

• Autonomic imbalance during the day in patients with inflammatory bowel disease in remission. Evidence from spectral analysis of heart rate variability over 24 hours.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20021101

• Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20021101

• The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production.

  Experimental and molecular pathology 20021001

• Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.

  Gut 20021001

• Which 5-ASA?

  Gut 20021001

• Ulcerative colitis in a patient with Wiskott-Aldrich syndrome.

  Endoscopy 20021001

• Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.

  Alimentary pharmacology & therapeutics 20021001

• Melatonin reduces colon immunological injury in rats by regulating activity of macrophages.

  Acta pharmacologica Sinica 20021001

• Dissociated ROS production and ceramide generation in sulfasalazine-induced cell death in Raw 264.7 cells.

  Journal of leukocyte biology 20021001

• Crohn disease in children.

  The American journal of nursing 20021001

• Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.

  Nephron 20020901

• Review article: biological agents in the treatment of Crohn's disease.

  Alimentary pharmacology & therapeutics 20020901

• Activation of peroxidase-catalyzed oxidation of 3,3',5,5'-tetramethylbenzidine with poly(salicylic acid 5-aminodisulfide).

  Biochemistry. Biokhimiia 20020901

• [Clinical features of Crohn's disease: its diagnosis and treatment].

  Zhonghua nei ke za zhi 20020901

• [Ulcerative colitis].

  Revue medicale de la Suisse romande 20020901

• Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid.

  Inflammatory bowel diseases 20020901

• Efficacy of cyclosporin in severe ulcerative colitis attack.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20020901

• Inflammatory bowel disease.

  The New England journal of medicine 20020808

• The effectiveness of budesonide therapy for Crohn's disease.

  Alimentary pharmacology & therapeutics 20020801

• Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines.

  European journal of pharmacology 20020719

• Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.

  Journal of controlled release : official journal of the Controlled Release Society 20020718

• Systematic review for non-surgical interventions for the management of late radiation proctitis.

  British journal of cancer 20020715

• Review article: treatment of mild to moderate ulcerative colitis and pouchitis.

  Alimentary pharmacology & therapeutics 20020701

• Review article: maintenance of remission in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20020701

• Review article: medical treatment of active Crohn's disease.

  Alimentary pharmacology & therapeutics 20020701

• Ileal Crohn's disease is best treated by surgery.

  Gut 20020701

• An in vitro and in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting.

  Chemical & pharmaceutical bulletin 20020701

• Infliximab improves quality of life in patients with Crohn's disease.

  Inflammatory bowel diseases 20020701

• N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.

  The American journal of gastroenterology 20020701

• Comparison of the electrochemical properties of some colon-specific prodrugs of mesalazine.

  Die Pharmazie 20020701

• Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives.

  Pharmacological research 20020701

• Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020701

• Idiopathic myelofibrosis associated with ulcerative colitis.

  Leukemia & lymphoma 20020701

• Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study.

  Alimentary pharmacology & therapeutics 20020601

• Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?

  The American journal of gastroenterology 20020601

• A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.

  The American journal of gastroenterology 20020601

• Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.

  The American journal of gastroenterology 20020601

• Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis.

  Scandinavian journal of gastroenterology 20020601

• Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20020601

• Formalin instillation for refractory radiation-induced hemorrhagic proctitis.

  Journal of surgical oncology 20020501

• Clinical and histological predictors of response to medical therapy in collagenous colitis.

  The American journal of gastroenterology 20020501

• Distal ulcerative colitis refractory to rectal mesalamine: role of transdermal nicotine versus oral mesalamine.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20020501

• [Pancreatic involvement in inflammatory bowel diseases in children].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20020501

• [Interstitial nephritis induced by mesalazine].

  Nihon Jinzo Gakkai shi 20020501

• [Angioedema in Crohn's disease possibly due to mesalazine].

  Gastroenterologie clinique et biologique 20020501

• Morphologic and morphometric analyses of acetic acid-induced colitis in rats after treatment with enemas from Myracrodruon urundeuva Fr. All. (Aroeira do Sertão).

  Phytotherapy research : PTR 20020501

• Oral desensitization to 5-ASA.

  Allergy 20020401

• Review article: monitoring for drug side-effects in inflammatory bowel disease.

  Alimentary pharmacology & therapeutics 20020401

• Drug-induced liver damage -- a three-year study of patients from one gastroenterological department.

  Medical science monitor : international medical journal of experimental and clinical research 20020401

• Fate of the rectum in patients undergoing total colectomy for Crohn's disease.

  The British journal of surgery 20020401

• Endoscopic therapy for radiation proctitis-induced hemorrhage in patients with prostatic carcinoma using argon plasma coagulator application.

  Surgical endoscopy 20020401

• Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses.

  Journal of veterinary pharmacology and therapeutics 20020401

• Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis.

  The American journal of gastroenterology 20020401

• [Nephrogenic diabetes insipidus secondary to chronic interstitial nephritis associated with mesalazine therapy].

  Revista clinica espanola 20020401

• Regulation of human B cell function by sulfasalazine and its metabolites.

  International immunopharmacology 20020401

• [Acute tubular necrosis with acute renal failure during the first month of treatment with 5-amino-salicylate (Pentasa(R))].

  Gastroenterologie clinique et biologique 20020401

• [Patients need no longer plan meals. Colitis therapy is simplified].

  MMW Fortschritte der Medizin 20020328

• Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein.

  British journal of cancer 20020318

• [Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital].

  Medizinische Klinik (Munich, Germany : 1983) 20020315

• Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease.

  Inflammatory bowel diseases 20020301

• New developments in the treatment of inflammatory bowel disease.

  Expert opinion on investigational drugs 20020301

• Constrictive pericarditis in chronic ulcerative colitis.

  Journal of clinical gastroenterology 20020301

• A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis.

  Alimentary pharmacology & therapeutics 20020301

• Possible mesalamine-induced pericarditis: case report and literature review.

  Pharmacotherapy 20020301

• Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.

  Digestive diseases and sciences 20020301

• Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.

  The American journal of gastroenterology 20020301

• Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1).

  European journal of gastroenterology & hepatology 20020301

• Intrarectal administration of 5-aminosalicylic acid to rabbits and dogs.

  Human & experimental toxicology 20020301

• [Mesalazine in ulcerative colitis. Fewer cases of colorectal carcinoma].

  MMW Fortschritte der Medizin 20020227

• An analysis of 10218 ulcerative colitis cases in China.

  World journal of gastroenterology 20020215

• Comparative absorption of 5-aminosalicylic acid (5-ASA) after administration of a 5-ASA enema and salazosulfapyridine (SASP) after an SASP suppository in Japanese volunteers.

  Biological & pharmaceutical bulletin 20020201

• Lack of evidence for fibrosing colonopathy by 5-ASA in humans.

  Digestive diseases and sciences 20020201

• Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.

  Japanese journal of cancer research : Gann 20020201

• Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study.

  Alimentary pharmacology & therapeutics 20020201

• Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis.

  Alimentary pharmacology & therapeutics 20020201

• Baboon syndrome from 5-aminosalicylic acid.

  Contact dermatitis 20020201

• [Acute pleuropericarditis in a patient with Crohn's disease controlled with chronic therapy with mesalazine].

  Revista clinica espanola 20020201

• Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.

  Journal of pediatric gastroenterology and nutrition 20020101

• In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20020101

• Balsalazide disodium.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020101

• Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children.

  The Journal of pediatrics 20020101

• Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis.

  Inflammatory bowel diseases 20020101

• The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review.

  Alimentary pharmacology & therapeutics 20020101

• A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis.

  Alimentary pharmacology & therapeutics 20020101

• A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis.

  Alimentary pharmacology & therapeutics 20020101

• Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease.

  Alimentary pharmacology & therapeutics 20020101

• Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies.

  Alimentary pharmacology & therapeutics 20020101

• A case of Behçet's disease accompanied by colitis with longitudinal ulcers and granuloma.

  Journal of gastroenterology and hepatology 20020101

• [Interferon status of patients with non-specific ulcerous colitis and its correction with interferon inducers].

  Terapevticheskii arkhiv 20020101

• Inflammatory bowel disease in mother or father and neonatal outcome.

  Acta paediatrica (Oslo, Norway : 1992) 20020101

• Colonic tuberculosis mimicking Crohn's disease: case report.

  BMC gastroenterology 20020101

• [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].

  Gastroenterologia y hepatologia 20020101

• Treatment of inflammatory bowel disease in the elderly: an update.

  Drugs & aging 20020101

• Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis.

  Drugs 20020101

• Comparative tolerability of therapies for ulcerative colitis.

  Drug safety 20020101

• Effects of chronic inflammatory bowel diseases on left ventricular structure and function: a study protocol.

  BMC public health 20020101

• New drugs 2002, part 1.

  Nursing 20020101

• [Crohn's disease and renal amyloidosis. Acute renal failure].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20020101

• Budesonide (Entocort EC Capsules): a review of its therapeutic use in the management of active Crohn's disease in adults.

  Drugs 20020101

• On the antioxidant properties of therapeutic drugs: quenching of singlet molecular oxygen by aminosalicylic acids.

  Redox report : communications in free radical research 20020101

• Topical treatment of pyoderma gangraenosum.

  Dermatology (Basel, Switzerland) 20020101

• Blockade of NF-kappaB activation and donation of nitric oxide: new treatment options in inflammatory bowel disease?

  Scandinavian journal of gastroenterology. Supplement 20020101

• Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.

  Scandinavian journal of gastroenterology. Supplement 20020101

• Malignancies in inflammatory bowel disease: fact or fiction?

  Scandinavian journal of gastroenterology. Supplement 20020101

• Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.

  Clinical and experimental rheumatology 20020101

• Therapy of spondylarthropathy in inflammatory bowel disease.

  Clinical and experimental rheumatology 20020101

• Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?

  Reviews in gastroenterological disorders 20020101

• [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report].

  Nephrologie 20020101

• Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

  The Cochrane database of systematic reviews 20020101

• The role of aminosalicylates in the treatment of ulcerative colitis.

  Acta gastro-enterologica Belgica 20020101

• [Crohn's disease in children].

  Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20020101

• Search of antimicrobial activity of selected non-antibiotic drugs.

  Acta poloniae pharmaceutica 20020101

• Alteration in aromatic hydroxylation and lipid oxidation status in the lungs of rats exposed to ozone.

  Toxicology mechanisms and methods 20020101

• Voltammetric studies of 2-hydroxy-5-[(4-sulfophenyl)azo]benzoic acid as a novel prodrug of 5-aminosalicylic acid.

  Journal of pharmaceutical and biomedical analysis 20011201

• Evolving medical therapies for ulcerative colitis.

  Current gastroenterology reports 20011201

• Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.

  Gut 20011201

• Mesalazine-induced pustular drug eruption.

  Journal of the American Academy of Dermatology 20011201

• Effective use of argon plasma coagulation in the treatment of severe radiation proctitis.

  Diseases of the colon and rectum 20011201

• Aminosalicylate as prophylaxis for Crohn's disease.

  Gut 20011201

• An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.

  The American journal of gastroenterology 20011201

• Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.

  The American journal of gastroenterology 20011201

• Mesalazine for ulcerative colitis complicated with diabetic nephropathy.

  Journal of gastroenterology 20011201

• Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs.

  The Journal of pharmacy and pharmacology 20011201

• [Is the lung a target organ in inflammatory bowel disease?].

  Recenti progressi in medicina 20011201

• Synthesis and characterization of methacrylic derivatives of 5-amino salicylic acid with pH-sensitive swelling properties.

  AAPS PharmSciTech 20011201

• Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer.

  International journal of radiation oncology, biology, physics 20011101

• Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.

  Gut 20011101

• Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.

  The Mount Sinai journal of medicine, New York 20011101

• Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.

  The Mount Sinai journal of medicine, New York 20011101

• Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.

  European journal of gastroenterology & hepatology 20011101

• Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid.

  Journal of pharmaceutical sciences 20011101

• Oro-facial granulomatosis: a laryngeal presentation.

  The Journal of laryngology and otology 20011101

• Systemic hypersensitivity reaction to mesacol.

  The Journal of the Association of Physicians of India 20011101

• Kinetic phenotypic diagnosis of N-acetylation polymorphism in patients based on ratio of urinary metabolites of salicylazosulfapyridine.

  International journal of pharmaceutics 20011023

• [A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].

  Lakartidningen 20011003

• Mesalamine induces manganese superoxide dismutase in rat intestinal epithelial cell lines and in vivo.

  American journal of physiology. Gastrointestinal and liver physiology 20011001

• Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study.

  Gut 20011001

• Review article: balsalazide therapy in ulcerative colitis.

  Alimentary pharmacology & therapeutics 20011001

• Recent advances in the treatment of the seronegative spondyloarthropathies.

  Current rheumatology reports 20011001

• Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug.

  Leukemia 20011001

• Isotretinoin-induced inflammatory bowel disease in an adolescent.

  The Annals of pharmacotherapy 20011001

• Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial.

  Digestive diseases and sciences 20011001

• Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.

  The American journal of gastroenterology 20011001

• Cardiomyopathy and pericardial tamponade in ulcerative colitis.

  European journal of gastroenterology & hepatology 20011001

• Managing the glucocorticoid dependent inflammatory bowel disease patient.

  Seminars in gastrointestinal disease 20011001

• Management of inflammatory bowel disease during pregnancy and nursing.

  Seminars in gastrointestinal disease 20011001

• Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.

  Seminars in gastrointestinal disease 20011001

• Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20011001

• 5-Aminosalicylate stimulates phospholipase D activity in macrophages.

  Biochimica et biophysica acta 20010928

• Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial.

  Lancet (London, England) 20010922

• [Conservative therapy of severe ulcerative colitis. More effective than internists believe!].

  MMW Fortschritte der Medizin 20010913

• NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines.

  American journal of physiology. Gastrointestinal and liver physiology 20010901

• Drug points: Hypersensitivity reaction to balsalazide.

  BMJ (Clinical research ed.) 20010901

• Review article: current therapeutic options for radiation proctopathy.

  Alimentary pharmacology & therapeutics 20010901

• [Generalized pustulous psoriasis: A novel extraintestinal manifestation of Crohn's disease?].

  Zeitschrift fur Gastroenterologie 20010901

• The hair of the dog.

  The American journal of gastroenterology 20010901

• Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis.

  Internal medicine (Tokyo, Japan) 20010901

• Headache during mesalamine therapy: a case report of mesalamine-induced pseudotumor cerebri.

  Journal of pediatric gastroenterology and nutrition 20010901

• [Collagenous colitis. A study of 11 cases].

  Annales de medecine interne 20010901

• Ulcerative colitis after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

  Bone marrow transplantation 20010901

• Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999.

  European journal of clinical pharmacology 20010901

• [Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].

  Gastroenterologie clinique et biologique 20010901

• Ulcerative colitis in Thailand: a clinical study and long term follow-up.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20010901

• Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.

  Journal of medicinal chemistry 20010830

• Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.

  Alimentary pharmacology & therapeutics 20010801

• Glucocorticoids and IL-10, but not 6-MP, 5-ASA or sulfasalazine block endothelial expression of MAdCAM-1: implications for inflammatory bowel disease therapy.

  Alimentary pharmacology & therapeutics 20010801

• [Metastatic Crohn's disease in childhood].

  Anales espanoles de pediatria 20010801

• Adult fibrosing colonopathy associated with mesalazine treatment.

  The American journal of gastroenterology 20010801

• Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease.

  The American journal of gastroenterology 20010801

• The expression of IL-12 p40 and its homologue, Epstein-Barr virus-induced gene 3, in inflammatory bowel disease.

  Inflammatory bowel diseases 20010801

• Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.

  Inflammatory bowel diseases 20010801

• Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis.

  Inflammatory bowel diseases 20010801

• Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression.

  Immunology 20010801

• [The new experimental ulcerative colitis model in rats induced by subserosal injection of acetic acid].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010801

• [Mesalazine-induced nephropathy].

  Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 20010801

• Oral balsalazide (Colazal) for ulcerative colitis.

  The Medical letter on drugs and therapeutics 20010723

• Mesalamine-induced unilateral eosinophilic pneumonia.

  AJR. American journal of roentgenology 20010701

• Comparison of 5-amino salicylic acid plus glucocorticosteroid with metronidazole and ciprofloxacin in patients with active ulcerative colitis.

  Journal of clinical gastroenterology 20010701

• Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20010701

• Recurrent atypical myxoid fibroepithelial polyp associated with vulvar Crohn's disease.

  International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 20010701

• 5-amino-salicylate in the management of inflammatory bowel disease.

  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20010701

• In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.

  European journal of pharmacology 20010622

• Sonoelectrochemically enhanced determination of 5-aminosalicylic acid.

  Talanta 20010621

• Diversion colitis in children with colovaginoplasty.

  BJU international 20010601

• Probiotics (Br J Surg 2001; 88: 161-2).

  The British journal of surgery 20010601

• Lacrimal gland inflammation as the presenting sign of Crohn's disease.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20010601

• Azo-containing urethane analogues for colonic drug delivery: synthesis, characterization and in-vitro evaluation.

  The Journal of pharmacy and pharmacology 20010601

• Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20010601

• [A case of successful mesalazine enema for rectal cavitating ulcer of Crohn's disease].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20010601

• Ulcerative colitis associated with interferon treatment for chronic hepatitis C.

  Journal of hepatology 20010601

• Incorporation of salicylic acid derivatives to hydrophilic copolymer systems with biomedical applications.

  Journal of materials science. Materials in medicine 20010601

• [Interstitial nephritis after treatment with mesalazine in the patient with ulcerative colitis].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010510

• Determination of 5-aminosalicylic acid related impurities by micellar electrokinetic chromatography with an ion-pair reagent.

  Journal of chromatography. A 20010504

• A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20010501

• Conventional treatment of Crohn's disease: objectives and outcomes.

  Inflammatory bowel diseases 20010501

• Familial microscopic colitis.

  Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20010501

• Crohn's disease of the esophagus: clinical features and outcomes.

  Inflammatory bowel diseases 20010501

• Inflammatory bowel disease and pregnancy.

  Inflammatory bowel diseases 20010501

• Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.

  Inflammatory bowel diseases 20010501

• Pyoderma gangrenosum associated with sclerosing cholangitis, type 1 diabetes mellitus and ulcerative colitis.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20010501

• [Hepatotoxicity of medications].

  Presse medicale (Paris, France : 1983) 20010414

• Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.

  Gut 20010401

• Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.

  Gut 20010401

• A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactions.

  Alimentary pharmacology & therapeutics 20010401

• From the Food and Drug Administration.

  JAMA 20010307

• Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use.

  Alimentary pharmacology & therapeutics 20010301

• Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance.

  Alimentary pharmacology & therapeutics 20010301

• Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report.

  Gastroenterology 20010301

• Treatment responses in collagenous colitis.

  The American journal of gastroenterology 20010301

• Lymph folliculitis in ulcerative colitis.

  Scandinavian journal of gastroenterology 20010301

• T-large granular lymphocyte leukemia accompanied by an increase of natural killer cells (CD3-) and associated with ulcerative colitis and autoimmune hepatitis.

  Leukemia & lymphoma 20010301

• Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.

  Alimentary pharmacology & therapeutics 20010201

• A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development.

  International journal of pharmaceutics 20010201

• A novel pH- and time-based multi-unit potential colonic drug delivery system. II. Optimization of multiple response variables.

  International journal of pharmaceutics 20010201

• Interstitial nephritis in patients with inflammatory bowel disease treated with mesalamine.

  Journal of clinical gastroenterology 20010201

• Look out for toxic effects of mesalamines!

  Journal of clinical gastroenterology 20010201

• Infliximab for the treatment of orofacial Crohn's disease.

  Inflammatory bowel diseases 20010201

• [Efficacy of mesalamine enema in the treatment of steroid-resistant or dependent distal ulcerative colitis].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20010201

• [Ulcerative esophagitis and colitis as rare manifestations of Adamantiades-Behcet disease].

  Zeitschrift fur Gastroenterologie 20010201

• Mesalamine maintenance therapy for Crohn's disease.

  Gastroenterology 20010201

• Inflammatory bowel disease.

  Endoscopy 20010201

• Effects of chondroitin sulfate on colitis induced by dextran sulfate sodium in rats.

  Japanese journal of pharmacology 20010201

• [Prognosis and treatment of chronic inflammatory bowel disease].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20010130

• Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

  Annals of internal medicine 20010116

• Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters.

  Alimentary pharmacology & therapeutics 20010101

• Evolving treatment strategies for inflammatory bowel disease.

  Annual review of medicine 20010101

• Can postoperative relapse of Crohn's disease be prevented?

  The American journal of gastroenterology 20010101

• On using the standard gamble to determine utilities for uncertain health states.

  Medical decision making : an international journal of the Society for Medical Decision Making 20010101

• Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases?

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• [Therapy of active Crohn disease with Boswellia serrata extract H 15].

  Zeitschrift fur Gastroenterologie 20010101

• [Guidelines of the DGVS. Acute process. German Society of Digestive and Metabolic Diseases].

  Zeitschrift fur Gastroenterologie 20010101

• [Guidelines of DGVS. Remission. German Society of Digestive and Metabolic Diseases].

  Zeitschrift fur Gastroenterologie 20010101

• Hydroxyl radical adduct of 5-aminosalicylic acid: a potential marker of ozone-induced oxidative stress.

  Biochemistry and cell biology = Biochimie et biologie cellulaire 20010101

• [Hypersensitivity to mesalazine after severe allergic reaction to sulfasalazine].

  Gastroenterologie clinique et biologique 20010101

• 5-Aminosalicylic acid protection against oxidative damage to synaptosomal membranes by alkoxyl radicals in vitro.

  Neurochemical research 20010101

• What can nephrologists learn from epidemiology?

  Journal of nephrology 20010101

• Tolerability of aminosalicylates in inflammatory bowel disease.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20010101

• TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide.

  BMC gastroenterology 20010101

• 5-Aminosalicylates in inflammatory bowel disease: choosing the right dose.

  Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20010101

• Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

  BMC gastroenterology 20010101

• [Therapeutic principles for chronic inflammatory bowel disease].

  Ugeskrift for laeger 20010101

• Pharmacokinetic considerations in the treatment of inflammatory bowel disease.

  Clinical pharmacokinetics 20010101

• Early bronchopulmonary involvement in Crohn disease: a case report.

  BMC gastroenterology 20010101

• Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study.

  Advances in therapy 20010101

• Eudragit FS 30 D: a new pH-sensitive polymer covering for mesalamine.

  European review for medical and pharmacological sciences 20010101

• [Drug therapy of Crohn disease].

  Duodecim; laaketieteellinen aikakauskirja 20010101

• [Can the postoperative relapse of Crohn disease be influenced?].

  Duodecim; laaketieteellinen aikakauskirja 20010101

• Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.

  Inflammatory bowel diseases 20001101

• Pyelonephritis caused by mesalazine.

  Nephron 20001001

• [Early renal failure caused by mesalazine].

  Vnitrni lekarstvi 20001001

• Mesalamine-induced chest pain: a case report.

  The Canadian journal of cardiology 20000501

• Interstitial nephritis in children with Crohn's disease.

  Clinical pediatrics 20000401

• Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.

  The Journal of rheumatology 20000301

• Mesalamine-induced granulomatous hepatitis.

  The American journal of gastroenterology 19990701

• [A case of ulcerative colitis with folate deficient megaloblastic anemia induced by sulfasalazine].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 19990701

• [Acute myocarditis due to mesalazine in a patient with ulcerative colitis].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 19990501

• Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.

  Clinical cancer research : an official journal of the American Association for Cancer Research 19990401

• Pericarditis associated with longstanding mesalazine administration in a patient.

  International journal of cardiology 19990227

• Chronic interstitial nephritis due to 5-aminosalicylic acid.

  American journal of nephrology 19990101

• Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.

  Alimentary pharmacology & therapeutics 19981201

• Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.

  International journal of hematology 19981201

• Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.

  Arzneimittel-Forschung 19981001

• Late onset interstitial nephritis associated with mesalazine treatment.

  BMJ (Clinical research ed.) 19980919

• Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.

  Journal of pediatric gastroenterology and nutrition 19980901

• Renal dysfunction and the treatment of inflammatory bowel disease (IBD): a case for monitoring.

  Australian and New Zealand journal of medicine 19980601

• Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.

  Clinical nephrology 19980401

• Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

  The Journal of clinical investigation 19980301

• Severe symptomatic sinus bradycardia associated with mesalamine use.

  The American journal of gastroenterology 19980301

• Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine.

  Nephron 19980101

• [Nephropathy and 5-aminosalicylic acid].

  Gastroenterologie clinique et biologique 19980101

• [Chronic interstitial nephritis and mesalazine: 3 new cases?].

  Gastroenterologie clinique et biologique 19980101

• [Chronic renal insufficiency (interstitial nephritis) under mesalazine].

  Gastroenterologie clinique et biologique 19980101

• Mesalazine activation of eosinophil.

  Lancet (London, England) 19971011

• Mesalazine-associated interstitial nephritis: twice in the same patient.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19970901

• Cholestasis associated with mesalazine therapy in a patient with Crohn's disease.

  Journal of hepatology 19970201

• 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease.

  Digestion 19970101

• Minimal-change nephropathy induced by 5-aminosalicylic acid.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19960601

• Mesalazine-associated interstitial nephritis.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 19960401

• Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.

  European journal of gastroenterology & hepatology 19950801

• 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.

  The Journal of pharmacology and experimental therapeutics 19950101

• [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].

  Nederlands tijdschrift voor geneeskunde 19941217

• Fever, vasculitic rash, arthritis, pericarditis, and pericardial effusion after mesalazine.

  BMJ (Clinical research ed.) 19940108

• [Recurrent pericarditis induced by mesalazine (5-ASA)].

  Therapie 19940101

• Bacterial metabolism of 5-aminosalicylic acid: enzymic conversion to L-malate, pyruvate and ammonia.

  Journal of general microbiology 19930501

• The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model.

  British journal of cancer 19921101

• Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.

  Gut 19920401

• Kawasaki-like syndrome after treatment with mesalazine.

  The American journal of gastroenterology 19910201

• Acute interstitial nephritis due to 5-aminosalicylic acid.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 19901115

• Inhibition of stress-induced gastric ulcers by sulphasalazine and its constituents (sulphapyridine and 5-aminosalicylic acid) in rats.

  Pharmacology 19900101

• Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.

  European journal of pharmacology 19891010

• Nephrotic syndrome after treatment with 5-aminosalicylic acid.

  British medical journal (Clinical research ed.) 19880521

• Adverse reactions to sulphasalazine and 5-amino salicylic acid in the same patient.

  Alimentary pharmacology & therapeutics 19870601

• The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat.

  Pathology 19821001

• Comparative nephrotoxicity of aspirin and phenacetin derivatives.

  British medical journal 19711127